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Abstract
The cause of human essential hypertension is not known, but it is 
characterised by increased vascular smooth muscle (VSM) 
contractility. Similar changes are present in rodent models of 
genetic hypertension, which have been extensively studied in order 
to elucidate their pathogenetic mechanisms. The work of this thesis 
has utilised two such models, namely the spontaneously 
hypertensive rat (SHR) and the Milan hypertensive strain (MHS).
, Altered regulation of adenylyl cyclase, the enzyme which produces 
the second messenger and vasodilator, adenosine 3 ’,S'-cyclic 
monophosphate (cAMP), has been reported in SHR vascular tissues; 
however, the roles of its guanine nucleotide regulatory proteins, 
G-proteins, (stimulatory, Gs, and inhibitory, Gj) in this abnormality 
have not been examined in detail. The regulation of adenylyl cyclase 
activity (ACA) has not been studied in any tissue from the MHS. 
Hence, it was of interest to investigate the regulation of ACA in 
VSM from the SHR and MHS, and examine the contribution from Gs 
and Gj to any abnormalities found. The pathogenetic mechanisms 
leading to hypertension in the SHR and MHS are probably different, 
and it was also of interest to compare the alterations in the 
regulation of ACA in the two models.
Altered regulation of ACA was shown in VSM from both 
hypertensive models. No significant differences were shown in the 
levels of the various G-protein subunits among SHR, Wistar-Kyoto 
(WKY) and Wistar VSM membranes. The function of Gj was also 
similar in these three strains; however, data suggest that the 
activity of Gs may be decreased in the SHR, and alterations in the 
level/activity of the adenylyl cyclase catalytic subunit may also 
exist in this strain.
The adenylyl cyclase system was studied in VSM from two 
age-groups of MHS rats. Significant reductions in the levels of Gsa 
(4 4  and 42kDa forms), Gj 3a  and the p-subunit were observed in both 
young (prehypertensive) and adult (hypertensive) MHS rats in 
comparison to age-matched controls. The function of Gj was similar 
in MHS and Milan normotensive strain (MNS) membranes from both 
age-groups. As Gj function was unchanged in the presence of a 
substantial reduction in the level of G j 3 a ,  it appears that Gj3 does 
not contribute to the inhibition of adenylyl cyclase in these rat VSM 
membranes, and instead may participate in altered transmembrane 
ion fluxes in the MHS. It was observed that Gs function may also be
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decreased in the MHS, and this may, in part, be explained by reduced 
levels of its a-subunits. Again, as in the SHR, data suggest that 
changes are likely in the level/activity of the catalytic subunit of 
adenylyl cyclase in the MHS.
The stimulatory responses of ACA to isoproterenol in the two 
hypertensive models were contrasting. In adult SHR membranes, a 
decreased response to isoproterenol was observed in comparison to 
controls. Membranes prepared from young MHS rats also exhibited a 
decreased stimulatory response to isoproterenol in comparison to 
, age-matched controls; however, this effect was reversed with age, 
and an increased response to isoproterenol was measured in adult 
MHS membranes. This difference in response to isoproterenol with 
age was paralleled by appropriate alterations in p-adrenergic 
receptor number in the MHS.
It is unlikely that these alterations in isoproterenol response 
(and p-adrenergic receptor number) are primarily responsible for the 
hypertension in MHS rats, as if this were the case, the trend would 
be expected to be reversed, as in the SHR. A more likely explanation 
is that these alterations represent some form of compensatory 
mechanism to the increasing blood pressure and possible increased 
VSM contractility in the MHS. Alterations in isoproterenol response 
may play varying roles in the pathogenesis of hypertension in these 
models, being of primary importance in the SHR, but serving as a 
compensatory relief to increasing blood pressure in the MHS.
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Chapter 1 Introduction
1.1 An introduction to guanine nucleotide regulatory proteins
1.1.1 Historical perspectives
(i) Formulation of second messenger hypothesis
Cellular activity is regulated by the concerted action of various 
.hormones, neurotransmitters and growth factors. These ligands bind 
to  specific receptors which traverse the plasma membrane; 
however, the mechanism by which the binding of a suitable ligand to 
a transmembrane receptor exerts an intracellular effect is unclear 
and is the subject of intense investigation. Data provided in 1957 by 
Rail e t a/, and Sutherland and Rail, led to the formulation of the 
second messenger hypothesis, whereby binding of a hormone 
(prim ary messenger) to specific plasma membrane receptors 
elicited the production of a second messenger, which was 
functionally active and able to control intracellular events. Rail e t  
al. (1 9 5 7 ) studied the relationship of epinephrine and glucagon to 
liver phosphorylase. The concentration of active phosphorylase in 
liver represents a balance between inactivation by liver 
p h o s p h o ry la s e  p h o s p h a ta s e  and r e a c t iv a t io n  by 
dephosphophosphorylase kinase (requires magnesium ions and 
adenosine 5'-triphosphate (ATP)). In cell-free liver homogenates, 
epinephrine and glucagon displace this balance in favour of the 
active phosphorylase. These investigators showed that the response 
of the homogenates to the hormones occurred in two stages. In the 
firs t stage, a particulate fraction of homogenates produced a 
heat-stable factor in the presence of the hormones; in the second 
stage, this factor stimulated the formation of liver phosphorylase in 
supernatant fractions of homogenates in which the hormones 
themselves were inactive. The heat-stable factor was identified as 
being an adenine ribonucleotide and was designated 3',5'-adenosine 
monophosphate (Sutherland and Rail, 1 9 5 7 ). Further research 
identified 3',5'-adenosine monophosphate as a cyclic monophosphate 
which is now termed adenosine 3\5'-cyclic monophosphate (cAMP). 
The enzyme catalysing the production of cAMP from ATP is known as 
adenylyl cyclase.
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(ii) GTP requirement
Rodbell and co-workers (1 97 1 ) provided the first evidence for the 
requirement of guanosine-5f-triphosphate (GTP) in the hormonal 
regulation of adenylyl cyclase. It was observed that GTP enhanced 
the initial rate of basal and glucagon-stimulated adenylyl cyclase 
activity in rat liver plasma membranes, and bound at sites distinct 
from the glucagon binding sites. In addition, isoproterenol (a 
p-adrenoceptor agonist) and a poorly hydrolysable analogue of GTP,
,guanosine 5'-[py-imido]triphosphate (p(NH)ppG), activated frog 
erythrocyte adenylyl cyclase to a level much higher than the sum of 
the activities produced by the catecholamine and the synthetic 
nucleotide tested separately (Schramm and Rodbell, 1975 ). It was 
found that p(NH)ppG was a potent activator of adenylyl cyclase in 
the absence of hormone, and even in the absence of a functional 
hormone receptor. These data suggested that the hormone may be 
required only transiently to facilitate an initial interaction of the 
enzyme with guanylyl nucleotides. The involvement of a guanylyl 
nucleotide binding site was suggested by the persistent activation 
of adenylyl cyclase by p(NH)ppG, which was in contrast to the effect 
of GTP, which produced a transient activation. This guanylyl 
nucleotide binding site was postulated to be capable of binding and 
hydrolysing GTP. Evidence for this was presented by Cassel and 
Selinger (1 9 7 6 ) who noted a 30-70%  increase in GTP hydrolysis in 
turkey erythrocyte membranes in the presence of catecholamines 
and a low concentration of GTP. The elucidation by this group of a 
technique to measure high affinity GTPase activity in membrane 
preparations led to the proposal of a mechanism for the control of 
adenylyl cyclase, whereby the coupling of a stimulatory hormone to 
a specific receptor caused the exchange of guanosine diphosphate 
(GDP) for GTP on a regulatory protein. Transient activation of 
adenylyl cyclase was terminated by hydrolysis of GTP on the 
regulatory protein, as shown by treatm ent of turkey erythrocyte 
membranes with cholera toxin. The toxin caused an enhancement of 
basal and catecholamine-stimulated adenylyl cyclase activities, 
dependent on the presence of GTP, and an inhibition of the 
catecholamine-stimulated guanosinetriphosphatase activity (Cassel 
and Selinger, 1 9 7 7 ). A regulatory protein, which is the site for 
GDP/GTP exchange, was isolated by Pfeuffer (1 9 7 7 ) from pigeon 
erythrocytes and led to the concept that the transduction of
23
information from receptor to effector requires a GTP-binding 
protein.
(iii) Dual regulation of adenvlvl cvclase
The possibility of hormonal inhibition of adenylyl cyclase, in 
addition to receptor-mediated stimulation of the enzyme, was 
discussed by Murad et al. (1962 ). This group observed a decrease in 
the formation of cAMP by heart adenylyl cyclase preparations from a 
number of species in the presence of acetylcholine and related 
compounds. Indeed, in 1975, Rodbell demonstrated inhibitory and 
stimulatory effects of p(NH)ppG on rat fat cells' adenylyl cyclase 
activity. The inhibitory effects of both p(NH)ppG and GTP were 
abolished, and stimulation occurred by increasing the concentration 
of magnesium ions and pH. Hence, it was postulated that adenylyl 
cyclase is under dual control by stimulatory and inhibitory guanine 
nucleotide regulatory proteins (G-proteins), term ed Ns and Nj, 
respectively, by Rodbell (1980 ).
1 .1 .2  Identification of the stimulatory (GO  and inhibitory (GO 
G-proteins
(i) Gs
It was shown by Gill and Meren (1 9 7 8 ) that cholera toxin catalysed 
the transfer of adenosine diphosphate-ribose (ADP-ribose) to a 
number of membrane-bound proteins under circumstances that 
resulted in the activation of adenylyl cyclase in lysed pigeon 
erythrocytes. The most readily modified membrane protein (Mr 
4 2 ,0 0 0 ) was the adenylyl cyclase-associated GTP-binding protein, 
Gs (previously termed Ns), and its modification by toxin was 
stimulated by guanine nucleotides. They observed that, in addition to 
adenylyl cyclase activity increasing in parallel with the addition of 
ADP-ribose to this protein, activity of the enzyme decreased in 
parallel with the subsequent reversal of ADP-ribosylation.
(ii) Gi
Pertussis toxin was shown to  produce a lte ra tio n s  in 
receptor-mediated control of cAMP production. In crude membrane 
preparations from  rat C6 glioma cells, pertussis toxin
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ADP-ribosylated a membrane protein with M r=41 ,000 , and GTP 
activation of membrane adenylyl cyclase was enhanced when 
membranes were incubated with pertussis toxin (Katada and Ui, 
1982 ). These two actions of pertussis toxin were strictly paralleled 
by one another in magnitude. The release of tonic inhibition of 
adenylyl cyclase activity, paralleled by the modification of the 
41kDa protein, thus identified this polypeptide as the putative, but 
previously unidentified, inhibitory G-protein, Gj (previously termed 
Nj), of the adenylyl cyclase cascade.
The fun ction a l e ffe c t of cholera to x in -ca ta ly s ed  
ADP-ribosylation of the Gs a-subunit is to attenuate the ability of 
Gsa to hydrolyse GTP, thus producing an irreversibly activated Gs 
a-subunit, as shown by Birnbaumer et al. (1 9 8 0 ) in rat liver plasma 
membranes. A fter treatm ent with cholera toxin, adenylyl cyclase 
becomes maximally activated and is no longer responsive to  
hormonal stimulation. In contrast, the functional effect of pertussis 
toxin-catalysed ADP-ribosylation of the Gj a-subunit is to prevent 
productive coupling between receptor and G-protein thus, 
receptor-mediated inhibition of adenylyl cyclase is attenuated after 
pretreatment with pertussis toxin. Burns e ta /. (1 9 8 3 ) demonstrated 
that treatm ent of neuroblastoma-glioma (N G 108-15 ) hybrid cells 
with pertussis toxin attenuated receptor-mediated inhibition of 
adenylyl cyclase by inhibiting opiate-stimulated GTPase.
1.1 .3  Purification of G-proteins
Studies of mutants of the S49 lymphoma cell line (see section 1.2.4) 
provided evidence that receptor, Gs, and adenylyl cyclase were 
separate entities. Bourne et al. (1 9 7 5 ) isolated a stable variant 
clone of mouse lymphosarcoma cells which was unresponsive to four 
different stimulators of adenylyl cyclase activity. This clone, eye- , 
was later shown to be deficient in Gs, providing a functional assay 
for the purification of Gs. The effects of p-adrenergic agonists and 
antagonists, characteristic of the wild-type S49 lymphoma cell, 
were reproduced by Ross and Gilman (1 9 7 7 ) in a reconstituted 
system. Membranes of mouse L cells that contain adenylyl cyclase, 
but lack p-adrenergic receptors were solubilised with detergent and 
added to eye- membranes, resulting in the production of a 
catecholamine-sensitive adenylyl cyclase system.
Gs was purified to homogeneity by Northup e t al. (1 9 8 0 ) and 
was shown to reconstitute guanine nucleotide-, fluoride-, and
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hormone-stimulated adenylyl cyclase activity in eye- membranes. 
Purified Gs also recoupled hormonal stimulation of the enzyme in 
the uncoupled variant of S49. Preparations of pure Gs contained 
three polypeptides with approximate molecular weights of 52 ,000 , 
4 5 ,0 0 0  and 35,000Da. The a-subunits, of either 52 or 45kDa, 
corresponded to the guanine nucleotide binding site, as well as the 
substrate for cholera toxin-catalysed ADP-ribosylation (Cassel and 
Pfeuffer, 1978). A p-subunit (35kDa) and also a y-subunit (8kDa) 
were found to be associated with Gs, and other G-proteins, including 
Gi.»
A protein with 4 1 ,0 0 0  and 35,000D a subunits was purified 
from rabbit liver membranes as the predominant substrate for 
pertussis toxin. This dimer restored the inhibitory effects  of 
guanine nucleotides and epinephrine on the adenylyl cyclase activity 
of pertussis toxin-treated human platelet membranes. It was shown 
that the subunits of the dimer dissociated in the presence of guanine 
nucleotide analogues or Al3+, Mg2+, and F“ ions, and that the 41kDa 
subunit had a high affinity binding site for guanine nucleotides. The 
characteristics of Gj-mediated inhibition of adenylyl cyclase have 
been studied in both S49 eye- and wild type membranes. It has been 
suggested that dissociation of Gj is responsible for inhibitory 
regulation of adenylyl cyclase in both S49 eye- and wild type 
membranes. In eye- membranes, a major fraction of the inhibition 
appears to result from the action of the a-subunit of Gj; however, 
the p-subunit appears to mediate inhibition in wild type membranes, 
which contain functional Gs (the p-subunits of Gj and Gs are 
functionally indistinguishable, and such inhibition can be explained 
by reduction of the concentration of the free a-subunit of Gs, as a 
result of its interaction with the p-subunit of Gj (Katada e t a/., 
1984 a,b,c)).
1 .1 .4  Heterogeneity of G-proteins
It has been demonstrated that more than a single pertussis 
toxin-sensitive G-protein exists. Purified preparations of pertussis 
toxin substrates from brain contained more than one polypeptide in 
the range of 39-41 kDa, along with p,y subunits. Subsequently, 
several additional heterotrimeric G-proteins have been identified 
and purified. Measurement of high-affinity guanine nucleotide 
binding in brain suggested that brain might be a rich source of 
GTP-binding proteins. This was confirmed by the purification of a
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novel G-protein, termed "other" G-protein (Go), which comprised 
approximately 1 to 2% of total brain membrane protein. It was thus, 
becoming apparent that the G-protein family was not restricted to 
Gs and Gj, and that additional heterogeneity was evident. The fact 
th a t Go co-purified with Gj from brain, suggested th a t the 
increasing variety of G-proteins might share structural similarities 
(Milligan and Klee, 1985).
1.1.5 Mechanism of G-protein action
Studies on cholera toxin by Cassel and Selinger (1 9 7 7 ) supported the 
view that the guanylyl nucleotide binding component of the adenylyl 
cyclase system plays a dual role. On the one hand, in the presence of 
hormone plus GTP it activates adenylyl cyclase; on the other hand, it 
functions in the hydrolysis of bound GTP and thus terminates the 
activation. Brandt and Ross (1 9 8 6 ) utilised labelled GTP to measure 
the binding and hydrolysis of GTP and the release of GDP. 
Agonist-liganded receptor stimulated both the binding of GTP and 
the release of the GDP product, and both processes were formally 
catalytic with respect to receptor, in th a t several (up to 8) 
molecules of Gs were stimulated per molecule of receptor. An 
investigation involving the functional reconstitution of p-adrenergic  
receptors and Gs in phospholipid vesicles also identified catalytic 
activation of Gs by receptor (under optimal conditions, 5 to 6 
molecules of Gs were activated per receptor) (Pedersen and Ross, 
1 9 8 2 ). A study examining the requirement for Mg2+ ions in the 
receptor activation of adenylyl cyclase postulated th a t the  
mechanism by which Mg2+ ions and receptors facilitate  Gs 
activation involves dissociation of Gsa activated subunits (with  
guanine nucleotide bound to them ) from Gs p,y subunits (with  
receptor and Mg2+ ions bound to them) (Iyengar and Birnbaumer, 
1 9 8 2 ). The dissociated Gsa-GTP is now in an activated state and 
may interact with a specific effector. This activation of Gsa is 
transient, and the bound GTP is hydrolysed to GDP by the a-subunit's 
intrinsic GTPase activity (Rodbell, 1980 ). The GDP-bound form of 
Gsa is now in an inactivated state and re-associates with its p,y 
subunits. Hence, Gs undergoes a cyclical pattern of activation 
followed by a deactivation (Figure 1 .1). This sequence of events 
applies not only to the mechanism of action of Gs, but to all 
G-proteins. Thus, G-proteins mediate a host of diverse signals 
including vision, olfaction, control of cell proliferation, ribosomal
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Figure 1.1 The binding and hydrolysis of GTP in the activation and 
deactivation of G-proteins. G-proteins couple agonist-activated  
receptors to effectors, and as this process is of limited duration, 
the G-protein undergoes a cyclical pattern of activation followed by 
deactivation. This figure is a diagrammatic representation of the 
mechanism of G-protein action, and is reproduced from Milligan 
(1988).
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protein synthesis and cellular regulation by an array of hormones 
and neurotransmitters, by similar activation/deactivation processes 
(Bourne, 1986).
G-proteins can be activated without the requirement for an 
agonist-occupied receptor. Poorly hydrolysable analogues of GTP, 
such as p(NH)ppG and guanosine 5'-[Y-thio]triphosphate (GTPyS), 
cause persistent activation of the G-protein (s till requires 
magnesium). Also, fluoroaluminates (AIF4 -) activate G-proteins if 
GDP is present in the GDP/GTP-binding site of the a-subunit. It was 
suggested that AIF4“ is in contact with the GDP, and since there are 
striking structural similarities between AIF4 - and PO4 3", it was 
proposed that AIF4 - mimics the role of the y-phosphate of GTP. 
Hence, the requirem ent for GDP-dissociation for G-protein  
activation is removed in the presence of AIF4- (Bigay et al., 1985).
Masters e t al. (1 9 8 9 )  took advantage of m utational 
replacements of specific residues in the GTP-binding pocket of the 
21kDa ras proteins (p 2 1 ras) which reduce their GTPase activity to 
produce a variety of G-protein mutants. Mutated a chains of Gs were 
expressed in an as-deficient S49 mouse lymphoma cell line, eye-. A 
mutated as, in which leucine replaced glutamine 227, constitutively 
activated adenylyl cyclase and reduced the GTPase activity of Gs- 
There was a smaller reduction in GTPase activity in another mutant 
in which valine replaced glycine 49. This mutant as was a poor 
activator of adenylyl cyclase, probably due to an impairment of the 
m utant protein's ability to attain the active (GTP-bound) 
conformation. These results suggested that residues near glutamine 
227 and glycine 49 of Gsa participate in the binding and hydrolysis 
of GTP.
There is evidence to suggest that the N-terminus of the 
a-subunit of G-proteins is important for interaction with p,y 
subunits. The functional domains of Gj1a and Goa have been studied 
using proteolysis by trypsin. In the presence of GTPyS, trypsin 
removed a 2kDa peptide from the N-terminus of these proteins. 
Tryptic cleavage did not affect the GTPase activity of the truncated 
molecules nor the apparent Km for GTP. However, removal of the 
2kDa am ino-terminal peptide prevented association of the 
a-subunits with p,y subunits, since the truncated a-subunits were no 
longer substrates for pertussis toxin (the apparent substrate for 
pertussis toxin-catalysed ADP-ribosylation is the apy heterotrimer) 
(Neer et al., 1988).
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1.1.6 Identification of receptor coupled to G-protein
Receptors which function through G-protein activation show an 
absolute requirement for GTP, and the receptor-mediated response 
can be attenuated by pretreatment with either pertussis or cholera 
toxin. A study by De Lean et al. (1 9 8 0 ) of radiolabelled agonist and 
antagonist interactions with the p-adrenergic receptor has revealed 
unique properties of agonist binding which may be indicative of the 
mechanism by which they activate the effector, adenylyl cyclase. It 
,has been shown that, while competition curves for antagonists 
versus radiolabelled antagonists are "steep" with slope factors 
("pseudo Hill coefficients") of 1, competition curves for agonists are 
"shallow" with slope factors less than 1 . The shallow agonist 
competition curves are compatible with at least two states of the 
receptor in the absence of guanine nucleotides, whereas, antagonist 
binding to the same receptor is characterised by a single affinity 
form insensitive to guanine nucleotides. The formation of the high 
affinity state of the agonist-receptor complex is a prerequisite for 
its action. The transition or "shift" from the high to the low affinity 
state  of the agonist-receptor complex, promoted by guanine 
nucleotides, is normally associated w ith an increase in 
agonist-induced adenylyl cyclase catalytic activity. De Lean et al. 
(1 9 8 0 ) studying turkey and frog erythrocyte p-adrenergic receptor 
systems proposed a ternary complex model to explain agonist 
binding to the p-adrenergic receptor. In this model, the reversal of 
the agonist-promoted formation of the high affinity ternary complex 
HRX (H=hormone; R=receptor; X=nucleotide binding site) to the low 
affinity form HR is promoted by guanine nucleotides which interact 
with X and destabilise the HRX complex. The nucleotide-bound 
component X, freed from the ternary complex HRX, interacts with the 
effector, adenylyl cyclase, and results in the activation of the 
latter. This model provides a general scheme for the activation by 
agonists of adenylyl cyclase-coupled receptor systems and can be 
equally applied to inhibition of adenylyl cyclase activity by 
a 2 -adrenergic receptor agonists and also to other systems where 
the effector might be different. Hence, if a receptor's affinity for 
agonist is altered in the presence of guanine nucleotides, then that 
receptor functions through activation of a G-protein.
The C-terminus of the a-subunit of G-proteins has been 
implicated in the interaction with receptor, as pertussis toxin 
catalyses the ADP-ribosylation of a residue close to the extreme
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C-term inus of G ja ,  attenuating productive coupling between  
receptor and G-protein, while keeping intact the ability of Gj to 
dissociate in response to activation by guanine nucleotides (Katada 
e t a/., 1986 ). More evidence for the C-terminus of Ga interacting 
with receptor has come from sequencing of com plem entary  
deoxyribonucleic acid (cDNA). A variant of the S49 mouse lymphoma, 
UNC, is unable to synthesise cAMP in response to stimulation by p- 
adrenergic agonists or by prostaglandin E i ; however, basal and NaF- 
stim ulated activities of adenylyl cyclase are normal, as are 
responses to p(NH)ppG and cholera toxin. There is a normal number of 
p-adrenergic receptors in these variant cell membranes; however, 
the interaction between the hormone-binding and the catalytic  
moieties of the adenylyl cyclase system is lost (Haga e t al., 197 7 ). 
The cDNAs encoding Gsa in both UNC and wild type S49 cells were 
sequenced and revealed a point mutation in the UNC mutant Gsa, 
replacing an arginine residue with a proline residue, six amino-acids 
from the C-terminus. Hence, a mutation at the C-terminus of Gsa 
resulted in the inability of Gs to in teract with stim ulatory  
receptors (Sullivan e ta /., 1987).
Receptors play a crucial part in the conveyance of information 
from the outside to the inside of a cell. There are several categories 
of cell surface receptors including, growth factor receptors (which 
have an intrinsic tyrosine kinase activity); multisubunit receptors 
(which are ion channels); receptors which function as carrier 
proteins; and receptors which activate G-proteins. Receptors that 
mediate their actions by stimulating G-proteins share structural as 
well as functional similarities (Strader e t al., 1989 ). Hydropathy 
analysis of the primary sequences of these receptors has revealed 
the existence of seven hydrophobic stretches of 2 0 -25  amino acids 
each, which are surrounded by eight hydrophilic regions of variable 
length. The transmembrane topology that has been proposed for the 
p-adrenergic receptor is shown in Figure 1.2. According to this 
model, each of the seven hydrophobic domains of the receptor forms 
a transmembrane a-helix, with the intervening hydrophilic loops 
exposed (a lte rn a te ly ) intracellularly and extracellularly; the  
amino-terminal region is exposed on the extracellular face of the 
membrane and the carboxyl-terminal region on the cytoplasmic face. 
The regions of greatest sequence similarity lie within the putative 
transmembrane helices of the receptors, with the hydrophilic loop 
regions being more divergent. G-protein-linked receptors are 
glycoproteins with heterogeneous glycosylation patterns th a t
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Figure 1.2 Model for the transmembrane topology of the p-adrenergic 
receptor. Horizontal lines represent the limits of the plasma 
membrane of the cell, with the region at the top of the page 
corresponding to the extracellular space and the region at the 
bottom representing the cytoplasm. Thus, according to this model, 
the receptor has seven transmembrane helices, with the amino 
terminus of the protein exposed extracellularly and the carboxyl 
terminus intracellularly. The amino acid residues represented by 
squares could be deleted from the protein without affecting ligand 
binding or protein folding, whereas the deletion of those residues 
shown in circles adversely affected either the folding or binding 
properties of the receptor. The residues shown in bold-faced circles 
are proposed to be involved in interactions with the ligand. The 
regions of the third intracellular loop delineated by the solid stripe 
were determined to be critical for G-protein coupling, whereas the 
region delineated by the broken stripe was required for 
agonist-mediated sequestration (reproduced from Strader e t a/., 
1989).
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contribute to their anomalous migration on polyacrylamide gels. All 
of the receptors whose sequences are known have 1-3 consensus 
sites for N-linked glycosylation near the amino-terminus of the 
protein (Dohlman e t a/., 1 9 8 7 ). The functional significance of 
receptor glycosylation is unclear, but does not appear to be required 
for either ligand binding or functional coupling to G-proteins, 
although it clearly plays a role in the expression of the protein at 
the cell surface and in the trafficking of the receptor through the 
cell.
G-protein-linked receptors must interact with both their 
specific ligand and G-protein, and identifying the domains of a 
receptor responsible for such binding has been the basis of much 
research. Chabre (1 9 8 7 ) proposed that G-proteins are cytoplasmic 
shuttles, localised on the membrane surface like the cytoskeleton. 
They interact transiently with receptors which are intrinsic 
membrane components and with effectors which are essentially 
peripheral. He suggested that their critical interactions are in the 
cytoplasm, not in the membrane; thus, they are more sensitive to the 
membrane surface charge and ionic environment than to the lipid 
milieu. Deletion mutagenesis directed at the sixth hydrophilic 
segment (third intracellular loop) of hamster p-adrenergic receptors 
expressed in mouse L cells, identified this region as being involved 
in receptor-m ediated Gs coupling. In particular, regions of the 
p-adrenergic receptor encompassing amino acids 2 2 2 -2 2 9  and 
2 5 8 -2 7 0 , which are predicted to form amphiphilic helices, were 
suggested to play a role in the agonist-promoted activation of Gs 
(S trader et al., 19 8 7 ). A study of chimeric a 2 -, p 2-adrenergic  
receptors ( a 2 - and P2 -adrenergic receptors have inhibitory and 
stimulatory effects, respectively, on the adenylyl cyclase system) 
showed that the fifth and sixth hydrophobic domains and the third 
intracellular loop were capable of conferring specificity for Gs 
coupling to the P2-adrenergic receptor. It was also observed that the 
seventh hydrophobic domain of the a 2- and P2-adrenergic receptors 
was a major determinant of both agonist and antagonist ligand 
binding specificity, and that several of the first five hydrophobic 
domains may contribute to agonist binding specificity (Kobilka e t  
al., 1988). However, research by O'Dowd et al. (1 9 8 8 ), examining the 
effects of multiple mutations of amino acid sequences in each of the 
cytoplasm ic domains of the human p 2 -adrenergic receptor, 
identified regions comprising amino acid sequences in the 
C-terminal segment of the third intracellular loop and in the
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N-terminal segment of the cytoplasmic tail as being critical 
contributors to formation of the binding site for Gs. Hence, the 
function of the three cytoplasmic loops and cytoplasmic tail 
common to each of the G-protein-coupled receptors has become the 
subject of intense interest and some controversy.
Receptor activation of G-proteins is a catalytic process, but 
unlike conventional enzymes, G-protein-linked receptors do not 
catalyse the formation or cleavage of covalent bonds. Instead, 
Wessling-Resnick e t al. (1987) revealed through kinetic studies, the 
observation of allosterism in the molecular interaction between0
rhodopsin (photon receptor) and transducin. Equilibrium binding 
studies showed that oligomeric assemblies of these molecules 
provided the basis for positive cooperative behaviour, and this 
cooperativity may be widespread in nature concerning other 
G-protein/receptor interactions.
1 .1 .7  Mechanism of G-protein interaction with effector
Adenylyl cyclase exists as multiple molecular species. A t least one 
major form of the enzyme in brain is activated by calmodulin, 
probably directly. Most species are also stimulated directly by a 
diterpene, forskolin, isolated from the roots of the aromatic herb 
Coleus forskohlii. The enzyme appears to be a single polypeptide 
with a molecular weight of approximately 1 50,000D a; it also 
appears to be a glycoprotein. GTPyS and AIF4 - activate Gs (which in 
turn activates adenylyl cyclase) by a similar mechanism involving 
subunit dissociation, and this stimulation of Gs by these agents is 
inhibited by Gpy. Inhibitory activity has been associated with Gja; 
however, in the presence of Gs, the primary source of inhibition is 
the Gj p,y-subunit complex, which doesnot directly inhibit adenylyl 
cyclase, but interacts with and deactivates Gsa (Gilman, 1987). The 
presence of a low concentration of the Gj p,y-subunit complex has 
also been observed to markedly inhibit Ca2+-calm odulin-stimulated  
adenylyl cyclase activity in rat brain membranes, while essentially 
not affecting Gs- or forskolin-stimulated activity. The inhibition 
appeared to be competitive with calmodulin, suggesting that the 
inhibition of calmodulin-stimulated adenylyl cyclase is a result of 
direct interaction of p,y-subunit complexes with calmodulin (Katada 
et a/., 1987).
The a-subunits of Gs and Gj link different sets of hormone 
receptors to stimulation and inhibition, respectively, of the same
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effector enzyme, adenylyl cyclase (Figure 1 .3). Masters et al. (1 98 8 )  
constructed a chimeric a j/a s  cDNA that encoded a polypeptide 
composed of the amino terminal 60% ( 2 1 2  amino acids) of an aj (aj2 ) 
chain and the carboxyl terminal 40% (1 6 0  residues) of as- The cDNA 
was introduced via a retroviral vector into S49 eye- cells, which 
lack endogenous as- Although less than half of the hybrid a -ch a in  
was derived from a s , its ability to  m ediate p-adrenoceptor 
stimulation of adenylyl cyclase matched that of the normal as 
polypeptide expressed from the same retroviral vector in eye- cells, 
indicating th a t carboxyl terminal amino acid sequences of as 
contain the structural features that are required for specificity of 
interactions with adenylyl cyclase, as well as with the hormone 
receptor. There is evidence indicating that the Ga carboxyl-terminus 
composes a part of the receptor-binding site or is a domain which is 
essential for controlling receptor activation of GDP/GTP exchange. 
Based on this evidence, Woon et al. (1 9 8 9 ) substituted the Gsa 
carboxyl terminus with sequences predicted to have significantly 
different secondary structure from Gsa, but which are known to be 
functional at the carboxyl terminus of other Ga-proteins. They
designed a Gs a chim eric construct in which the  last 
38-carboxyl-term inal amino acids were replaced by the last 
36-carboxyl-terminal residues of a Gja protein. When this chimeric 
transcrip t was expressed in COS cells, cAMP levels were
persistently elevated, resulting from a dominant, constitutively  
active Gs-like activity. Kinetic studies suggested that the chimeric 
G-protein may exhibit an enhanced rate of GDP-dissociation,
implying th a t in addition to interacting with receptor, the
C-terminal region of Ga may also play a role in the regulation of 
guanine nucleotide exchange.
A study utilising solubilised turkey erythrocyte membranes 
supports the view that Gs and the catalytic unit of adenylyl cyclase 
are tightly associated and do not come apart during the process of 
enzyme activation by the p-adrenergic receptor (Arad e ta /., 1984). 
These authors proposed that the p-adrenergic receptor activation of 
adenylyl cyclase is by a simple "collision coupling" between the 
receptor and the tight complex of Gs and the catalytic unit of 
adenylyl cyclase. Functional studies with antibodies to the as 
carboxyl-terminal decapeptide by Simonds e t al. (1989b ) suggested 
that the C-terminal region of Gsa is not the site of interaction with 
e ffe c to r . It  was shown th a t these  antibo d ies  could 
immunoprecipitate adenylyl cyclase activity in detergent extracts
3 3
Figure 1.3 Dual control of adenylyl cyclase. Regulation of adenylyl 
cyclase is achieved by both stimulatory and inhibitory receptors. 
These processes are mediated via Gs and Gj, respectively, whose 
heterotrimeric nature is indicated. Participants of this signalling 
system interact via mobile collisions in the plane of the membrane.
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from GTPyS- or fluoride-preactivated bovine brain membranes; thus, 
binding of a$ to effector and carboxyl-terminal antibody was 
mutually compatible.
1 .1 .8 G-protein cloning and sequence homology
Sequence data from purified G-proteins allowed the cloning of 
complementary DNAs that encoded putative G-protein a-subunits. To 
date there are at least nine different classes of a-subunits. Gs and 
,Gj are thought to be expressed ubiquitously, and are responsible for 
the regulation of adenylyl cyclase activity. Four types of as cDNA 
have been cloned that differ in nucleotide sequence in the region 
th a t corresponds to amino acid residues 7 1 -8 8 . SI nuclease 
protection experiments revealed at least two forms of as messenger 
ribonucleic acid (mRNA), and alternative splicing of precursor RNA 
was proposed as the mechanism for generating four species of as 
mRNA (Bray et al., 1986 ). Most cells contain two forms of the 
a-subunit of Gs; their apparent molecular weights being 4 5 ,0 0 0  and 
52,000D a. Two cDNAs that correspond to distinct mRNAs for Gsa 
have been cloned from a bovine adrenal library and sequenced, 
revealing identical sequences except for a single stretch of 46  
nucleotides in the coding region, where four are altered and 42 are 
deleted in the shorter cDNA. Expression of the two cDNAs in COS-m6 
cells yielded protein products with apparent molecular weights of 
45 and 52kDa, and Robishaw et al. (1 9 8 6 ) proposed that the mRNAs 
encoding these proteins arise from a single gene by internal
alternative RNA splicing. Mumby e t al. (1 9 8 6 ) raised antisera
against purified subunits of G-proteins and against synthetic
peptides that correspond to defined regions of G-proteins. Using an 
antiserum which recognises both the 52 and 45kDa forms of Gsa, 
they observed wide variation in the ratios of the 52 and 45kDa 
Gsa-subunits among various tissues tested by immunoblotting. The 
exact relationship of the two forms of this a-subunit remains
unknown. There is evidence that the 45kDa a-subunit of Gs has 
greater functional activity than the 52kDa a-subunit (Walseth et al., 
1 9 89 ). It has been observed that cAMP accumulation in response to 
forskolin, cholera toxin, or isoproterenol is dramatically increased 
in HIT T-15 cells, a clonal cell line of Syrian hamster pancreatic 
islet p cells, as a function of passage number. It was shown that 
although the amounts of the 52kDa form of Gsa and the 40kDa 
pertussis toxin substrate did not change with passage number, the
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level of the 45kDa form of Gsa increased in the later passages. 
Extracts from HIT cell membranes from various passages were 
reconstituted in S49 e y e  membranes, and it was found that 
extracts derived from later passages reconstituted three to four 
times more adenylyl cyclase activity in e y e  membranes than 
extracts from earlier passages. These data suggested that 
functional differences exist between the Gs a-subunits, with the 
smaller 45kDa subunit being more efficacious in coupling to cAMP 
synthesis than the larger 52kDa subunit. However, a study by 
.Graziano et al. (1 9 8 7 ), which involved insertion of cDNAs that 
encode the two forms of Gsa into plasmid vectors for expression in 
Escherichia coli, showed that both forms of Gsa can reconstitute 
isoproterenol-, guanine nucleotide-, and fluoride-stim ulated  
adenylyl cyclase activ ity  in S49 eye- cell membranes to  
approximately the same degree, suggesting that there is no 
functional difference between the two forms of Gsa.
The activity of calcium channels has been examined in 
membrane patches excised from guinea pig cardiac myocytes and 
bovine cardiac sarcolemmal vesicles incorporated into planar lipid 
bilayers (Yatani et al., 1987). It was shown that GTPyS independently 
prolonged the survival of excised calcium channels, as did Gsa 
purified from the plasma membranes of human erythrocytes. Thus, in 
addition to regulating calcium channels indirectly through  
activation of cytoplasmic kinases, G-proteins can regulate calcium 
channels directly.
In addition to  investigating cDNA clones encoding 
Gsa-subunits, Bray e t al. (1 9 8 7 ) obtained two cDNA clones from a 
Xgtl 1 cDNA human brain library that correspond to Gja-subunits. The 
nucleotide sequence of human brain aj is highly homologous to that 
of bovine brain aj, and the predicted amino acid sequences are 
identical. However, it has been noted that human and bovine brain aj 
cDNAs differ significantly from a j cDNAs from human monocytes, 
rat glioma, and mouse macrophages in amino acid ( 8 8 % homology) 
and nucleotide (7 1 -7 5 %  homology) sequences (the  nucleotide 
sequences of the 3' untranslated regions differ markedly). Hence, 
comparison of human brain and human monocyte aj cDNAs suggested 
that the two types of human aj are transcribed from separate genes. 
The nucleotide sequences of aj cDNAs revealed that a j genes are 
subject to strong selective pressure in the coding region and the 5' 
and 3' untranslated regions. Comparison of amino acid sequences 
predicted from aj cDNAs suggest that a jl (from human brain, bovine
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brain and bovine pituitary) and a\Z (from human monocytes, rat C6 
glioma cells and mouse macrophages) proteins may differ in 
function as well as in tissue distribution and abundance.
Studies in vertebrate olfactory tissue have indicated that 
certain smells stimulate adenylyl cyclase in a GTP-dependent 
manner. A rat olfactory cDNA library was screened with an 
oligonucleotide probe and 32 recombinant clones encoding five 
distinct types of G-protein a-subunits were isolated. The majority 
of the clones encoded Gsa, while the remaining clones encoded Goa, 
Gjl a , Gj2a, and a novel species, Gj3a. (To date, three sub-types of Gj 
have been isolated, namely G jl, Gj2 and Gj3, which are all sensitive 
to  ADP-ribosylation by pertussis toxin. Gj2 is universally 
distributed and has been implicated to have functional roles in the 
inhibition o f adenylyl cyclase and in the stim ulation of 
phospholipase C. Gj3 has an undefined distribution, but is thought to 
be expressed universally. There is evidence to suggest that this 
inhibitory G-protein is involved in the regulation of K+ channels. Gjl 
has a limited distribution, but high levels have been observed in 
brain tissue. The function of Gjl is not yet clear (Milligan, 1 9 8 9 ).)  
The predicted protein sequences of each of the rat cDNA clones have 
been aligned. It was found that Gsa is the most divergent, retaining 
approximately 40%  identity with any of the other a-subunits. The 
a-subunits for Go and the Gj-proteins share greater homology; Goa 
shares 73%  identity with Gjl a ,  6 8 % with Gj2a, and 70%  with Gj3a. 
Gj2a shares 8 8 % identity with Gjl a  and 85% identity with Gj3a, 
while Gjl a  and G j3 a a re  the most homologous with only 22 
differences out of 354 residues (94%  identity). The 18-amino acid 
stretch implicated in guanine nucleotide binding (Gsa 4 3 -6 0 )  is 
perfectly conserved in all of the G-proteins, whereas the most 
divergent region among all of the G-proteins occurs between amino 
acid residues 65 and 150. Comparison of each of the predicted 
protein sequences from rat with those from other species indicated 
th a t minimal divergence occurred during speciation. Specifically, 
corresponding Ga-subunits across species share greater than 98%  
identity, whereas different Ga-subunits within a species share only 
4 0 -94%  identity. Thus, protein sequence comparisons have indicated 
th a t individual Ga-subunits are more highly conserved across 
species than are any of the different Ga-subunits within a species 
(Jones and Reed, 1987).
In contrast to the diversity in the number of G-protein 
a-subunits, a similar degree of diversity regarding G-protein
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p-subunits has not been observed. Levine et al. (1 9 9 0 ) screened 
bovine and human retina cDNA libraries and isolated clones encoding 
three distinct types of G-protein p-subunit. p i-, p2- and p3-subunit 
cDNA clones were found to encode 36,000, 3 5 ,0 0 0  and 37,221 Da 
forms of the p-subunit, respectively. The amino acid sequences of 
the three p-subunits are closely related; 83%  identity between p i -  
and p3-subunits and 81%  identity between p2- and p3-subunits. 
However, the 3'-untranslated regions of the three cDNAs show no 
significant homology. The N-terminal region contains the greatest 
/diversity in amino acid sequence and predicted secondary structures 
in the p family of proteins, indicating that this area contains sites 
that confer specificity on the interactions between p proteins and 
a- or y-subunits. The complete amino acid sequence of the y-subunit 
of transducin from cattle retina has been reported (Ovchinnikov e t  
a/., 1985). The polypeptide chain of the y-subunit consists of 69 
amino acid residues, with Mr 8 0 0 8 .7Da.
1.1.9 Regulation of G-protein levels
It is possible that aging may lead to altered expression of 
G-proteins. A study by Green and Johnson (1 9 8 9 ) observed a 3-fold 
increase in the level of Gja, and a 2-fold increase in the level of Gsa 
(43kDa form only), when adipocyte membranes from young (2-month) 
and older (18-month) rats were compared. The levels of Goa, Gja and 
the p-subunit were quantified in atria and ventricles during 
embryonic chicken cardiac development. Altered G-protein levels 
were noted during organ development, and these changes were shown 
to be associated with changes in G-protein-mediated regulation of 
adenylyl cyclase activity (Luetje et al., 1987). A study by Silbert et 
al. (1 9 9 0 )  implied that protein translation controls may be 
important determinants of G-protein a-subunit concentrations in 
biological membranes. They observed different degradation rates for 
Goa, but similar steady-state protein levels and approximately 
equal mRNA levels in GH4 cells (rat pituitary cell line) and in 
primary rat cardiocytes, suggesting the rate of Goa synthesis was 
different in GH4 cells and cardiocytes.
Adrenal steroid hormones and catecholamines play central 
roles both in maintaining survival in times of stress and in 
regulating normal physiological responsiveness. Glucocorticoids 
regulate responsiveness of many different cells and tissues to 
hormones that act by stimulating adenylyl cyclase. Exposure to
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steroid hormones may result in increases in receptor density, 
enhanced coupling, and enhanced adenylyl cyclase activity. If 
reductions in receptor density, coupling and adenylyl cyclase 
activity are induced through desensitisation, steroid hormones may 
act to return the receptor-cyclase system to a more normal state of 
sensitivity (Davies and Lefkowitz, 1984). In a rat pituitary cell line, 
GH3 , exposure to dexamethasone doubled the specific activity of 
adenylyl cyclase in membrane extracts. A 5-fold increase in RNA 
encoding the a-chain of Gs, as well as a 2 -fold increase in 
membrane-bound as-polypeptide, were observed, and may, at least 
in part, contribute to the glucocorticoid-induced enhancement of 
adenylyl cyclase activity in these cells (Chang and Bourne, 1987). 
The results from a study by Saito et al. (1 9 8 9 ) indicate that Gsa and 
Gja are under the coordinated control of glucocorticoids in rat brain, 
and dem onstrate that G-proteins are physiological targets of 
glucocorticoids in vivo. They found that chronic corticosterone 
administration to normal rats and adrenalectomised rats increased 
levels of Gsa immunoreactivity, mRNA, and ADP-ribosylation, but 
decreased levels of Gja mRNA and tended to decrease levels of Gja 
immunoreactivity. In contrast, levels of Goa and the p-subunit 
immunoreactivity and mRNA were not influenced by corticosterone 
tre a tm en t. However, adrenalectomy, w ithout corticosterone  
replacement, produced the opposite effects on Gsa and Gja compared 
to  sham-operated controls, indicating that these G-proteins are 
regulated by this class of steroid hormone under physiological 
conditions in vivo.
The regulation of G-proteins has been examined in 3T3-L1 
cells during d ifferentia tion  from a fib rob last-like  to  an 
adipocyte-like phenotype. Gsa levels and specific activity increased 
by approxim ately 6 -fold and 3 -fo ld , respectively, during 
differentiation. Both Gja and Goa levels increased by approximately 
4-fold over this same period. In addition, the increase in the levels 
of the p-subunits (35  and 36kDa forms) was approximately 2-fold. 
Quantitative immunoblotting identified a decrease in the overall 
ratio of p- to a-subunits of G-proteins, from approximately 4 .7  in 
fibroblasts to 2.5 in adipocytes, suggesting that in differentiation 
not only is the complexion of G-proteins altered, but more 
importantly, the relative amounts of a - to p-subunits are regulated. 
The increase in p-subunits was most pronounced during the early 
part of the time course of differentiation, when the amount of 
Gsa/mg of membrane protein was more or less constant. Thus, the
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change in the ratio of p- to Gsa-subunits was greatest at this time 
and may affect, in a manner opposite to hormone activation, the 
availability of Gsa for GTP binding and adenylyl cyclase activation. 
It seems likely, therefore, that the increasing excess of p-subunits 
in 3T3-L1 cells is responsible for the a tte n u a tio n  of
GTP-stimulated adenylyl cyclase activity (Watkins et al., 198 7 ).
1.2 Abnormalities of G-proteins in disease states 
/1 .2.1 Pseudohypoparathyroidism
Pseudohypoparathyroidism (PHP) is a genetic disorder associated 
with a decreased responsiveness of hormones which function 
through Gs in order to activate adenylyl cyclase (Motulsky e t al., 
1 9 8 2 ). The erythrocytes of patients with PHP Type la have been 
shown to have decreased Gs activity, whereas those of patients with 
PHP Type lb have normal Gs activity. This decreased Gs activity 
(measured by the ability to restore adenylyl cyclase activity to 
membranes prepared from S49 eye" cells) also occurs in the 
platelets of PHP Type la, but not of PHP Type lb patients. Gj activity 
was unaltered in platelets from patients with PHP Type la, as
observed by inhibition of adenylyl cyclase via the a 2-adrenoceptor.
Levine e t al. (1 9 8 8 )  analysed total RNA from cultured  
fibroblasts obtained from PHP Type la patients and observed an 
-5 0 %  reduction in mRNA levels for Gsa, but normal mRNA levels for 
Gja. These investigators were not able to show a clear correlation 
between the extent of reduction of mRNA for Gsa and either the 
extent of reduction of Gs activity in the cells or the clinical 
phenotype. Thus, the relevance of reduced Gs expression to this 
syndrome and the factors controlling Gs expression are far from  
clear.
1.2.2 Chronic ethanol administration
Acute exposure to ethanol leads to the stimulation of adenylyl 
cyclase activity, presumably due to its effects on increasing lipid 
fluidity (Whetton et al., 1983). However, chronic exposure to ethanol 
attenuates adenylyl cyclase activity, as determined both in cell 
systems and in lymphocytes and platelets from alcoholic subjects. 
Part of this inhibitory e ffec t may be due to the membrane 
lipid-mediated adaptive response to chronic ethanol administration.
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This leads to increased levels of cholesterol incorporation into 
membranes, a lipid whose elevation in biological membranes can 
lead to the attenuation of adenylyl cyclase activity. However, it is 
clear that such a lipid-mediated e ffect cannot account for the 
magnitude of the diminished receptor-coupled adenylyl cyclase 
activity in cells treated chronically with ethanol.
In a study by Mochly-Rosen and colleagues (1 9 8 8 ), it has been 
shown that chronic treatm ent of a neuroblastoma cell line 
(NG 108-15) with ethanol led to the reduced expression of Gsa. This 
,was monitored by both reconstitution into e y e  cells and by using a 
specific anti-peptide antibody. The lesion appeared to be due to 
decreased synthesis of Gsa, rather than enhanced degradation, as the 
mRNA concentrations were also reduced by a comparable amount 
(-30% ).
1.2.3 Growth hormone secreting pituitary adenomas
Secretion from somatotrophic cells is known to be controlled by 
alterations in the intracellular concentration of cAMP. A number of 
human growth hormone (GH)-secreting adenomas have been shown to 
have abnormally high intracellular concentrations of cAMP, and to 
show very high rates of secretion of GH in the absence of 
stimulation by growth hormone releasing hormone (GHRH). Indeed, in 
such cells, GHRH had little e ffec t on both the intracellular 
concentration of cAMP and on the rate of GH secretion.
When the adenylyl cyclase activity of GH-secreting adenomas 
was studied in isolated membranes (Vallar e t al., 1 9 8 7 ), no 
stimulation by GTP or by fluoride was observed. In contrast, 
adenylyl cyclase stimulation by Mg2 + was greatly increased, 
suggesting that either Gs or adenylyl cyclase, in these tumour cells, 
has adopted a highly (fully) activated conformation. It has been 
shown that the lesion is indeed due to the presence of a 
hyper-responsive form of Gs in these cells. Extraction of Gs from 
adenoma cell membranes and its subsequent incorporation into the 
membranes of eye- cells conferred the same hyper-responsiveness 
to  Mg2 + on the adenylyl cyclase of eye* cells. Also, cholera 
tox in -trea tm ent of these adenoma cells, whilst causing the 
ADP-ribosylation of Gsa, did not elicit activation, presumably 
because Gs was already in an active conformation. Such altered Gs 
was not found in all hypersecreting adenomas, but was observed in a 
substantial group. Further work by this group (Landis e t a/., 1989)
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identified somatic mutations that inhibit the GTPase activity of Gsa 
in these tumours. Thus, the resulting activation of adenylyl cyclase 
bypasses the cells' normal requirement for trophic hormone.
1.2.4 S49 lymphoma cell line
A mutant, eye*, derived from this cell line provided the means for 
the first unequivocal demonstration of a G-protein, namely Gs- 
Plasma membranes from e y e  cells offer a useful reconstitution  
system for Gs as the eye* cell line fails to express Gs whilst still 
expressing p-adrenoceptors and adenylyl cyclase (Gilman, 1987 ).
The underlying selection mechanism of mutants of this cell 
line is that elevation of intracellular cAMP levels are cytotoxic to 
these cells. A mutant cell line called UNC has an aberrant Gs which 
although capable of stimulating adenylyl cyclase when activated  
directly, using either NaF or a poorly hydrolysable GTP analogue, 
p(NH)ppG, could not mediate p-adrenoceptor stimulation of this 
enzyme, suggesting a lesion in the domain of Gsa which interacted 
with the p-adrenoceptor (Haga e ta /. ,  1977). Consistent with this 
was the failure to observe guanine nucleotide-mediated effects on 
p-agonist binding to the p-adrenoceptor. Sequence analysis of the 
gene for Gsa from these cells has shown a single point mutation at 
the C-terminal end of this protein, giving credence to the suggestion 
th a t it is the C-terminal end of G-protein a-subunits  which 
interacts with specific receptors.
Another mutant form of S49 cells which shows a lesion in 
G-protein mediated coupling has been identified, namely H21a 
(Bourne e ta /. ,  1982). The adenylyl cyclase of these cells fail not 
only to respond to p-adrenoceptor agonist stimulation, but also to 
activation by ligands which interact with Gs directly, such as NaF, 
poorly hydrolysable GTP analogues and cholera toxin. However, 
guanine nucleotide analogues are capable of modifying p-agonist 
binding, indicating that the form of Gs expressed in these cells is 
capable of coupling to the p-adrenoceptor, but is incapable of 
coupling to adenylyl cyclase. Sequence analysis of the gene for Gsa 
from these cells has identified a single point mutation at residue 
226 , where glycine is replaced by alanine. The region where this 
mutation lies is highly conserved amongst the various G-proteins 
and thus seems an unlikely domain for providing the required 
specificity to direct Gsa to interact with a specific second 
messenger system i.e. adenylyl cyclase. However, it may be that this
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highly conserved domain is responsible for transducing a 
conformational change between the GTP-binding domain and the 
domain, postulated to be at the N-terminal region of Gsa, 
responsible for interacting directly with adenylyl cyclase. 
Experiments using tryptic proteolysis to probe for conformational 
changes induced by guanine nucleotides did show aberrations from 
the normal, indicating that this single mutation can alter the 
GTP-induced conformational changes in Gsa (Miller et a l, 1988).
1.2.5 Adrenalectomy
In the adipocytes of adrenalectomised rats there is an impaired 
lipolytic response to adrenaline (p-adrenoceptor) stimulation (Ros 
e t a/., 1989). Although the number of p-adrenoceptors appears not to 
be reduced by adrenalectomy, and there is no change in the amount of 
adenylyl cyclase, as indicated by forskolin-stimulated adenylyl 
cyclase activity, there appears to be a marked reduction in Gs, as 
determined by the cholera toxin-catalysed ADP-ribosylation of Gsa. 
A comparable reduction in G-protein p-subunit was also noted. 
Adrenalectomy may thus, reduce ligand-stimulated adenylyl cyclase 
activity by attenuating the expression of Gs in adipocytes.
1.2.6 Hypothyroidism
Hypothyroidism can be experimentally induced in rats by treatment 
with 6-propyl-2-thiouracil. In adipocytes from such hypothyroid 
animals, receptors which are linked to the inhibition of adenylyl 
cyclase show an increased responsiveness compared to that noted in 
control animals, suggesting that hypothyroidism might lead to an 
increase in the expression of Gj in adipocytes from these animals. 
Certainly, in rats this would appear to  be the case, as 
hypothyroidism has been shown to lead to an enhanced labelling of 
the 40kDa a-subunit of Gj. Indeed, specific anti-peptide antibodies 
have been used to provide clear evidence of enhanced expression of 
Gja in adipocyte membranes from hypothyroid animals (3-fold  
greater than controls). Such changes in the amount of Gja appeared 
to be paralleled by alterations in p-subunit expression, which may 
indicate some co-ordination in the expression of these two proteins 
(Milligan et al. , 1987).
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1.2 .7  Heart failure
Changes in the intracellular concentration of cAMP are believed to 
play a fundamental role in the contractile response of cardiac 
tissue. Thus, p-adrenergic stim ulation is seen to  prom ote  
c o n tra c tio n , and se lective  inh ib itors of cA M P-specific  
phosphodiesterases have the potential, albeit experimentally, for 
use in treating congestive heart failure. Reduced p-adrenergic 
responsiveness appears to be characteristic of the myocardium in 
/congestive heart failure, and enhanced Gj function may offer one 
contributing factor (Ginsburg et al., 1983 ). Reduced numbers of 
p-adrenergic receptors have been found in tissue obtained from  
failing hearts (Fowler et a/., 1 986 ); however, whether this is 
sufficient to account for the loss of responsiveness is unclear. It 
has been shown that when turkey erythrocyte adenylyl cyclase is 
stim ulated by p-adrenergic receptor agonists then -9 0 %  of 
p-adrenoceptors have to be lost before any significant reduction in 
the ability of p-adrenoceptor agonists to activate adenylyl cyclase 
occurred (Tolkovsky and Levitzki, 1978).
Horn e t al. (1 9 8 8 ) examined the hypothesis stating that Gs, 
which couples the p-adrenergic receptor to adenylyl cyclase 
activity, is also decreased in congestive heart failure. In addition to 
the 40%  decrease in lymphocyte p-adrenergic receptors in patients 
with congestive heart failure, they found an 80% decrease in levels 
of Gs compared with age- and sex-matched healthy control subjects. 
Myocardial Gs levels correlated significantly with lymphocyte Gs 
levels.
1 .2 .8  Diabetes and insulin-resistant states
(i) Animals - chemicallv-induced diabetes
Treatm ent of rats with either streptozotocin or alloxan elicits the 
destruction of the pancreatic p cells which secrete insulin. This 
induces diabetes and also causes insulin-resistance in liver and 
adipose tissues. Such an effect can be reversed by insulin therapy.
In hepatocytes and adipocytes from such diabetic rats there 
appear to be alterations in the levels and/or function of Gj. Levels of 
G j2 a ,  G j3 a  and the 42kDa, but not the 45kDa, form of Gsa were 
markedly decreased in hepatocyte membranes from diabetic animals. 
G-protein p-subunits in plasma membranes were unaffected by
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diabetes induction. Immunoblot analysis showed that levels of the 
catalytic unit of adenylyl cyclase were increased in hepatocyte 
membranes upon induction of diabetes. Under basal conditions, G j2a  
from hepatocytes of diabetic animals was found to be both 
phosphorylated to a greater extent than G j 2 a  isolated from  
hepatocytes of normal animals, and furthermore was resistant to 
any further phosphorylation. Treatm ent of isolated plasma 
membranes from normal, but not diabetic, animals with purified 
protein kinase C caused the phosphorylation of G j2 a .  Treatment of 
membranes from diabetic animals with alkaline phosphatase caused 
the dephosphorylation of G j2a  and rendered it susceptible to 
subsequent phosphorylation with protein kinase C. Low 
concentrations of the poorly hydrolysable GTP analogue, p(NH)ppG, 
inhibited adenylyl cyclase activity in hepatocyte plasma membranes 
from normal, but not diabetic, animals (Bushfield e t a/., 1990a).
Adipocyte membranes from animals made diabetic with 
streptozotocin had their inhibitory functions of Gj abolished, as 
assessed by the inhibitory action of low concentrations of p(NH)ppG 
upon forskolin-stimulated adenylyl cyclase activity, and by the 
inh ib itory action of high concentrations o f GTP upon 
isoproterenol-stimulated adenylyl cyclase activity. In contrast, 
receptor-mediated inhibitory responses of Gj, effected by adenosine, 
prostaglandin Ez or nicotinate, were either unchanged or even 
apparently more effective in membranes from diabetic animals. 
Induction of diabetes did not cause any change in the adipocyte 
plasma membrane levels of G j l a ,  G j2 a  or of Gsa,  but elicited an 
increase in the level of G j3 a .  The induction of diabetes reduced the 
specific activity of adenylyl cyclase in adipocyte membranes and 
enhanced the stimulatory effect of isoproterenol. It is suggested 
that diabetes causes selective changes in the functioning of Gj in 
adipocyte membranes, which removes the tonic GTP-dependent 
inhibitory function of this G-protein (Strassheim et al., 1990 ).
The factor which leads to the loss of Gj function remains to be 
established. Certainly, the fact that two very different compounds, 
namely alloxan and streptozotocin, elicited this effect, suggests 
that they did not exert any direct action. Indeed, this was confirmed 
by the fact that insulin therapy of streptozotocin diabetic animals 
restored Gj function.
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(ii) Animals - genetically acquired diabetes and obesity
A ltered adipocyte G-protein expression and adenylyl cyclase 
regulation have been observed in genetically acquired diabetic 
(db /db) mice (Strassheim et a/., 1 9 9 1 ) .  Adipocyte membranes from 
diabetic animals showed marked elevations in the levels of G j1 a ,  
which were almost twice those found in membranes from their 
normal, lean littermates. In contrast, no apparent differences were 
noted in levels of Gj2a ,  G j3a ,  Gsa (42  and 45kDa forms) and the 
p-subunit. Adenylyl cyclase activity was similar in membranes from 
both normal and diabetic animals under basal conditions and also 
when stimulated by optimal concentrations of either NaF or 
forskolin. However, the ability of isoproterenol, glucagon and 
secretin to stimulate adenylyl cyclase activity was greater in 
membranes from normal animals compared with membranes from  
diabetic animals. Receptor-mediated inhibition of adenylyl cyclase, 
as assessed using prostaglandin Ei (PGEi) and nicotinate, was 
s im ila r using m em branes from  both  sources, bu t 
phenylisopropyladenosine was a slightly more effective inhibitor in 
membranes from diabetic animals. Hence, a doubling in the  
expression of Gjl appears to have little discernible effect upon the 
inhibitory regulation of adenylyl cyclase.
Obese ( fa / fa )  Zucker rats, unlike their lean (F a /F a )  
l i t te rm a te s , are hyperinsulinaem ic and show tissu e  
insulin-resistance although they are not classified as being 
diabetic, as no pronounced hyperglycaemia is exhibited. However, 
these genetically obese Zucker rats may be a better model of human 
non-insulin dependent diabetes than chemically-induced diabetic 
rats which have undergone pancreatic p cell destruction. Hepatocyte 
membranes from both lean and obese Zucker rats exhibited adenylyl 
cyclase activity that could be stimulated by glucagon, forskolin, NaF 
and elevated concentrations of p(NH)ppG. In membranes from lean 
animals, functional Gj was detected by the ability of low 
concentrations of p(NH)ppG to inhibit forskolin-activated adenylyl 
cyclase. In hepatocyte membranes from obese animals, no functional 
Gj activity was detected. Quantitative immunoblotting showed that 
hepatocyte plasma membranes from both lean and obese Zucker rats 
had similar amounts of Gja. Hence, it was suggested that liver 
plasma membranes from obese Zucker rats express an inactive Gj 
a-subunit. Thus, lesions in liver Gj functioning are seen in 
in s u lin -re s is ta n t obese ra ts  and in a llo xan - and
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streptozotocin-induced diabetic rats, which also show resistance as 
regards the acute actions of insulin. Liver plasma membranes of 
obese animals also showed an impairment in the coupling of 
glucagon receptors to Gs-controlled adenylyl cyclase. Membranes 
from obese animals were shown to exhibit a reduced ability for a 
high concentration of p(NH)ppG to activate adenylyl cyclase. The use 
of ADP-ribosylation by cholera toxin to label the 43kDa and 52kDa 
forms of Gsa showed that a reduced labelling occurred using liver 
plasma membranes from obese animals. It is suggested that 
abnormalities in the levels of expression of primarily the 52kDa 
form of Gsa may give rise to the abnormal coupling between 
glucagon receptors and adenylyl cyclase in liver membranes from 
obese Zucker rats (Houslay et al., 1989).
A study by Strassheim et al. (1992 ) investigated p-adrenergic 
regulation of adenylyl cyclase activity in heart tissue membranes 
from the genetically obese Zucker rat, the genetically obese CBA 
mouse and the genetically obese diabetic (d b /d b ) mouse. 
Responsiveness to p-adrenergic stimulation was impaired in 
membranes from the obese Zucker rat, but not in the other models. 
Cardiac membranes from obese Zucker rats showed both reduced 
p-adrenergic receptor number and altered coupling between  
p-adrenergic receptors and Gs- In contrast, no alterations in either 
the levels of Gs or the functional interaction between this protein 
and the catalytic moiety of adenylyl cyclase were observed. Hence, 
dissimilar alterations in the control of adenylyl cyclase were 
observed in these three genetic models of obesity.
(iii) Humans - non-insulin dependent diabetes mellitus
There are two types of diabetes mellitus in humans, namely insulin 
dependent diabetes mellitus (Type I )  and non-insulin dependent 
diabetes mellitus (Type I I ) .  Type I diabetes in humans arises from 
pancreatic destruction (similar to chemically-induced diabetic rats) 
resulting in low insulin levels. The levels and function of G-proteins 
have not been examined in humans with this type of diabetes. The 
cause of Type I I  diabetes in humans is unknown; however, patients 
with this type of diabetes are insulin resistant (similar to obese 
Zucker rats). The role of G-proteins in humans with Type n diabetes 
has been studied in platelets. Adenylyl cyclase activity and levels of 
G-proteins have been compared in platelets from normal and 
non-insulin dependent diabetic (NIDDM) male subjects (Livingstone
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et al., 1991). No differences were noted in basal and NaF-stimulated 
adenylyl cyclase activities; however, the degree of stimulation 
achieved by both forskolin and prostaglandin Ei was lower in 
platelet membranes from diabetic subjects compared with those 
from normal control subjects. Decreased a 2-adrenoceptor-mediated  
inhibition of prostaglandin Ei-stim ulated adenylyl cyclase activity  
was evident in platelet membranes from diabetic subjects compared 
to  controls. Analysis of G-protein a-subunits, using specific
anti-peptide antisera, showed that platelets from all subjects
exhibited the Gj2 and Gj3, but not the G jl, forms of the inhibitory 
G-protein Gj, and all expressed the 42kDa species of Gsa. Whilst 
platelets of diabetic subjects had levels of Gs which were
comparable to those found in control subjects, their levels of Gj2
and Gj3 were some 49% and 75%, respectively, of those found in 
platelets from control subjects. It was suggested that changes in 
adenylyl cyclase functioning and G-protein expression may 
contribute to altered platelet functioning in NIDDM subjects.
(iv) Summary
In conclusion, it is evident from these data that diabetes, whether 
occurring in humans (Type I I ) ,  genetically insulin-resistant obese 
rats or experimentally-induced diabetic rats, is associated with 
abnormal Gj function. Altered levels and/or activity of Gj have been 
noted in a range of tissues, namely hepatocytes, adipocytes and 
platelets. Although there are differences in the levels of the various 
sub-types of Gj in diabetic subjects with respect to controls, these 
differences vary depending on the model of human diabetes and 
tissue studied. It is apparent, however, that Gj function is in some 
way abolished in all of the systems studied.
1.3 Genetic hypertension
1.3.1 Human essential hypertension
In most patients with high blood pressure the cause is not known, 
and these subjects are said to have essential hypertension (EH). In 
the past years, studies have underlined the role of genetic factors in 
the development of hypertension in man, stimulating investigators 
to  look for possible biochemical-functional alterations that could be 
considered as a direct phenotypic expression of underlying genetic
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abnormalities. It is becoming increasingly clear that hypertension is 
a complex disease, in which the final phenotype "high blood 
pressure" or "vascular complications" can be reached through various 
genetic mechanisms, all interacting differently with a range of 
confounding environmental factors. It is, therefore, very difficult to 
dissect the various pathogenetic mechanisms caused by different 
intermediate phenotypes in a random mating population like the 
human one, without the aid of appropriate models such as the 
genetically hypertensive rat in which hypertension develops through 
, fewer and better defined genetic mechanisms, with little influence 
from the environment (Cusi et al., 1990). Clues to the pathogenesis 
of hypertension can be found by examining epidemiological 
associations of the disorder.
(i) Hypertension, obesity, and glucose intolerance
Hypertension, obesity, and glucose intolerance (impaired glucose 
tolerance and non-insulin dependent diabetes) are commonly 
associated in epidemiological studies, suggesting a common 
pathogenetic mechanism. Analysis of epidemiological data shows an 
impressive pattern of overlap among hypertension, diabetes, and 
obesity that amplifies with age. For example, it can be estimated 
th a t in the fifth decade of life, only some 15%  of diabetic 
individuals are non-obese and normotensive, and, conversely, only 
approximately 2 0 % of obese subjects have normal glucose tolerance 
and blood pressure, whereas only about one-th ird of the 
hypertensive population is free of both diabetes and obesity 
(Ferrannini et al., 1990). Impaired glucose tolerance and obesity are 
characterised by hyperinsulinaemia, which reflects peripheral 
insulin resistance. Non-insulin dependent diabetes is also an 
insulin-resistant state, although absolute levels of insulin may be 
in the normal range or lower. Hyperinsulinaemia has been ascribed a 
pathogenetic role in hypertension via a range of pathogenic 
mechanisms, including increased renal sodium retention.
(ii) Cell membrane cation transport
Abnormalities of cell membrane cation transport have been 
dem onstrated in obesity, non-insulin dependent diabetes and 
hypertension. These, as well as the obligatory linkage of cellular 
sodium efflux and potassium influx, and the regulatory role of
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insulin in cell membrane cation transport, raise the possibility that 
such shifts in internal cation distribution are associated with 
insulin resistance and/or hyperinsulinaemia (Modan e ta / . ,  1985). A 
recent study by Ohno et al. (1 9 9 3 ) has shown that in young, lean 
norm otensive offspring of essential hypertensives, insulin 
sen s itiv ity  correlates inversely w ith intracellu lar calcium  
concentration in platelets. Hence, impaired insulin sensitivity and 
disturbed calcium metabolism exist before the onset of 
hypertension, and their association may contribute to its 
development. Thus, numerous abnormalities in the function of 
plasma membranes have been described in patients with EH, some of 
which may be important in the development of hypertension. Losse 
e t al. (1 9 6 0 ) were the first investigators to report elevation of 
intracellular sodium in erythrocytes obtained from subjects with 
EH. They demonstrated increased net sodium flux across the 
erythrocyte membrane, suggesting cell permeability to sodium was 
increased in hypertensive patients (Wessels e t a/., 1967). Increased 
cell-membrane permeability to sodium and the consequent rise in 
the intracellular sodium concentration would normally stimulate 
sodium efflux through stimulation of the energy-dependent 
ouabain-sensitive sodium pump. This was reported by Postnov e t al. 
(1977).
Studies of white-cell electrolyte handling may more closely 
re flec t the physiology of other nucleated cells. Increased 
intracellular sodium in these cells was suggested by work done by 
Edmondson e t al. (1 9 7 5 ). Ambrosioni e t al. (1 9 8 1 ) showed an 
increase in intracellular sodium in lymphocytes, which was directly 
correlated with blood pressure.
Two other carrier-mediated transport pathways have been 
investigated in erythrocytes from humans with EH and have been 
found to be abnormal. Frusemide-sensitive sodium-potassium  
co-transport was decreased in a group of patients with EH (Garay e t  
a/., 1980 ), while sodium-lithium counter-transport was observed to 
be increased in a group of hypertensive subjects (Canessa e t al., 
1980).
Since membrane ion transport is such a fundamental
participant in smooth muscle excitation-contraction, it seems 
likely that these abnormalities are in some way related to the 
process which elevates blood pressure. Vascular smooth muscle
contraction is mediated by an increase in ionised calcium in the
cytoplasm in the region of the contractile protein (Bolton, 1979).
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This change is produced by the entry of calcium ions into the cell, 
the effect of which is amplified by the release of calcium bound by 
the cell membrane and by intracellular stores. The increase in 
cell-membrane permeability to calcium is due to the opening of two 
types of ion channel. One opens in response to depolarisation 
produced by a change in sodium or potassium gradient across the 
membrane. Receptor-operated channels, on the other hand, respond 
to specific agonists by increasing cell-membrane permeability to 
calcium and to other ions. A degree of depolarisation may, therefore,
, result from agonist binding to receptors, with the resultant opening 
of potential-mediated as well as receptor-mediated channels. Two 
hypotheses have been put forward to link cation transport with the 
processes mediating smooth muscle contraction. One postulates 
physiological inhibition of transmembrane calcium movements, 
whilst the other postulates an intrinsic membrane abnormality.
Rather than incriminating a specific abnormality of one 
pathway in EH, a genetic membrane defect has been postulated 
(Canessa et al., 1981 and Orlov et al., 1982). Thus, in addition to 
abnormalities of sodium and potassium handling, red-cell membrane 
viscosity is increased (Orlov and Postnov, 1982) and calcium binding 
by red-cell membranes reduced in EH (Postnov e t al., 1979 ). If this 
is associated with an increase in free intracellular calcium either 
directly or as a result of decreased affinity for the ATP-dependent 
calcium extrusion pump, this would provide a basis for enhanced 
smooth muscle tone. If increased intracellular calcium, as a result 
of a decreased cell-membrane affinity for calcium, was responsible 
for enhanced smooth muscle contractility, the previously described 
changes in potassium and sodium handling could merely represent a 
marker for the primary abnormality. It is also possible, however, 
th a t they are more directly linked to calcium handling. Two 
properties of calcium may be relevant. Firstly, increasing 
intracellular calcium enhances red-cell sodium and potassium  
permeability (Romero and Whittam, 1971), and there is a close 
relationship between potassium loss from red-cell ghosts and 
intracellular calcium (Whittam, 1968 and Romero, 1 9 7 6 ). Secondly, 
high external calcium concentrations stabilise smooth muscle cell 
membranes, reducing potassium efflux and inhibiting excitation 
(Rothstein, 1968 and Holloway & Bohr, 1973).
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(iii) Role of G-proteins in altered cell membrane function
G-proteins are membrane proteins which provide an essential link 
between cell surface receptors and second messenger generating 
systems, such as adenylyl cyclase (Houslay, 1984). In addition, these 
proteins appear to regulate the function of a number of 
transmembrane ion channels (e.g. potassium (Yatani et al., 1988) and 
calcium (Hescheler e ta /. ,  198 7 ) channels). Since alterations of 
G-protein activity would affect many aspects of cell membrane 
function, as demonstrated in diabetes mellitus (Gawler et al., 1987) 
and obesity (Houslay et al., 1989 ), it is of interest to examine 
w hether such changes occur in human genetic hypertension. 
Hypertension-associated abnormalities of cAMP metabolism have 
been studied in human platelets (Resink et al., 1986). Platelets from 
hypertensive subjects had an enhanced cAMP accumulation response 
to  prostaglandin Ei (tw o-fold increase in prostaglandin Ei 
sensitivity). The degree of adenylyl cyclase activation in response 
to  forskolin was greater in hypertensive than normotensive 
subjects, suggesting that the catalytic subunit of the enzyme is the 
rate-lim iting step of this hormonal information transduction. 
Platelets from hypertensive subjects were more sensitive to  
epinephrine-induced inhibition of the stim ulatory e ffec ts  of 
prostaglandin Ei on cAMP accumulation. This increased sensitivity 
to  inhibition of adenylyl cyclase activity may contribute to enhanced 
stim ulated vasoconstriction and an increased risk for coronary 
infarction and cerebrovascular accidents in hypertension. It was 
proposed that the enhanced adenylyl cyclase stimulation and cAMP 
accumulation response to prostaglandin Ei in platelets from  
hypertensives reflect a potentiated negative feedback controlling 
mechanism. Such an adaptive mechanism may function to protect the 
platelets against calcium overload and to dampen their participation 
in hemostatic and thrombotic processes. A study by McLellan e t al. 
(1 9 9 0 )  examined the role of G-proteins in this abnormal platelet 
adenylyl cyclase activity (ACA) reported in humans with essential 
hypertension (Resink et al., 1986). ACA under basal conditions and in 
the presence of forskolin were observed to be similar in the 
essential hypertensives and their controls. Activation of the 
inhibitory G-protein, Gj, with a low concentration of p(NH)ppG and 
adrenaline/propranolol did not differ between patients with EH and 
normotensive controls. However, greater stimulation of ACA in the 
presence of prostaglandin Ei was seen in platelets from essential
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hypertensives than in platelets from controls. The levels of 
G-protein subunits were measured, by immunoblotting using specific 
anti-peptide antisera, but no differences were found in the levels of 
Gsa, Gj2 a and the p-subunit in p late lets  from  essential 
hypertensives and normotensive controls. Hence, this study 
confirmed abnormal ACA in platelets from patients with essential 
hypertension. Although no differences were found in the levels of 
the G-proteins concerned with the dual regulation of ACA, abnormal 
G-protein functioning may contribute to these abnormalities. Hence, 
abnormal regulation of ACA has been reported by different groups in 
platelets from humans with essential hypertension. There are no 
data regarding G-protein function in vascular smooth muscle from 
human hypertensives due to the difficulty in obtaining such tissue. 
However, animal models of human essential hypertension can 
provide relevant tissues to study. Genetically hypertensive rats are 
valuable models for such studies, as it is possible to have direct 
access to vascular tissues, and hypertension develops in these rats 
with little influence from the environment.
1.3.2 Rodent models of human essential hypertension
Almost all studies of membrane electrolyte transport have been 
carried out in the rat, and the majority have utilised genetic 
hypertension in an inbred strain, on the grounds that this may 
provide a better model for EH in man than models which require 
administration of mineralocorticoids or renal manipulations. The 
demonstration of similar changes in different tissues of genetically 
hypertensive rats and in patients with EH may throw light upon the 
mechanisms responsible for blood pressure elevation in both 
species.
There are several genetically hypertensive rat strains 
available internationally, including spontaneously hypertensive rats 
(SHR), stroke-prone spontaneously hypertensive rats (SHRSP), Dahl 
salt-sensitive strain, Lyon hypertensive rats and Milan hypertensive 
strain (MHS). The work of this thesis examines two animal models of 
human EH, the SHR (Chapters 3 and 4) and the MHS (Chapters 5 and 6 ). 
The SHR is insulin resistant, as are humans with EH, and the 
elevated blood pressures of both the SHR and the MHS (Dall'Aglio e t  
al., 1991) are associated with hyperinsulinaemia, as in the case of 
hypertensive humans.
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A study by Horie et al. (1 98 6 ) obtained comparable data from 
several hypertensive rat strains under the same experimental 
conditions. The SHRSP and SHR showed markedly higher blood 
pressure levels and earlier blood pressure rises in comparison with 
other hypertensive strains. (The MHS develops mild hypertension for 
the first two months after birth and shows no further augmentation 
of hypertension during the process of aging, so th a t the 
developmental course of hypertension is different from EH, which 
tends to increase gradually with age.) All hypertensive strains 
showed increases in left ventricular weight in proportion to blood 
pressure rises. Kidney weights were significantly decreased only in 
MHS compared with its control, while they were either unchanged or 
significantly  greater in other hypertensive strains. These 
comparative data indicate the early involvement of cardiovascular 
structural alterations, especially left ventricular hypertrophy in the 
development of genetic hypertension in all rat strains, whether the 
hypertension is primary or secondary. It is proposed that renal 
functional insufficiency may contribute to the pathogenesis of 
hypertension in MHS with significantly reduced kidney sizes. These 
differences noted in SHRs and MHS suggest possible differences in 
the pathogenic mechanisms of genetic hypertension. Further details 
of the two models studied in this thesis are described below.
(i) The Okamoto spontaneously hypertensive rat (SHR)
The development of the SHR strain was started in 1959 by Okamoto 
and Aoki. The SHR strain, which is derived from Wistar-Kyoto (WKY) 
rats, is unique (in addition to the SHRSP) among the various 
hypertensive rat models because it not only develops hypertension 
spontaneously, but also hypertension-related complications without 
any additional inducements such as salt loading (Yamori, 1981). The 
SHR has severe hypertension and develops cardiovascular 
complications frequently and is, therefore, a valuable model for 
cardiovascular diseases in hypertension. Also, early development of 
hypertension in the SHR, in which genetic factors are concentrated 
by the long-term repetition of selective breeding, can also be noted 
in humans (confirmed by epidemiological and clinical studies) (Londe 
e t a\.y 1971 and Harlan et a/., 1979). Similarly, cardiac hypertrophy 
in hypertension develops early in the SHR, as well as in children or 
young adults with borderline or mild hypertension (Yamori e t al., 
1979).
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Blood pressure is determined by cardiac output and total 
peripheral resistance, and the former is related to circulating 
volume regulation by cardiac, renal, or adrenal functions, while the 
latter is based on either a functional vasopressor-depressor system 
or structural changes of resistance arteries. Volume factors seem 
to play no role in the development of hypertension in the SHR 
(Trippodo e ta /., 1978 ), and consistent with these findings, cardiac 
output is normal or reduced in this model. On the other hand, total 
peripheral resistance is increased in the SHR, indicating that
functional or structural factors increasing the to ta l peripheral
' resistance are more important than volume factors in this 
hypertensive model. These findings appear to be similar to essential 
hypertension at its established stage.
a. Altered vascular structure
In this strain, hypertension is hemodynamically maintained by the 
increased total peripheral resistance, as mentioned previously, and 
it is now commonly accepted that structural vascular alterations 
substantially contribute to this increase in the to ta l peripheral 
resistance (Folkow e t al., 1 9 7 3 ). Such structural vascular
alterations, measured as an increased wall thickness/lumen ratio
and detected by hind limb perfusion experiments, can be commonly 
observed in a number of types of hypertension. Morphological 
analysis of structural vascular changes in the aorta clearly 
indicates that both hyperplasia and hypertrophy of smooth muscle 
cells, with concomitant increase in elastic component, are involved 
in the process of structural vascular alterations in adult SHRs with 
established hypertension. The structural changes reflect altered 
vascular smooth muscle cell (VSMC) growth and differentiation, and 
this process of adaptive metabolic change can be regarded as the 
common path to structural changes (Yamori, 1976). Therefore, the 
common mechanisms for increasing total peripheral resistance in 
hypertension are increased vascular contractility and structural 
vascular changes induced by accelerated vascular protein synthesis. 
Moreover, an enhanced intracellular water content in arterial walls 
appears to contribute to increased tota l peripheral vascular 
resistance (Cox, 1 9 7 9 ), and may be related, as well as altered 
functional vascular reactivity, to alterations in receptors and 
cellular membranes in SHR erythrocytes, vascular smooth muscle, 
etc. In summary, the functional vascular alterations, primarily
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caused by neural vasomotor activation and activation of cellular 
membrane mechanisms of vascular smooth muscle cell contraction, 
are involved in the initiation of spontaneous hypertension, and the 
structural vascular changes brought about by vascular protein 
synthesis, activated by the rise in blood pressure and increased 
neuronal input, may contribute to the further development or 
maintenance of hypertension.
b. Membrane cation transport abnormalities
Genetic analysis of blood pressure in the SHR has indicated that 
hypertension is a multifactorial disease caused by autosomal 
additive inheritance of at least three to five major genes (Tanase e t  
al., 1 9 7 0 ), as similarly suggested for essential hypertension in men. 
Heritability or the degree of genetic determination of blood pressure 
is greater in the SHR than in human essential hypertension. Although 
no biochemical abnormalities have so far been proved to be causally 
related to the pathogenesis of genetic hypertension either in the 
SHR or in humans, studies employing the SHR as well as 
hypertensive men suggest that some biomembrane abnormalities 
commonly detected in erythrocytes, etc., may be involved in the 
cellular mechanism of genetic hypertension, and might also be 
utilised as genetic markers of hypertension (De Mendonca e t al., 
1980  and Canessa et al., 1980). Most studies of the erythrocyte and 
arterial wall maintained in artificial media have shown increased 
sodium-potassium permeability associated with increased turnover 
of these cations (Jones, 1 9 7 4 ). Increased cell-m em brane  
permeability to sodium and potassium would normally be associated 
with increased activity of (Na+/K +)-A T P ase -m ed ia ted  sodium  
pumping in SHRs. There is evidence for this in vascular smooth 
muscle from SHRs (Hermsmeyer, 19 7 6 ). Webb and Bohr (1 9 7 9 )  
investigated the relaxation of vascular smooth muscle produced by 
depolarising the cell membrane with increased potassium  
concentration in the surrounding medium. Such relaxation was 
greater in SHRs than in normotensive controls, although the duration 
of relaxation was no different. The difference in response between 
SHRs and normotensive controls could be eliminated by ouabain. This 
was in terp re ted  as indicating increased ac tiv ity  of the  
ouabain-sensitive sodium pump in SHRs, and is consistent with 
o th er studies indicating increased sodium and potassium  
permeability and the resulting stimulation of the electrogenic
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sodium pump. Therefore, in the most widely studied genetic model of 
hypertension, the Okamoto SHR, cell-membrane permeability to 
sodium is increased and this is associated with increased active 
sodium pumping through (Na+/K+)-ATPase activity.
Calcium binding was observed to be decreased in SHR 
erythrocytes (Postnov et al., 1979 and Devynck e t a/., 1981), 
adipocytes (Postnov and Orlov, 1980), arterial wall (Wei e t a/., 
1976) and aortic smooth muscle (Zsoter e ta /., 1977). SHR adipocyte 
cell-membrane fluidity was also observed to be decreased (Orlov e t  
a/., 1982 ). Hence, similar changes regarding cation transport in 
humans with EH exist in SHRs, emphasising its relevance as an 
animal model of EH in man.
Abnormal regulation of ACA in vascular tissues (and 
non-vascular tissues) from the SHR has been demonstrated (see 
section 3.1 for details). However, the roles of adenylyl cyclase's 
regulatory G-proteins, Gs and Gj, in this abnormality have not been 
examined in detail. Adenylyl cyclase is under dual control, hence, the 
production of the second messenger and vasodilator, cAMP, can be 
stimulated and inhibited. Thus, increased vasoconstriction in the 
SHR may arise from a decreased stimulation and/or an increased 
inhibition of adenylyl cyclase activity. It is possible that a common 
membrane defect may be responsible for the changes in membrane 
cation transport, decreased membrane flu idity, and altered  
regulation of ACA in the SHR. The increased vascular smooth muscle 
(VSM) contractility and altered vascular structure in the SHR may 
also be related to a possible common membrane defect.
(ii) The Milan hypertensive strain (MHS)
The Milan hypertensive strain and the Milan normotensive strain 
(MNS) descend from two mating pairs of Wistar origin rats from an 
outbred colony, which had mean blood pressures of 164mmHg and 
168mmHg. The hypertensive strain was obtained by breeding for high 
blood pressure and the control strain was obtained by breeding for 
normal blood pressure (Bianchi et al., 1984).
The MHS is another useful animal model for studying the 
mechanisms th a t may be responsible for human essential 
hypertension. For example, Bianchi e ta /. (1 9 8 4 ) measured different 
factors in the prehypertensive phases of both rats and humans and 
compared the results with those obtained for appropriate controls 
of the same age. They chose the prehypertensive phase in order to
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detect changes that existed before the development of hypertension, 
and which cannot be secondary to the hypertension, per se. Moreover, 
during the time-interval between birth and the development of overt 
hypertension, the genetic factors responsible for hypertension may 
already have produced biochemical or physiological abnormalities. 
Due to the difficulty of defining a prehypertensive phase in human 
subjects, young normotensive subjects with two hypertensive 
parents were compared with subjects of the same age, but with two 
normotensive parents, on the assumption that, later in life, the 
former will develop hypertension more frequently (about 50% ) than
/
the latter (about 2%). This group observed that a number of features 
in the MHS are similar to those observed in human essential 
hypertension, with simliar changes in whole-kidney function  
(glomerular filtration rate and renal blood flow), morphology of the 
kidney and adrenal (by light or electron microscopy), 24 hour urinary 
e le c tro ly te  output, extracellu lar fluid volume, to ta l and 
exchangeable body Na+, plasma electrolytes, plasma and urine 
osmolarity, plasma aldosterone, and plasma catecholamines.
The key role of the kidney in this animal model of hypertension 
has been dem onstrated. Studies of the e ffe c t o f kidney 
cross-transplantation between adult MHS rats and adult MNS rats 
showed that the MHS kidney produced hypertension in MNS rats. 
Transplantation has also been carried out between MHS and MNS rats 
at one month of age, when the difference in donor blood pressure 
was slight and of short duration, to determine whether this pressor 
effect of the MHS kidney was primary in nature or secondary to renal 
injury due to prolonged perfusion at high blood pressure of the MHS 
donor kidney. The blood pressure measured 120 days after kidney 
transplantation into one-month-old MHS rats was 152±2m m Hg in 
recipients of MHS kidneys and 130±5mmHg in recipients of MNS 
kidneys (p <0 .01 ). Therefore, MHS kidneys have a greater pressor 
effect even when taken from young donors with almost equal blood 
pressure, demonstrating that the pressor effect of the MHS kidney 
exists prior to hypertension (Fox and Bianchi, 1976). In addition, the 
relative sodium retention in MHS rats, during the development of the 
blood pressure difference between the two strains, is in keeping 
with a renal origin of hypertension in MHS. To evaluate further the 
role of the kidney, whole kidney clearance and micropuncture 
techniques were used to study whole kidney and single nephron 
filtration rate and proximal fluid reabsorption in both strains 
before, during and after the development of hypertension in MHS.
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Both single nephron and whole kidney glomerular filtration rates are 
significantly lower in young MHS rats before the development of 
hypertension, while in adult animals, whole kidney glomerular 
filtration rate is equal, and superficial single nephron filtration  
rate is higher in MHS rats (discrepancy explained by lower number of 
glomeruli in MHS kidney) (Bianchi and Baer, 1976).
Sodium transport across red cell membranes was measured 
with the red cell volume in prehypertensive MHS and MNS rats. 
Moreover, a genetic analysis involving crosses between the two 
strains and backcrosses of the first generation of hybrids with the
t
two parental strains was carried out in an attem pt to evaluate 
whether the red cell volume and kidney weight traits segregate 
together with the blood pressure in these hybrid generations 
(Bianchi, 1 9 8 1 ). The results obtained dem onstrated that the 
prehypertensive MHS have smaller red cell volume, lower 
intracellular Na+ concentration, and faster outward Na+ cotransport 
across their cell membranes. These differences in red cell function 
were consistent with the increased transtubular transport of ions 
and water in MHS kidneys and with the lower weight of these 
kidneys in spite of a similar number of nephrons. Moreover, in the 
hybrid generations there was an inverse correlation between the 
volume of the red cells in young rats or the weight of the kidney 
measured in the adult age, and the level of blood pressure reached by 
the same animal in the adult age. All these findings are consistent 
with the hypothesis that young prehypertensive MHS rats have a 
genetically determined faster transport of ions across their cell 
membranes, and th a t this abnormality is responsible for the 
differences in renal function between MHS and MNS rats.
Red blood cell abnormalities were apparent in lethally 
irradiated (MHSxMNS) Fi hybrids which were recipients of bone 
marrow from MHS. In these rats, Na+-K+ cotransport was increased, 
and intracellular Na+ content and cell volume were decreased 
(Bianchi et al., 1985 ). Smaller volume and Na+ content have also 
been demonstrated in MHS proximal tubular cells. Also, the Na+ 
transport is faster and the Ca2+ ATPase at V max is lower in these 
cells and in erythrocytes (Bianchi e t a/., 1 9 8 6 ). These results 
indicate that the MHS erythrocyte abnormalities may well be 
associated with the primary cause of spontaneous hypertension in 
rats, as erythrocyte abnormalities are genetically determined 
within the stem cells.
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A study by Parenti e t  a/. ( 1 9 9 1 )  examined the  
(N a +/K+)-ATPase activity from the kidney cortex of MHS and MNS 
rats in active solubilised enzyme preparations and in isolated 
basolateral membrane vesicles. Kinetic analysis of the purified 
enzyme showed that the Vmax value was significantly higher in MHS 
rats. The difference between MHS and MNS was not linked to a 
different number of sodium pumps, but was related to the activity 
of the enzyme. Using basolateral membrane vesicles, an increased 
ATP-dependent ouabain-sensitive sodium tran sp ort was also 
demonstrated in MHS rats. These results support the hypothesis that 
a higher tubular sodium reabsorption may be involved in the 
pathogenesis of hypertension in this rat strain.
A recent study by Ferrari e t al. (1 9 9 2 )  has investigated  
whether cytoplasmic or membrane skeleton abnormalities may be 
possible causes of faster N a + /K  + /C I -  co transport in MHS 
erythrocytes. It has been observed that the difference in Na+/K +/Ch  
cotransport is no longer present in inside-out vesicles of 
e ry th ro c y te  m em branes. Resealed ghosts  re ta in ed  the  
characteristics of the Na+/K + /C I_ cotransport of the original 
erythrocytes, suggesting that an abnormality in the membrane 
skeletal proteins may play a role in the d ifferent N a + /K + /C h  
cotransport modulation between MHS and MNS erythrocytes.
In summary, the MHS rat serves as an alternative and useful 
model for human essential hypertension. Although there is a range of 
data on cell ion flux abnormalities in this strain, there is little  
information on the regulation of second messenger generating 
systems, such as adenylyl cyclase, and no data on G-protein 
abnormalities.
1.4 Aims of study
1.4.1 Regulation of adenvlvl cvclase ac tiv ity  in genetically  
hypertensive rat vasculature
A ltered  regulation of adenylyl cyclase a c tiv ity  has been 
dem onstrated  in SHR vascular tissues in comparison to  
normotensive controls (see section 3.1 for details), and may 
contribute to increased vascular reactivity in this rat model. These 
previous studies, however, did not concern themselves with the 
underlying mechanisms responsible for the altered regulation of this 
second messenger generating system. The roles of stimulatory and
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inhibitory G-proteins of the adenylyl cyclase system were examined 
in vascular tissue from SHRs (Chapters 3 and 4 ), MHS (Chapters 5 
and 6 ), and their appropriate controls, as abnormalities in the 
levels/function of these G-proteins have been observed in diabetes 
and other insulin-resistant states (see section 1 .2 .8 ), which share 
insulin-resistance and hyperinsulinaemia with genetic hypertension.
1.4.2 Common primary cause of hypertension in SHRs and MHS?
Membrane signal transduction was examined in vascular tissue from 
two rodent models of human EH. There is early involvement of 
cardiovascular structural alterations, especially le ft ventricular 
hypertrophy, in the developmental process of genetic hypertension in 
both SHRs and MHS; however, renal functional changes may 
contribute to the pathogenesis of hypertension in MHS (but not 
SHRs), which has significantly reduced kidney sizes (Horie e t a/., 
1 9 8 6 ). These observations suggest possible differences in the 
pathogenic mechanisms responsible for genetic hypertension in SHRs 
and MHS. However, both models exhibit major changes in 
transmembrane ion fluxes, which may be of primary importance in 
the development of increased blood pressure; there are no data on 
the regulation of ACA in the MHS. It was, therefore, of interest to 
compare the role of G-proteins involved in the regulation of ACA in 
the two models of human EH, and to examine in detail the regulation 
of ACA in the MHS.
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Chapter 2 Materials and Methods
2.1 Materials
All reagents employed were of the highest quality available and 
were obtained from the following suppliers:
2.1.1 General reagents
The following reagents were purchased from Sigma Chemical
#
Company Ltd., Poole, Dorset, United Kingdom: soybean trypsin 
inhibitor, collagenase (type n ), elastase (type IV), calcium chloride, 
tris (hydroxymethyl) aminomethane pH 7 to pH 9, cupric sulphate, 
sodium potassium tartrate , bovine serum albumin (fraction V), 
deoxycholic acid (sodium salt), alumina (typ e  W N-3:neutral), 
magnesium acetate, adenosine 5'-triphosphate (A 2 3 8 3 ), adenosine 
S'.S'-cyclic monophosphate (A 6885), dithiothreitol (DTT), imidazole, 
adenosine 5 f-triphosphate (A 3 3 7 7 ) , adenosine 3 , ,5 '-cyc lic  
monophosphate (A 9 5 0 1 ), manganese chloride, forskolin, sodium 
fluoride, (-)-isoproterenol ((+ )-b ita rtra te  salt), (-)-epinephrine  
((+ )-b ita rtra te  salt), DL-propranolol, carbamylcholine chloride 
(carbachol), 5-hydroxytryptamine, neuropeptide Y, prostaglandin E i, 
a c ry la m id e , N ,N '-m e th y le n e -b is -a c ry la m id e , N ,N ,N ',N '-  
tetramethylethylenediamine (TEMED), glycine, urea, bromphenol blue, 
coomassie brilliant blue G, potassium phosphate (monobasic, 
an h yd ro u s ), th im e ro s a l, non idet P -4 0 , o -d ia n is id in e , 
N-[2-Hydroxyethyl]piperazine-N'-[2-ethane-sulphonic acid] (HEPES).
The following products were obtained from BDH Chemicals 
Ltd., Poole, Dorset, United Kingdom: hydrochloric acid, sodium 
dodecyl sulphate (SDS), Folin & Ciocalteu's phenol reagent, 
trichloroacetic acid, acetic acid (glacial), glycerol, ammonium  
persulphate, methanol, disodium hydrogen orthophosphate dihydrate, 
gelatine powder (approx. 150  bloom from pig skin), hydrogen 
peroxide solution, magnesium chloride, disposable plastic cuvettes.
The following chemicals were supplied by FSA Laboratory 
S u pp lies , Lo ug hb orou gh , U n ited  K ingdom : sucro se ,
diam inoethanetetra-acetic acid disodium salt (EDTA), sodium 
carbonate, sodium hydroxide, sodium chloride, potassium chloride.
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The following products were purchased from Boehringer 
Mannheim UK (Diagnostics & Biochemicals) Ltd., East Sussex, United 
K ing do m : c re a t in e  p h o s p h a te , c r e a t in e  k in a se ,
gu ano sine-5 '-triph osp hate , guanosine 5'-[Y-thio]triphosphate, 
guanosine 5'-[PY-imido]triphosphate.
The following were supplied by Bio-Rad, Hertfordshire, United 
Kingdom: cation exchange resin (dowex 50W -X4, 2 0 0 -4 0 0  mesh, 
hydrogen form), columns (for adenylyl cyclase assay).
Bethesda Research Laboratories-Life Technologies, Inc., 
Paisley, United Kingdom supplied: prestained protein molecular 
weight standards (molecular weight range 1 4 ,3 0 0 -2 0 0 ,0 0 0 ), 1.5mm  
spacers, vertical gel electrophoresis systems.
The Scottish Antibody Production Unit, Law Hospital, Carluke, 
Scotland provided: horseradish peroxidase-labelled donkey
anti-rabbit IgG (polyclonal).
Anderman & Co. Ltd., Laboratories Supplies Division, Surrey, 
United Kingdom supplied: nitrocellulose (0.45^m ).
National Diagnostics, Manville, New Jersey, USA supplied: 
ecoscint-A.
Pfizer, Sandwich, Kent, United Kingdom supplied: UK 14304.
2.1 .2  Tissue culture products
The following tissue culture products were obtained from GIBCO 
BRL, Paisley, United Kingdom: Dulbecco's modified Eagle medium 
((high glucose) with L-glutamine, with 4500m g /l D-glucose, without 
s o d iu m  p y r u v a te ) ,  m in im um  e s s e n t ia l m ed iu m , 
pen ic illin -strep tom ycin  solution, fo e ta l ca lf serum (h ea t  
inactivated), horse serum (heat inactivated), tissue culture flasks 
(25cm 2, 80cm 2 and 175cm2), 50ml centrifuge tubes.
ICN Flow Laboratories, High Wycombe, Buckinghamshire, United 
Kingdom supplied: L-glutamine.
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The Department of Virology, University of Glasgow, Glasgow, 
Scotland supplied: trypsin (0 .25%  in tris saline (tris saline: NaCI 
0.8% , KCI 0.038% , Na2HP0 4  0.01%, dextrose 0.1%, tris 0.3%, phenol 
red 0 .0015% , penicillin lOOunits/ml, streptomycin 0.01% , pH 7 .7  
with HCI)), versene (0 .02%  in phosphate-buffered saline consisting 
of NaCI 0.8% , KCI 0 .0 2 %, Na2 H P 0 4 0.115% , KH2PO4 0.033% , 
diam inoethanetetra-acetic acid disodium salt 0 .0 2 %, phenol red 
0.0015% , pH 7.12-7.3).
2 .1 .3  Radiochemicals
The following radioisotopes and products were purchased from  
Amersham International pic, Buckinghamshire, United Kingdom: 
[a3 2 P] adenosine 5'-triphosphate, [ 8 - 3 H] adenosine 3 ',5 '-c y d ic  
m onophosphate, ( - ) - 3 - p  2 5 l] iodocyanopindolol, [ 1 2 5 1 ] - 1 g 
(anti-rabbit, whole Ab from donkey), hyperfilm-MP, hypercassette 
(18x24cm ), hyperscreen intensifying screens (18x24cm ), sensitize 
pre-flash unit.
2.2 Animals
Spontaneously hypertensive rats, Wistar-Kyoto rats and Wistar rats 
were purchased from two different suppliers, namely Charles River 
Ltd., Margate, Kent, United Kingdom and Harlan Olac Ltd., Oxon, 
United Kingdom. The rats arrived at 10 weeks of age and were 
sacrificed by a blow to the head within one week of arrival. Before 
sacrifice, the rats had their weights and systolic blood pressures 
(SBP) measured (tail-cuff method (McAreavey e t a/., 1 9 8 5 )) using a 
M ettler PE 2000  balance (Fisons, Crawley, Sussex, United Kingdom) 
and a W+W electronic BP recorder 8 0 0 6  (Kontron Electronics, 
W atford, United Kingdom), respectively. SBP were measured in 
conscious rats which were warmed at 37°C  for 15 minutes and 
readings were made without anaesthesia by means of inflation of 
tail-cuff and a piezo-electric crystal detector connected to a blood 
pressure recorder. SBP were calculated from the mean of six 
recordings for each rat. The rats were fed on rat and mouse 
maintenance diet, allowed free access to H20  and kept under 
constant light conditions.
SHRs and normotensive control rats were used in this study at 
10-11 weeks of age, as by this age SHRs had significantly elevated 
blood pressures and established hypertension in comparison to
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age-matched control rats. Figure 2.1 shows the systolic blood 
pressures of SHRs and WKY rats related to age. Data are mean±S.E. 
(standard error of the mean) of measurements made from eight rats 
of each strain.
Part of the work in this study involved the Milan hypertensive 
strain as an animal model of human essential hypertension. Vascular 
smooth muscle cells isolated from the thoracic aortas of MHS and 
MNS rats were kindly supplied by Dr. Patrizia Ferrari, Prassis 
Sigma-Tau Research Institute, Milan, Italy. VSMC were isolated from 
aortas of young rats (30  days old) and adult rats (6 0  days old). From 
Figure 2.2 it can be seen that young MHS rats have slightly, but 
significantly increased systolic blood pressures in comparison to  
age-matched MNS rats, while adult MHS rats have significantly 
elevated systolic blood pressures and are hypertensive compared to 
MNS rats of the same age.
2.3 Apparatus
Laminar flow hood (MDH, Andover, Hampshire, United Kingdom), CO2 
incubator (ASSAB Medicin AB, Stockholm, Sweden), microscope 
(Leitz Labovert, Wetzlar, Germany), 11x64m m  polystyrene tubes, 
universals and plastic Pasteur pipettes (standard and fine tipped) 
(Alpha Laboratories Ltd., Hants., United Kingdom), millex-GS 0.22^m  
filte r unit (Millipore Ltd., Herts., United Kingdom), 'polytron1, 
kinematica, C H -6010 kriens-LU PT 1 0 -35  (The Northern Media 
Supply Ltd., North Humberside, United Kingdom), Beckman DU-70 
spectrophotometer (Beckman, Buckinghamshire, United Kingdom), 
scintillation vials (LIP, Shipley, West Yorkshire, United Kingdom), 
LKB Wallac 1217  rackbeta (liquid scintillation counter), glass 
plates, teflon combs, electrophoresis constant power supply ECPS 
3 0 0 0 /1 5 0 , LKB Bromma 2005  transphor power supply (Pharmacia 
Biosystems Ltd., Milton Keynes, United Kingdom), NE 1612 gamma 
counter (Nuclear Enterprises, EMI, United Kingdom), T itertek cell 
harvester (2  valve) (Flow Laboratories, High W ycom be, 
Buckinghamshire, United Kingdom), Whatman glass microfibre 
filters (W hatman International Ltd., Maidstone, Kent, United 
Kingdom), radio-immuno-assay disposable cups (Sarstedt Ltd., 
Leicester, United Kingdom).
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Figure 2.1 Graph relating systolic blood pressure to age for SHRs and 
WKY rats. Systolic blood pressure measurements were initiated at 4 
weeks of age and terminated at 20 weeks. Data are mean±S.E. for 
measurements taken from eight rats of each strain.
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Figure 2.2 Graph relating systolic blood pressure to age for MHS and 
MNS rats. Systolic blood pressure measurements were taken from 
weaning until two months of age. Blood pressure was measured at 
the tail in conscious rats. Data are mean±S.E. for measurements 
taken from six rats of each strain.
Sy
st
ol
ic
 
blo
od
 
pr
es
su
re
 
(m
m
H
g)
80 - |
MHS
7 0 - MNS
6 0 -
50-
4 0 -
30 -
2 0 -
110
25-30 30-40 40-50 50-60 60-70
Age (Days)
2.4 General procedures
2.4.1 Glassware
All items of glassware were washed in solutions of the detergent 
decon 75 (Decon Laboratories Ltd., Hove, United Kingdom), rinsed 
thoroughly with tap water, then distilled water and dried in an oven 
at 37oc.
2.4.2 Micropipettina
Solution volumes in the range of 0 .05-25 .00^1  were transferred  
accurately using Rainin EDP-plus electronic pipettes obtained from  
Rainin Instrument Co., Inc., Woburn, USA. Volumes in the range of 
25-1000^1 were transferred reproducibly using Finnpipettes  
purchased from Labsystems, Helsinki, Finland.
2.4.3 pH Measurement
Measurements of pH were performed using a digital pH/temperature 
meter obtained from Electronic Instruments Ltd. (United Kingdom). 
This apparatus was regularly standardised with a solution of pH 7 
prepared from buffer tablets.
2 .4 .4  Centrifugation
Accelerations of 2,000xg were attained using a Damon/IEC division 
D PR-6000 centrifuge purchased from International Equipment 
Company (Bedfordshire, United Kingdom). Accelerations of 
110,000xg were achieved using an LKB Bromma 2 332  ultrospin 85 
obtained from Pharmacia Biosystems Ltd. (Milton Keynes, United 
Kingdom).
2.5 Cell culture
2.5.1 Vascular smooth muscle cell preparation
Figure 2.3 is a photograph of a rat's intestine, illustrating the 
mesenteric artery. Mesenteric arteries were excised from six rats 
of each strain under sterile conditions, cleaned and transferred to a 
mixture (10m l) containing collagenase (1 .2 5 m g /m l), elastase
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Figure 2 .3  Photograph of a rat's intestine, illustrating  
mesenteric artery.
(0 .2 5 m g /m l) and soybean trypsin inhibitor (0 .0 5 m g /m l). A fter  
incubation at 37°C  for 5 minutes, any remaining fat, adventitia and 
endothelium were removed. The arteries were cut into small pieces 
( l - 2 mm), transferred to fresh enzyme mixture and incubated until a 
single cell suspension was obtained.
Cells isolated in this manner have previously undergone a 
series of tests to properly characterise them. Firstly, the method of 
isolation (i.e. first digestion) removes adventitia (fibroblasts). An 
antibody raised against Factor Vm  (visualised by a fluorescent 
secondary antibody) was used to identify any endothelial cells in the 
cultures, but proved negative. Electron microscopy of the cells 
showed micropinocytotic vesicles, common to smooth muscle cells, 
and an abundance of myofilaments. Also, angiotensin n caused 
contraction of spindle-like cells (observed using time-lapse video) 
and measurements of angiotensin n  receptor number on the cells 
after six passages were comparable to physiological measurements.
VSMC were isolated from thoracic aortas from MHS and MNS 
rats. Aortas were removed aseptically from four rats of each strain 
and age-group, cleaned of adherent connective tissue, and cut into 
small rings. The tissue was incubated in 12ml of minimum essential 
medium with 0.2mM CaCl2 , 1 mg/ml of collagenase, 0 .375m g /m l of 
soybean trypsin inhibitor, 0 .125m g/m l of elastase and 2.0m g/m l of 
bovine serum albumin (BSA) for 90 minutes at 37°C  in a revolving 
w ater bath. The partially digested tissue fragments were then 
collected with a coarse stainless steel mesh, resuspended in 2 0 ml 
of minimum essential medium, titrated 1 0  times through a 14-g  
stainless steel cannula, and sieved through a lOO^m  mesh to 
separate the dispersed cells from undigested tissue fragments. The 
resulting cell suspension was centrifuged (200xg , 5 minutes) and 
then resuspended in 20ml of Dulbecco's modified Eagle medium 
supplemented with 10% calf serum and antibiotics (Brock e t a/., 
1 985 ). Figure 2.4 is a photograph showing VSMC, isolated from Milan 
rat thoracic aortas.
2 .5 .2  Cell growth
The VSMC were grown in Dulbecco's modified Eagle medium  
containing 1 0 % (v /v )  foetal calf serum, 1 0 % (v /v )  horse serum, 
L-glutam ine (2m M ), penicillin (lO O U /m l) and streptom ycin  
(lOO^ig/ml) at 37°C in a humidified 5% CO2 to 95%  air atmosphere.
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Figure 2 .4  Photograph of VSMC isolated from Milan rat thoracic 
aortas.
2.5 .3  Cell subculture
Once cells had grown to confluence, the growth medium was 
decanted and the cells washed with versene and then a mixture of 
versene/trypsin (4  volumes versene: 1 volume trypsin). The cells 
were incubated at 37°C  for a short time until all the cells had 
become detached from the surface of the flask. A volume of growth 
medium was added and a single-cell suspension attained by 
repeatedly triturating the cell solution with a fine-tipped Pasteur 
pipette. The cell solution was transferred to a larger flask (or 
divided among a greater number of flasks of the same size) and an 
appropriate volume of growth medium added.
2.6 Plasma membrane preparation
Production of plasma membranes directly from rat mesenteric 
arteries and VSMC was similar. VSMC (or finely chopped mesenteric 
arteries) were homogenised in ice-cold 10mM tris /lm M  EDTA, pH 7.5 
(250m M  sucrose for arteries) using a 'polytron' a t setting '5 f 
(maximum speed for arteries) for 2x12 seconds. The homogenate 
was centrifuged at 2 ,000xg for 10 minutes at 4 °C  to remove 
unbroken cells, cellular debris and nuclei. The resulting supernatant 
was centrifuged at 110,000xg for 1 hour at 4°C  to obtain a crude 
plasma membrane fraction which was resuspended in lOmM tris/HCI 
pH 7.5, aliquoted and stored at -70°C.
2 .7  Protein determination
The protein concentrations in the plasma membrane preparations 
were measured colorim etrically using Peterson's modification  
(1 9 7 7 )  of Lowry and co-workers' protocol (1 9 5 1 ) based on bovine 
serum albumin as standard.
Stock Solutions:
Solution A 0.1%  (w /v ) copper sulphate in 0.2%  (w /v ) sodium 
potassium ta rtra te  and 1 0 % (w /v )  sodium  
carbonate
Solution B 10% (w /v ) sodium dodecyl sulphate
Solution C 0.8M sodium hydroxide
Solution D 0.15%  (w /v ) sodium deoxycholate
Solution E 72% (w /v ) trichloroacetic acid
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Just prior to use, stock solutions A, B and C were mixed with 
distilled H2 O in the following ratio A:B:C:H2 0 , 1:1:1:1, to produce 
solution F.
Protein standards were prepared in duplicate (using a 1 mg/ml 
solution of bovine serum albumin) to construct a standard curve for 
a maximum of 50^g of protein per sample. Unknowns were assayed in 
10 and 15^1 volumes in triplicate. Each sample volume was made up 
to 1ml with distilled H2O, 100^1 of solution D added and left to 
stand at room temperature for 10 minutes. 100^1 of solution E was 
then added, the samples mixed and then centrifuged at 2 ,0 0 0 xg for 
15 minutes at room temperature. The supernatants were discarded 
and each sample pellet was resuspended in 1 ml of distilled H2O. 1 ml 
of solution F was added, the samples mixed and left to stand at room 
tem perature for 10 minutes. 0.5m l of a solution of Folin & 
Ciocalteu’s phenol reagent and distilled H2 O (1 volume Folin & 
Ciocalteu's:5 volumes H2O) was added to each sample, mixed, and 
left to stand at room temperature for 30  minutes. The absorbance of 
light by each sample was assessed spectrophotometrically at 750nm  
in a Beckman DU-70.
2.8 Adenvlvl cvclase assay
Two step chromatography (Salomon) method
Adenylyl cyclase activity was measured by the method of Salomon 
(1 9 7 9 ). In this assay, the formation of [32P]cAMP from [ a 32P]ATP 
was measured in the presence of GTP and magnesium ions.
2.8.1 Sample preparation
The reaction mix (final volume of 50^1) was essentially th a t 
described by Sharma e t a/. (1 9 8 2 ) and included an ATP regenerating 
system consisting of creatine phosphate (5mM) and creatine kinase 
(5 0U /m l), in addition to tris acetate, pH 7.6  (25m M ), magnesium 
acetate (5m M ), ATP (0.5m M ), cAMP (0 .05m M ), DTT (Im M ), BSA 
(0.1 m g/m l), GTP (0.01 mM), [a 32P]ATP (1x10 6cpm/assay), 5^g of 
freshly thawed membrane protein and the ligand(s) of interest. 
Assay tubes were kept on ice at all times and the reaction started 
by removal to a 30°C  water bath. After 15 minutes, the reaction was 
terminated by removal to ice and the addition of 100^1 of a stopping 
solution, pH 7.5 consisting of sodium dodecyl sulphate (2 % (w /v )),
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ATP (45m M ) and cAMP (1 .3m M ). 50^1 of [ 3H]cAMP (approx. 
10,000cpm ) was added to each tube prior to boiling for 3 minutes. 
1 ml of deionised water was then added to each sample, and the 
[ 3 2P]cAMP content of each tube determined.
2 .8 .2  Preparation of dowex and alumina columns
The method used to quantify the amount of cAMP produced by each 
sample was identical to that of Salomon (1 9 7 9 ) and involves the 
separation of cAMP from other nucleotides by dowex and then 
alumina chromatography. Dowex AG 50W -X4 (2 0 0 -4 0 0  mesh) was 
washed repeatedly with deionised water until the effluent was 
colour-free. The dowex was mixed with deionised water to a slurry 
( 1:1 v /v  ratio) and 2 ml samples of homogeneous slurry were added 
to  glass wool-stoppered columns. The water was allowed to drain 
out and the columns filled with deionised water to allow all the 
beads to settle and form the column bed. The columns were then 
washed with 2ml of 1M HCI and stored at room temperature. Prior to 
use, each column was washed with 2 0 ml of deionised water.
The alumina columns were prepared by the addition of 0.6g of 
dry neutral alumina to glass wool-stoppered columns. The columns 
were washed with 12ml of 1M imidazole buffer, pH 7.3, followed by 
15m l of 0.1 M imidazole buffer, pH 7.3  and stored at room 
temperature. On the day of use, each column was washed with 8 ml of 
0.1 M imidazole buffer, pH 7.3.
2 .8 .3  Separation of cAMP on dowex columns
Prior to sample chromatography, the nucleotide elution profiles for 
each column were determined. This was performed by applying a 
mixture of [3 H]cAMP and [ a 3 2 P]ATP to the column and determining 
the elution volumes.
Assay blank systems were prepared containing approximately 
l x l 0 4 cpm [a 32P]ATP and l x l 0 4 cpm [3H]cAMP standards. 1ml H2O 
was added to each assay blank which was then decanted into a 
dowex column. The ATP and cAMP were eluted from the column by 
successive washes of the column with 0.5m l of water. Fractions 
were collected in vials containing 13m l o f ecoscint and 
radioactivity determined by scintillation counting in a dual label 
programme. The elution volumes required to elute the cAMP from the 
dowex columns were then determined from a graph as shown (Figure
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2 .5 ). Typical recovery from the dowex columns was always between 
70 and 80%.
The elution volume required to elute the cAMP from the 
alumina columns was determined as for the dowex columns. The 
cAMP was eluted from the alumina columns by successive washes of 
the columns with 0.5ml of O.TM imidazole buffer. Recoveries were 
similar to that obtained for the dowex columns.
2 .8 .4  Determination of cAMP produced bv membrane fractions
Samples (total volume 1.2ml) were added to prepared dowex columns 
and the ATP eluted with 1.5ml of water. 4ml of water was then 
added to the dowex columns and this eluate allowed to run directly 
onto the alumina columns. The cAMP fraction was eluted into vials 
containing 13ml of ecoscint, with 5ml of 0.1 M imidazole buffer, pH 
7.3.
The cAMP fractions obtained were counted on a dual label 
scintillation counting programme which automatically corrected for 
'spillover' from each channel. The amount of cAMP produced by each 
sample was calculated by taking into account the recovery from  
each column, based on the recovery of the [3H]cAMP internal 
standard, and corrected to 100%. Data was thus calculable in pmoles 
of cAMP produced per 15 minutes per mg of membrane protein.
2 .8 .5  Data analysis
Where appropriate, data were analysed for statistical significance 
using the Mann-Whitney U test for non-parametric data.
2 .9  Gel electrophoresis
Gel electrophoresis was carried out according to the discontinuous 
system described by Laemmli (1 9 7 0 ).
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Figure 2.5 The elution profiles of ATP and cAMP standards from  
dowex AG 50W-X4 (hydrogen form) and neutral alumina columns. The 
elution profiles of [ a 32P]ATP and [ 3H]cAMP from dowex 50W-X4 (H+ 
form) columns (Figure 2.5a) and the elution of [3H]cAMP from neutral 
alumina columns (Figure 2 .5b) were determined. Firstly, by the 
addition of a [ 3H]cAMP standard (1x10 4 cpm) and an [a 32P]ATP 
standard ( 1x 1 0 4 cpm) to a dowex column, followed by elution from 
the column by repeated addition of 0.5ml volumes of H2O (Figure 
2.5a). Secondly, an [ a 32P]ATP standard ( Ix lO 4 cpm) and a [ 3H]cAMP 
standard ( Ix lO 4 cpm) were added to a dowex column and eluted by 
the addition of 1.5ml and a further 4ml of H2O, respectively. The 
[ 3H]cAMP standard was eluted from the alumina column by repeated 
addition of 0.5m l volumes of 0.1 M imidazole buffer, pH 7.3 (Figure 
2.5b). The progress of both standards was monitored by counting 
0.5ml fractions of eluate in a scintillation counter.
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2.9.1 Resolving gel preparation
Stock Solutions (stored at 4°C):
Solution A 1.5M tris, 0.4%  (v /v ) SDS, pH 8 .8  with HCI
Solution B 0.5M tris, 0.4%  (v /v ) SDS, pH 6 .8  with HCI
Solution C 3 0 %  ( w /v )  a c ry la m id e , 0 .8 %  ( w /v )
N,N'-m ethylene-bis-acrylam ide  
Solution D 50% (v /v ) glycerol
Solution E 10% (w /v ) ammonium persulphate (made daily)
Solution F TEMED
Reservoir buffer: 0.025M  tris, 0 .1 92M glycine, 0.1%  (v /v ) SDS.
10%  (v /v )  acry lam id e /0 .27%  ( v /v )  N ,N '-m ethylene-b is- 
acrylamide gels were prepared from the stock solutions as follows:
Solution Volume (ml)
A 9
C 12
D 2.4
E 0.135
F 0 .0 1 2
h2o 12.3
The solution was immediately mixed and poured between two 
glass plates (200x200m m ) with 1.5mm spacers. The gel was layered 
with 0 .1%  (v /v )  SDS to exclude air, and le ft to  set at room 
temperature for approximately 2 hours.
2 .9 .2  Stacking gel preparation
Stacking gels were prepared from the stock solutions as follows:
Solution Volume (ml)
B 3.75
C 1.5
E 0.15
F 0.008
H20 9.7
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The solution was immediately mixed, layered on top of the 
resolving gel and allowed to polymerise around a 1 0 -well teflon  
comb.
Electrophoresis was performed overnight at 50V  at room 
temperature (Pharmacia power supply).
2.9.3 Sample preparation 
Protein precipitation
Samples were prepared for gel electrophoresis by sodium  
deoxycholate/trichloroacetic acid precipitation. 6.25^1 of 2% (w /v ) 
sodium deoxycholate was added to each sample, followed by 750^1 
of H2O, and then 250^1 of 24%  (w /v ) trichloroacetic acid. Samples 
were mixed then centrifuged at 1 2 ,0 0 0 xg for 2 0  minutes at room 
temperature, after which time the supernatants were removed and 
the pellets dissolved in 20^1 of 1 M tris base followed by 20^1  of 
Laemmli buffer (Laemmli, 1970) which consisted of 5M urea, 0 .1 7M 
SDS, 0.4M DTT, 0.05M tris/HCI pH 8.0, 0 .01%  bromphenol blue. The 
samples were then boiled for 3 minutes (Maizel, 1969), ready for gel 
electrophoresis.
2 .9 .4  Gel protein staining
A fter electrophoresis, the gel was placed in a tray on a stirring 
table and covered in stain solution which consisted of 0 .1 % (w /v )  
coomassie blue in 45%  (v /v ) H2O, 45%  (v /v ) methanol, 10% (v /v )  
acetic acid (glacial) for 2 hours. The stain solution was removed and 
replaced with destain solution (identical to  stain solution, but 
lacking coomassie blue) until excess stain had been removed to  
leave a clear background, and proteins were apparent on the gel as 
discrete bands.
2 .10  Western blotting
Proteins were separated under appropriate resolving conditions on 
SDS polyacrylamide gels overnight at 50V . The proteins were 
transferred to a nitrocellulose sheet for 2 hours at 1.5 Amps in an 
LKB transblot apparatus (Towbin e t a/., 1 9 7 9 ) with blotting buffer 
which consisted of 0 .1 92M glycine, 0.025M  tris, 20%  (v /v ) methanol. 
The sheet was then "blocked" for 2 hours at 37°C  with 5% (w /v )
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"marvel" (Premier Brands Ltd., S tafford, United Kingdom) in 
tris-buffered saline (TBS) consisting of 0.5M NaCI, 0 .02M  tris, pH 
7 .5 . The "marvel" was washed off with distilled H2 O, and the 
nitrocellulose sheet incubated overnight a t 3 7 °C  with the 
appropriate primary antiserum in 1 % (w /v )  gelatin, 0 .2 % (v /v )  
nonidet P-40 in phosphate-buffered saline (PBS) consisting of 
2.68mM KCI, 1 .47mM KH2P04, 137mM NaCI, 8.31 mM Na2HP0 4 .2 H20 . 
Next day, the antiserum was removed and the sheet subjected to 
thorough washing with distilled H20 , then a 10 minute wash in PBS, 
0.2%  nonidet P-40. The blot was then incubated for 2 hours at 37°C  
with a second antibody (horseradish peroxidase-labelled anti-rabbit 
IgG). This antibody was then removed, and the sheet subjected to 10 
minute washes in distilled H20  then PBS, 0.2%  nonidet P-40. The 
sheet was then washed thoroughly in PBS before being developed in 
40m l of lOmM tris, pH 7.5 with 0 .025%  (w /v ) ortho-dianisidine as 
substrate (Gawler e t a/., 1987 and Bushfield e ta /., 1990a ). (Both 
first and second antibodies could be reused for up to four times, and 
were stored at 4 °C  using 0 .0 0 4 %  (w /v )  thim erosal as an 
anti-bacterial agent.)
The bands on the nitrocellulose sheets were quantified by 
incubation at 37°C  for 2 hours with [ 1 2 5 l]-labelled anti-rabbit IgG. 
The [ 1 2 5 l]-lgG was removed and the sheet rinsed with PBS, 0.2%  
nonidet P-40. The sheet was then washed thoroughly with PBS, 
dried, and the bands subsequently cut out and counted using an NE 
1 6 1 2  gamma counter. (An alternative (and on occassions an 
additional) method of quantifying the bands on the nitrocellulose 
sheets was to subject the dried nitrocellulose sheets to  
autoradiography. Hyperfilm-MP was pre-exposed to an instantaneous 
flash of light using a sensitize pre-flash unit. The developed 
autoradiograph was then analysed by densitometric scanning using a 
Shimadzu dual-wavelength flying-spot scanner CS-9000 (VA Howe & 
Co., Banbury, Oxon, United Kingdom).)
2.11 Antibody production
All antisera used were generated against synthetic peptides, 
essentially as described by Goldsmith and colleagues (1 9 8 7 ) .  
Synthetic peptides were obtained from Biomac Ltd., University of 
Glasgow, Glasgow, Scotland.
3mg of the appropriate peptide and lOmg of keyhole limpet 
haemocyanin were dissolved slowly in 1 ml of 0 .1 M phosphate buffer,
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pH 7.0. 0.5ml of 21 mM glutaraldehyde (also in 0.1 M phosphate buffer, 
pH 7 .0 ) was then added dropwise with stirring and the combined 
1.5ml incubated overnight at room temperature.
The 1.5ml solution was mixed with an equal volume of 
complete Freund's adjuvant and briefly sonicated with a Branson 
'soniprobe' (Type 7532B ). 1ml aliquots of the resulting emulsion 
were injected in multiple subcutaneous sites in New Zealand white 
rabbits. Four weeks later, each animal received a booster 
immunisation with material identically prepared, except one half as 
much keyhole limpet haemocyanin and peptide were injected in 
incomplete Freund's adjuvant.
Bleeds were performed monthly with approximately 15ml 
taken from the ear artery and collected into a glass universal. Blood 
was left to clot overnight at 4°C and the plasma removed and 
centrifuged at 1,000xg in a Beckman TJ 6 for 10 minutes to pellet 
any remnants of the clot. The supernatants so produced were 
aliquoted into 250^,1 volumes and stored at -70°C  until use.
A range of different antisera were produced in the manner 
described, as summarised in Table 2.1.
2 .12  Antibody purification
Crude antisera were chromatographed on a 1.5x2cm  column of 
protein-A-sepharose 4B. A 5ml volume of antiserum in glycine 
buffer (1.5M glycine, 3M NaCI, pH 8 .9) was added to the column and 
allowed to equilibrate. The column was washed with glycine buffer 
until the eluate had an A 2 8O of 0 .0  and was then eluted with 0.1M  
citric acid, pH 4 .0  into 2M tris/HCI pH 7.5. The eluted IgG fractions 
were dialysed overnight against 1 ,000  volumes of 10mM tris/HCI, 
0.1 mM EDTA, pH 7.5, and lyophilised. Just prior to use, samples were 
reconstituted to the required dilution with the same buffer.
2 .13  Dose-responses for the anti-peotide antisera
Before the anti-peptide antisera were used routinely to quantify the 
levels of the different G-protein subunits in rat vascular tissue 
plasma membranes, dose-response curves were constructed for each 
primary antibody, plotting amount of membrane protein against 
amount of radioactivity incorporated. From the resulting graphs, a 
protein concentration within the linear part of the plot was chosen 
as the value of membrane protein to be loaded on the 10%
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Antiserum  Peptide employed G-protein sequence Antiserum identifies
CS1 RMHLRQYELL Gs« 3 8 5 - 3 9 4 Gsa
S G 2 KENLKDCGLF Transducin a  
3 4 1 - 3 5 0
Transducin a ,  G j l  a ,  
G j2 a
I 3 C KNNLKECGLY Gj3a 3 4 5 - 3 5 4 G j3 a
B N3 MSELDQLRQE Pi ( 1 - 1 0 ) P
C Q 2 QLNLKEYNLV Gqa 3 5 1 - 3 6 0  
Gi i a  3 5 0 - 3 5 9
Gqa, G i la
Table 2.1 Specificities of anti-G-protein antisera.
acrylam ide/0.27%  N,N'-methylene-bis-acrylamide gels. Figure 2.6  
shows an example of a dose-response curve constructed using an
anti-G j2a antiserum (SG2) in combination with [ 1 2 5 l]-lgG. The
amount of membrane protein chosen to be loaded on gels in order to 
quantify the levels of the Gj2 a-subunit in membranes was 60 \j®. 
Table 2 .2  lists the results from the dose-response curves 
constructed for the other anti-peptide antisera.
2 .14  Binding assays
Binding of [ 125 l]-cyanopindolol ( [ 1 2 5 I]CYP) to membranes was 
performed in assays (250^1) with 15^g of membrane protein in 
20mM HEPES, pH 8.0, containing 5mM MgCl2 and 1 mM EDTA (buffer A) 
for 45  minutes at 30°C  over which time equilibrium was achieved. 
[ 1 2 5 I]CYP bound to the membranes was collected by vacuum
filtration  through Whatman GF/C filters, which were washed
continually for 32 seconds with ice-cold buffer A. Non-specific 
binding was determined in parallel assays by the inclusion of lO^M 
propranolol. Blank values were determined by replacement of 
membrane protein with buffer. Non-specific binding was subtracted 
from total binding in order to determine specific binding.
Analysis of the specific binding data was performed using 
EBDA and LIGAND programmes from a collection of radioligand 
binding analysis programmes by G.A. McPherson (version 3 .0 ), 
published and distributed by Elsevier-BIOSOFT, Cambridge, United 
Kingdom.
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Figure 2.6 Dose-response for anti-Gj2a antiserum (SG2). The amount 
of membrane protein to be used in the quantification of Gj2 
a-subunit levels was chosen from the linear portion of the graph 
plotting protein concentration against radioactivity incorporated.
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Antiserum Amount of membrane protein (^g)
CS1 50
SG2 60
I3C 50
BN3 50
CQ2 25
Table 2.2 Results of optimal quantities of membrane protein chosen 
from dose-responses for anti-peptide antisera.
Chapter 3 Comparison of vascular G-oroteins in SHRs and Wistar
rats
3.1 Introduction
The enzyme adenylyl cyclase plays an important role in determining 
vascular tone, generally by counteracting  Ca2 + - in d u c e d  
vasoconstriction (Tomlinson e t a/., 1985). Therefore, changes in ACA 
may be relevant to altered vascular reactivity in hypertension. 
Altered regulation of adenylyl cyclase has been reported in vascular 
tissues from the SHR. Reduced ACA in response to p-adrenergic 
stimulation has been demonstrated in mesenteric vasculature (Amer 
e t al., 1974 ), aorta (Amer e t a/., 1974; Amer, 1973; Triner e t al., 
1975; Bhalla and Sharma, 1982 and Anand-Srivastava, 1 9 8 8 ) and 
myocardium (Amer e ta /., 1974; Anand-Srivastava, 1988; Bhalla and 
Ashley, 1978; Bhalla et a/., 1980; Sharma e t a/., 1982; Kumano e t a/., 
1983 and McLellan e t a/., 1993) of the SHR. Thus, Amer e t al. (1 9 7 4 )  
observed a s ign ificantly  e levated  in trace llu la r guanosine 
3 \ 5 f-cyclic monophosphate (cGMP):cAMP ratio in the aortas and 
mesenteric arteries from SHRs. This group also noted that ACA in 
both the aortas and hearts of the hypertensive animals was less 
sensitive  to  stim ulation  by the  p-adrenergic stim ulant, 
isoproterenol. Triner e t al. (1 9 7 5 ), using thoracic aortic strips, 
observed a higher basal ACA in SHRs, which was not significantly 
different from the value measured in WKY rats. NaF-stimulated ACA 
in SHRs was significantly higher, while the relaxing e ffe c t of 
isoproterenol at all concentrations on a dose-response curve was 
markedly smaller, as was the cAMP response. A study performed by 
Bhalla and Sharma (1 9 8 2 ) showed no difference in the basal ACA in 
the caudal artery of SHRs as compared to WKY rats, but guanine 
nucleotide-, isoproterenol-, and flu oride-s tim u la ted  enzym e  
activity was significantly lower in SHRs. Anand-Srivastava (1 9 8 8 )  
studied ACA in the myocardial sarcolemma and aorta of SHRs and 
WKY controls. Basal enzyme activity was decreased in the SHR as 
was stimulation by isoproterenol, NaF, forskolin, GTP and p(NH)ppG. 
These studies reported altered regulation of ACA in SHR vascular 
tissues (in particular, reduced response to  p-adrenergic 
stimulation), but did not examine the mechanism(s) underlying this 
abnormality.
In a study examining Gs function in vascular tissue from the 
SHR, Asano and colleagues (1 9 8 8 )  suggested th a t defects in
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relaxation of femoral arterial strips in response to p-adrenoceptor 
stim ulation were due to  a ltered function  of a cholera  
toxin-sensitive G-protein i.e. Gs. Bhalla and co-workers ( 1 9 8 0 )  
suggested that sensitivity of the adenylyl cyclase enzyme to 
isoproterenol in SHR myocardial membrane preparations was 
decreased. Further studies by this group suggested that ACA and the 
number of p-adrenergic receptors in rat heart decrease with age and 
th a t in hypertension, a specific decrease in isoproterenol 
stimulation of cyclase appears at all stages of development. Kumano 
e t al. ( 1 9 8 3 ) ,  also studying myocardial membranes, observed that 
ACA was unchanged in SHRs compared to WKY rats measured under 
basal conditions or following stimulation by NaF, a GTP analogue, 
MnCl2 , or forskolin. However, isoproterenol-stim ulated cyclase 
activity in SHRs was decreased as was p-adrenergic receptor 
density, with no change in receptor affinity. A study by McLellan e t  
al. ( 1 9 9 3 )  assessed whether changes in G-protein expression and 
fun ction ing  w ere responsible fo r reduced p-adrenergic 
agonist-stimulated ACA in SHR myocardium. Similar experiments 
were performed in non-vascular tissue (renal cortex) to investigate 
whether any observed changes were part of a more widely 
distributed membrane defect. A reduced ACA in response to  
forskolin, NaF, PGEi, glucagon and isoproterenol was observed in 
SHR myocardium compared with WKY. However, with the exception of 
forskolin-stimulated activity, which was greater in SHRs than in 
Wistar rats, SHR myocardial ACAs were similar to those in Wistar 
rat membranes. Immunoblotting studies showed similar levels of 
G-protein subunits (G sa ,  G j l a ,  G j2 a ,  G j3 a ,  Goa and p) in all three 
strains. Studies of renal cortical plasma membranes failed to  
identify any differences in ACA or in G-protein subunit levels. 
Hence, SHRs, WKY rats and Wistar rats exhibited differences in 
myocardial ACA which were not seen in renal cortical plasma 
membranes. It was suggested that these differences were not 
related to differences in G-protein levels, and probably reflected  
strain differences in Gs function. Michel e t al. ( 1 9 9 3 )  also examined 
whether alterations in cardiac G-protein number or function, or 
both, were involved in the desensitisation of adenylyl cyclase 
responsiveness in the SHR. The amounts of immunodetectable Gsa, 
Gja, Gqa and p-subunit did not differ significantly in SHR and WKY 
myocardial membranes. The function of Gsa was quantified by 
reconstitution of cardiac cholate extracts into e y e  cell membranes 
with subsequent measurement of NaF-stim ulated ACA. It was
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observed that Gs function did not differ significantly in myocardial 
membranes from SHRs and WKY rats. As reduced stimulation of ACA 
in vascular smooth muscle might lead to  altered vascular 
responsiveness to vasodilator ligands, these findings may be 
important in the pathogenesis of hypertension.
Reduced p-adrenergic stimulation in SHR vascular tissues may 
not be a consequence of just altered Gs levels/function and/or 
p-adrenoceptor num ber/affinity. In addition, abnormalities in the 
levels and/or function of Gj may exist. Reduced function of Gj has 
been reported in platelets from the SHR. Coquil and Brunelle (1 9 8 9 )  
compared the effects of p(NH)ppG on ACA of platelet membranes in 
SHRs and WKY rats. In the presence of forskolin, low concentrations 
of p(NH)ppG inhibited the enzyme activity in both strains, but the 
maximal level of inhibition was significantly lower in SHRs. The 
significance of this, and its relevance to  vascular tissue remain 
unclear.
The SHR (and human essential hypertension) share a number of 
common pathophysiological features w ith diabetes m ellitus, 
including resistance to the action of insulin and hyperinsulinaemia, 
and it is of interest that abnormal expression and function of Gj has 
also been reported in human non-insulin dependent diabetes mellitus 
and in animal models of diabetes. Livingstone e t al. (1 9 9 1 ) compared 
ACA and G-protein levels in platelets from normal and non-insulin 
dependent diabetic male subjects. Whilst no differences were noted 
in basal and NaF-stimulated ACA, the degree of stimulation achieved 
by both forskolin and PGEi, was lower in diabetic subjects. Lower 
a 2 -adrenoceptor-m ediated inhibition of PGEi-stim ulated ACA in 
platelet membranes from diabetic subjects was evident. Whilst 
platelets of diabetic subjects had levels of Gsa which were 
comparable to those found in control subjects, their levels of Gj2a 
and Gj3a were reduced. Gawler and colleagues (1 9 8 7 ) showed that 
experimentally-induced Type I diabetes led to the loss of expression 
of Gja in rat liver. Strassheim e t al. (1 9 9 0 ) noted that adipocyte 
membranes from rats made diabetic with streptozotocin had their 
GTP-dependent, but not receptor-dependent inhibitory function of Gj 
on ACA abolished. This group also observed that induction of 
diabetes did not cause any change in the levels of Gjl a , Gj2a and Gsa 
in adipocyte membranes, but elicited an increase in the level of 
Gj3a. The induction of diabetes reduced the specific activity of 
adenylyl cyclase in adipocyte membranes and enhanced the  
stimulatory effect of isoproterenol. Further studies by Bushfield e t
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a /.  (1 9 9 0 a )  using h e p a to c y te  m em b ra n e s  fro m
streptozotocin-diabetic animals showed markedly decreased levels 
of G j2 a ,  G j3 a  and the 42kDa, but not the 45kDa, form of Gsa 
compared with controls. In hepatocyte membranes, immunoblot 
analysis showed that levels of the catalytic unit of adenylyl cyclase 
were increased upon induction of diabetes. Under basal conditions, it 
was noted that Gj2 from hepatocytes of diabetic animals was both 
phosphorylated to a greater extent and resistant to  any further 
phosphorylation. Low concentrations of p(NH)ppG inhibited ACA in 
hepatocyte membranes from normal, but not diabetic, animals. These 
studies reported altered regulation of ACA in human diabetes 
mellitus and animal models of the condition, w ith significant 
alterations in Gi levels and function.
It was, therefore, of interest to examine whether altered 
G-protein levels or function in VSM membranes from hypertensive 
animals might account for the abnormal regulation of adenylyl 
cyclase in response to p-adrenergic stimulation. It was also of 
interest to examine whether changes in Gj function, similar to those 
observed in human diabetes mellitus and animal models of the 
condition, might be present in vascular tissue from the SHR. 
G-protein levels and function were studied using plasma membranes 
prepared from mesenteric arteries. A similar set of experiments 
were performed using membranes prepared from vascular smooth 
muscle cells isolated from mesenteric arteries, to  investigate  
whether any abnormalities in the regulation of ACA and/or G-protein 
levels/function, noted in mesenteric artery membranes, persisted in 
vascular tissue cultured out of its physiological environment.
The outbred Wistar strain, rather than Wistar-Kyoto rats, was 
chosen as the control group in this study, in view of evidence that 
the WKY rats obtainable from most commercial suppliers display 
marked genetic heterogeneity. Kurtz and Morris (1 9 8 7 ) obtained WKY 
rats from two of the largest commercial suppliers in the United 
States and systematically measured the growth rate and blood 
pressure of these rats under identical physical and metabolic 
conditions. They found that WKY rats from one source differed from 
those of the other in both growth rate and blood pressure. In 
particular, DNA fingerprinting on genomic DNA of WKY rats showed 
evidence of genetic variability not only among WKY rats from two 
different breeding facilities, but also among WKY rats within a 
single breeding facility (Kurtz e t a/., 1989 and Samani e t a/., 1989). 
SHR and WKY strains from one source only shared approximately 50%
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of their DNA fingerprint bands in common, providing evidence of 
extensive genetic polymorphism between these strains (St. Lezin e t  
al., 1992 ). Johnson e t a/. (1 9 9 2 ) estimated the amount of genetic 
divergence between the SHR and WKY strains using a method of 
restriction fragment length polymorphism analysis. They found an 
extremely high amount of divergence, given the known origin of 
these two strains, which is comparable to the maximum divergence 
possible between unrelated humans.
3.2 Materials and Methods
3.2.1 Rats
Spontaneously hypertensive rats and Wistar rats were purchased 
from Charles River Ltd., Margate, Kent, United Kingdom. The rats 
were male and were sacrificed at 11 weeks of age. Prior to  
sacrifice, the rats had their systolic blood pressures and weights 
measured (see section 2.2 for details): SHR 208±2.7m m Hg; Wistar 
144±2.5mmHg, p=0.001 and SHR 258±1.9g; Wistar 286±2.7g, p=0.001, 
respectively. Measurements were made from ten rats of each strain 
and significance was assessed by t-test analysis.
3 .2 .2  Smooth muscle cell preparation and maintenance
VSMC were isolated by enzymic digestion from mesenteric arteries 
according to the procedure outlined in section 2 .5 .1 . The cells were 
grown in culture through four passages by following the methods of 
sections 2.5.2 and 2.5.3.
3 .2 .3  Preparation of membranes
Production of plasma membranes from mesenteric arteries and 
VSMC is outlined in section 2.6.
3 .2 .4  Measurement of protein concentration
Protein concentrations in the membrane preparations were  
determined using the method outlined in section 2.7.
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3.2.5 Adenvlvl cvclase activity
The regulation of adenylyl cyclase activity was monitored by the 
method of Salomon (1 9 7 9 ) outlined in sections 2.8.1 and 2.8.4.
3.2 .6  Quantification of 6-protein subunits
The levels of the G-protein subunits were quantified using a 
combination of SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
(see section 2.9 for details) and immunoblotting with specific 
anti-peptide antisera (see section 2 .10 for details).
3.3 Results
3.3.1 Regulation of adenvlvl cvclase activity in mesenteric artery 
membranes
Adenylyl cyclase activity assays were performed using mesenteric 
artery plasma membranes isolated from SHRs and Wistar rats. The 
basal level of ACA in SHR membranes was significantly higher than 
that measured in Wistar: SHR 690±73  pmol cAMP/15min/mg; Wistar 
445±52 , p=0.0181 (Figure 3.1). In the presence of MnCl2 (2x10~2M), a 
higher ACA was again observed in SHR membranes; however, it was 
not significantly different from the value measured in Wistar 
membranes: SHR 7 1 7 ± 1 0 9  pmol cAMP/15m in/m g; Wistar 5 0 2 ± 4 8  
(Figure 3 .1 ). (A high concentration of Mn2+ ions uncouples adenylyl 
cyclase from its regulatory G-proteins (Limbird e t al., 1 9 7 9 ).)
The results of regulation of adenylyl cyclase have been 
expressed as % change from basal activity (measured in the absence 
and presence of Mn2+ ions) due to the differences observed in basal 
ACA, in the absence and presence of Mn2+ ions, in SHR and Wistar 
membranes. Figures 3 .2 (a ) and 3 .2 (b ) show the % change in ACA 
expressed relative to basal activity measured in the absence of 
Mn2+ ions in SHR and Wistar mesenteric artery membranes after the 
addition of forskolin (1 0 _4M), NaF (1 0 _2M) and isoproterenol 
( 1 0 - 4 M), P G E i ( 1 0 '5M), respectively. There were significant 
differences in the extents of stimulation caused by the addition of 
NaF (SHR 324±35% ; Wistar 782±87% , p=0 .0019), isoproterenol (SHR 
11 ±8%; Wistar 48±11% , p=0.0356) and PGEi (SHR 19 ± 1 0%; Wistar 
77±16% , p=0 .0053), with a decreased response in SHR membranes. 
The response to forskolin was decreased in SHR membranes
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Figure 3.1 Adenylyl cyclase activity in SHR and Wistar mesenteric 
artery membranes measured in the absence and presence of MnCl2 
(2 x 1 0 “2M). Data are mean±S.E. for eight experiments using different 
membrane preparations.
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compared to Wistar, but the difference was not statistically  
significant (SHR 358±41% ; Wistar 493±63% ).
The overall results were not altered by expressing data 
relative to  basal activity measured in the presence of MnCl2 
(2 x 1 0 _2M). Figures 3 .3 (a ) and 3 .3 (b ) show the effects on ACA in 
response to forskolin (1 0 ’ 4 m), NaF (1 0 “2M) and isoproterenol 
( 1 0 _4M), PGEi (10"5M), respectively. There were significant 
differences in the extents of stimulation in the presence of NaF 
(SHR 335±53% ; Wistar 662±64% , p=0.0039) and PGEi (SHR 16±6%; 
W istar 52±8% , p = 0 .0 0 8 6 ), with a decreased response in SHR 
membranes. The responses to forskolin and isoproterenol were 
reduced in SHR membranes compared to Wistar, but the differences 
were not statistically significant (forskolin: SHR 349±24% ; Wistar 
423±57%  and isoproterenol: SHR 10±7%; Wistar 28±8% ).
Variable inhibition was seen with forskolin-stimulated ACA in 
SHR and Wistar membranes in response to a range of ligands 
(adrenaline (1 0 “5M)/propranolol (1 0 “5M) (this combination being 
equivalent to an a 2-adrenoceptor agonist), carbachol (1 0 _3M) and 
5-hydroxytryptam ine (1 0 " 5 M )), but overall no s ign ifican t 
differences were seen (adrenaline/propranolol: SHR -8±3% ; Wistar 
-0 .4 ± 1 0 % , carbachol: SHR -1 7 ± 4 % ; W istar -4 ± 1 4 %  and
5-hydroxytryptamine: SHR -20±5% ; Wistar -4±10% ). The extents of 
inhibition in both sets of membranes, in response to these ligands, 
were not increased in the presence of isoproterenol (data not 
shown).
3 .3 .2  Regulation of adenvlvl cvclase activity in VSMC membranes
Adenylyl cyclase activity assays were performed using VSMC 
membranes isolated from the mesenteric arteries of SHRs and 
W istar rats. The basal level of ACA in SHR membranes was 
significantly higher than that measured in Wistar membranes: SHR 
1 1 96 5 ±1259  pmol cAMP/15min/mg; Wistar 2618 ±2 7 6 , p=0.0304.
The results of regulation of adenylyl cyclase have been 
expressed as % change from basal activity measured in the absence 
of Mn2+ ions. Figure 3 .4  shows the responses of SHR and Wistar 
VSMC membranes in the presence of forskolin (1 0 “4M), NaF (1 0 -2M) 
and isoproterenol (10"4 M). There were significant differences in the 
extents of stimulation caused by the addition of forskolin (SHR 
689±52% ; Wistar 1050±59% , p=0.0304), NaF (SHR 285±6% ; Wistar
82
Figure 3.3 % Change in ACA expressed relative to basal activity 
measured in the presence of MnCl2 (2x10"2M) in SHR and Wistar 
mesenteric artery membranes in the presence of (a) forskolin 
( 1 0 _4M) and NaF (1 0 -2M) and (b) isoproterenol (1 0 _4M) and PGEi 
(1 0 "5M). Data are meaniS.E. for eight experiments using different 
membrane preparations.
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Figure 3 .4  % Change in ACA expressed relative to basal activity 
measured in the absence of MnCl2 in SHR and Wistar VSMC 
membranes in the presence of forskolin (1 0 _4M)f NaF (1 0 “2M) and 
isoproterenol (1 0 _4M). Data are mean±S.E. for eight experiments 
using different membrane preparations.
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769±49% , p=0.0304) and isoproterenol (SHR 76±7% ; Wistar 230±23% , 
p =0.0304), with a decreased response in SHR membranes.
The inhibitions of forskolin-stimuJated ACA in response to a 
combination of adrenaline (10"5M) and propranolol (1 0 _5M) in SHR 
and Wistar membranes were measured. Similar extents of inhibition 
were observed in both sets of membranes: SHR -9±3% ; Wistar 
-11 ±7%.
3 .3 .3  Levels of G-protein subunits in mesenteric artery membranes
Preliminary immunoblotting experiments identified Gsa (two forms; 
44  and 42kDa), G j2 a ,  G j3a  and the p-subunit in rat VSM plasma 
membranes, whereas Goa and G j l a  were absent. The levels of these 
different G-protein a-subunits and the p-subunit were compared in 
SHR and W istar mesenteric artery membranes using specific 
anti-peptide antisera, as described in Table 2.1 and section 2 .1 3 .  
Figures 3 .5 ,  3 .6 , 3 .7  and 3 .8  are photographs of nitrocellulose sheets 
probed with CS1, SG2, I3C and BN3 antisera, respectively. The 
p rim a ry  a n tib o d ie s  w ere  d e te c te d  by h o rserad ish  
peroxidase-labelled anti-rabbit IgG and colour development with 
ortho-dianisidine as substrate. The bands on the nitrocellulose 
sheets were quantified with [ 125l]-labelled anti-rabbit IgG (Table 
3 . 1 ) .  There were no significant differences in the levels of the 
different G-protein subunits present in SHR and Wistar mesenteric 
artery membranes.
3 .3 .4  Levels of G-protein subunits in VSMC membranes
The levels of Gsa (both forms; 44 and 42kDa), G j2 a ,  G j3a  and the 
p-subunit were quantified in SHR and Wistar VSMC membranes. As in 
mesenteric artery membranes, there were no significant differences 
in the levels of the different G-protein subunits present in SHR and 
Wistar VSMC membranes (results not shown).
3 .4  Discussion
3.4.1 Reduced stimulation of adenvlvl cvclase activity via Gg and 
receptors in SHRs
A significant reduction in the stimulation of ACA in VSM and VSMC 
from the SHR, compared with Wistar control, has been observed. The
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Figure 3.5 Nitrocellulose sheet with SHR and Wistar mesenteric 
artery membranes probed with Gsa-specific Ab (CS1). 5 (V g  of 
membrane protein was loaded in each lane. Two forms of Gsa are 
apparent (44  and 42kDa), with the 44kDa form being predominant in 
VSM. 1-3=W istar membranes, 4-6=SHR membranes and 7=human 
platelet membrane.
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Figure 3.6 Nitrocellulose sheet with SHR and Wistar mesenteric 
artery membranes probed with transducin a ,  G jla , Gj2a-specific Ab 
(SG2). Since rat VSM does not express detectable levels of G j l a  and 
transducin distribution is restricted to photoreceptor-containing  
tissues, the antiserum SG2 will only identify G j2 a  in rat VSM. 60n.g 
of membrane protein was loaded in each lane. 1 -3=W istar  
membranes, 4-6=SHR membranes and 7=human platelet membrane.
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Figure 3 .7  Nitrocellulose sheet with SHR and Wistar mesenteric 
artery membranes probed with Gj3a-specific Ab (I3C ). 50^g of 
membrane protein was loaded in each lane. 1-3=W istar membranes 
and 4&5=SHR membranes.
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Ficure 3 .8  Nitrocellulose sheet with SHR and Wistar mesenteric 
artery membranes probed with p-subunit-specific Ab (BN3). 50ng of 
membrane protein was loaded in each lane. 1-3=SHR membranes and 
4-5=Wistar membranes.
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G-protein subunit SHR (counts/minute) Wistar (counts/m inute)
Gs« (44kDa) 3221±126 31 80±232
Gsa (42kDa) 1819±95 1928±58
Gj2ot 3254±377 3795±237
G j3 a 717±44 662±44
p 1517±75 1439±91
Table 3.1 Quantification of bands on nitrocellulose sheets with SHR 
and Wistar mesenteric artery membranes using [ 125l]-labelled Ab. 
Data represent mean±S.E. for four experiments using different 
membrane preparations. Statistical analysis of results did not 
disclose any significant differences.
overall results examining Gs and Gj levels and function were similar 
in membranes made directly from the mesenteric artery and in 
membranes prepared from VSMC isolated from mesenteric arteries. 
The increased basal ACA measured in SHR mesenteric artery  
membranes was also observed in membranes prepared from VSMC 
isolated from SHR mesenteric arteries. Thus, culturing vascular 
tissue did not perturb the regulation of ACA nor G-protein 
leve ls /fun ctio n . The reduced adenylyl cyclase response to  
stimulation which has been demonstrated was seen with two  
different ligands, which activate the enzyme via receptors coupled 
to Gs, namely isoproterenol and PGEi. Other investigators (Triner e t  
a l ., 1 9 7 5 ) have reported difficulties in achieving hormonal 
stimulation of adenylyl cyclase in broken cell preparations of 
vascular smooth muscle, possibly reflecting physical disruption of 
the linkages among receptor/G-protein/adenylyl cyclase in such 
preparations. Indeed, relatively slight stim ulatory responses to  
isoproterenol and PGEi were observed in this study. However, the 
responses were significantly reduced in SHR membranes and the  
abnormality was also noted with an agent, NaF, which activates 
adenylyl cyclase via receptor independent activation of Gs. The 
decreased adenylyl cyclase response in VSM does not appear to be a 
consequence of a direct change in the catalytic subunit itself: 
forskolin , which d irectly  ac tiva tes  the c a ta ly tic  subunit 
independently of receptors, produced responses in SHR and Wistar 
membranes which were not significantly different. Additionally, the 
decreased responsiveness in SHR membranes was also seen when the 
data were expressed as % change relative to basal activity measured 
in the presence of MnCl2 (which uncouples adenylyl cyclase from its 
regulatory G-proteins, and may represent a more realistic basal 
measurement (Limbird et al., 1979)). It seems, therefore, that there 
is a true decrease in responsiveness of adenylyl cyclase to  
stimulatory agents in VSM membranes from the SHR, which is not 
accounted for by an intrinsic change in the basal activity of the 
enzyme.
3 .4 .2  Gi levels and function
These data are consistent with other studies which have examined 
ACA in vascular tissues from SHRs and control rats (see section 3.1 
for details). These previous studies did not, however, examine the 
underlying reason for the reduced adenylyl cyclase response in the
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SHR. This study has examined whether this altered responsiveness 
could be explained by abnormalities in the amount or function of 
either Gs or Gj. No evidence of altered inhibition of ACA in response 
to  a number of ligands, which act via Gj (including studies where Gj 
was activated in the presence of partly stimulated ACA (with  
isoproterenol)), was found, suggesting that the function of this 
G-protein was normal. Similarly, G j 2 a -  and G j3a-subunit levels 
were not altered in SHR membranes compared with Wistar (rat VSM 
does not express detectable levels of G j la ) .  The functional 
significance of Gj sub-types has yet to be established, although 
there is mounting evidence which suggests that at least Gj2 can 
serve to inhibit adenylyl cyclase (Bushfield e ta /., 1990b; McKenzie 
and Milligan, 1990; Simonds e ta /., 1989a and Senogles e ta /., 1990). 
There is evidence (Pobiner et a/., 1991) which suggests that Gj3 can 
elic it inhibition of ACA via angiotensin I I  receptors in rat 
hepatocytes. These data contrast with findings from studies on SHR 
platelet membranes reported by Coquil and Brunelle (1 9 8 9 ) , who 
noted that Gj function, as measured by activation w ith low 
concentrations of p(NH)ppG, was significantly reduced. They  
suggested that this could account for the increased cAMP response 
noted in platelets from hypertensive rats in response to  PGEi. 
However, the relevance of platelet studies in hypertensive animals 
is uncertain, and no direct measurement was made of Gs function in 
that study.
3 .4 .3  Evidence of increased Gi levels in SHRs compared with WKY 
rats
Anand-Srivastava e ta /. (1 9 9 1 ) measured the levels of G-proteins in 
aorta and heart from SHRs and WKY rats. The level of Gj was 
significantly increased in the hearts and aortas from SHRs, while 
the level of Gs was similar in SHRs and controls. Stimulatory 
responses to epinephrine, isoproterenol, dopamine and forskolin 
were diminished in SHR hearts and aortas as compared to  WKY 
(Anand-Srivastava, 1988 ). This group suggested that an increased 
level of Gj in SHRs may be associated with the decreased ACA in 
response to stimulatory hormones. It was suggested th a t the  
increased level of Gj may be one of the mechanisms responsible for 
the diminished vascular tone and impaired myocardial functions in 
hypertension. Anand-Srivastava e ta /. (1 9 9 1 ) observed significantly 
higher mRNA levels of Gj2a and Gj3a in hearts and aortas from SHRs
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as compared to WKY, however, the mRNA levels of Gs were not 
different in SHRs from WKY, indicating increased expression of 
genes of Gj2a and Gj3a  and not of Gs in heart and aorta from SHRs. 
The level of Gjcx was observed by Bohm e t al. ( 1 9 9 2 )  to be increased 
in membranes of hypertrophic hearts from SHRs w ithout heart 
failure. In addition, myocardial p-adrenoceptors were reduced in 
SHRs. These studies used the WKY strain of rat as a normotensive 
control; however, genetic heterogeneity has been reported in this 
strain of rat (see 3.1 for details), highlighting concerns about the 
suitability of WKY rats as a normotensive control group in studies 
with the SHR.
3 .4 .4  Gg levels and function
Immunoblotting studies did not show any alterations in the levels of 
the two Gs a-subunits within plasma membranes from the SHR, 
excluding a contribution from altered Gs levels to the changes in 
ACA. Levels of the p-subunit were not different in membranes from  
SHRs and Wistar rats. Although there are data which suggest that 
Py-subunit complexes can contribute to regulation of ACA (Federman 
e t a/., 1 9 9 2 ) ,  this does not account for the altered ACA in SHRs. 
Instead, these data may support an abnormality of Gs function. 
Asano et al. ( 1 9 8 8 )  suggested that defects in relaxation of femoral 
arterial strips, in response to p-adrenoceptor stimulation, were due 
to  altered function of a cholera toxin-sensitive G-protein i.e. Gs- 
Work by Murakami and colleagues ( 1 9 8 7 )  studying the p-adrenergic  
receptor-adenylyl cyclase system of cardiac membranes in SHRs 
suggested a reduction in the activity of Gs- Stimulation of ACA by 
either forskolin or purified Gs was higher in SHRs; however, 
stimulations of ACA by isoproterenol and GTP were similar in SHRs 
and controls. Although there was no difference in the amount of Gs 
in SHR m em branes, the functional a c tiv ity  o f Gs in 
cholate-extracted membranes from SHRs was significantly lower 
than that from control rats. There were no strain differences in the 
number and affinity of p-adrenergic receptors, the function and 
amount of Gi, and the amount of py-subunits. These findings would, 
therefore, tend to support the data presented here.
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3.4.5 Role of p-adrenergic receptors in decreased stimulation of
adenvlvl cvclase activity
The SHR is a model of hypertension which shows reduced sensitivity 
to insulin (insulin resistance), a finding which is also present in 
human essential hypertension. In a study of another animal model 
which displays insulin resistance (the diabetic (d b /d b ) mouse), a 
decreased adenylyl cyclase response to isoproterenol was noted in 
adipose tissue (Strassheim e t al., 1991). In that study, there was no 
change in the level of Gs, although a marked increase in the level of 
Gjl a-subunit was demonstrated in adipocyte membranes from the 
d b /d b  animals compared with their normal, lean litterm ates. 
However, a study by Begin-Heick (1 9 9 2 ) observed a decreased level 
of Gsa (46kDa form) in adipocyte plasma membranes of db/db mice 
compared with homozygous controls, but there was no significant 
difference in the level of the 42kDa form of Gsa. There were also 
reduced levels of Gjl a and G j2ain the db mutant. Gjl a-subunit is 
not, however, expressed in rat VSM, and it is not believed to have a 
role in the modulation of ACA. The apparent explanation for the 
decreased adenylyl cyclase response in the db/db mouse appears to 
be a reduction in p-adrenoceptor number. Cardiac membranes from  
the obese Zucker rat, which is not diabetic, but nevertheless 
profoundly insulin-resistant and hypertensive, dem onstrated  
reduced p-adrenergic stimulation of adenylyl cyclase in comparison 
to  lean controls (Strassheim e t a/., 1 9 9 2 ). The heart tissue 
membranes from  obese Zucker rats showed both reduced 
p-adrenergic receptor number and altered coupling between  
p-adrenergic receptors and Gs- However, no alterations in either the 
level of Gs or the functional interaction between Gs and the 
catalytic m oiety of adenylyl cyclase were observed. Although 
p-adrenoceptor number was not measured in this study, other 
investigators have failed to agree on observed changes in 
p-adrenoceptor number and affinity in SHR vascular tissues (Bhalla 
e t a/., 1 9 8 0  and Kumano e t al., 1 9 8 3 ). However, these data 
demonstrate a significantly decreased adenylyl cyclase response to 
NaF, which activates Gs independently of receptors, and support the 
notion that the decreased ACA observed in the SHR is due to altered 
Gs function or coupling rather than altered receptor number.
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3.4 .6  Physiological relevance of reduced stimulation of adenvlvl
cvclase activity in SHRs
The reason for the apparent abnormality of Gs function is unclear, 
and the significance of reduced adenylyl cyclase response to  
stimulatory agents in SHR vascular membranes also remains to be 
determined. If the higher basal ACA found in SHR VSM membranes 
were part of a compensatory mechanism to reduce the elevated 
blood pressure, a higher response to isoproterenol would be expected 
in SHRs. However, since the response to isoproterenol was decreased 
in SHRs, the more likely interpretation is that the higher basal ACA 
in SHRs may be a compensatory mechanism for the deficient 
capability of the enzyme to respond to p-adrenergic stimulation. On 
the other hand, ACA, under physiological conditions, is unlikely to 
exist in the basal state, as it would be continually regulated 
(stim ulated and inhibited) by circulating hormones. Therefore, 
m easurem ent of basal ACA in this study is probably not 
representative of the in vivo situation. Indeed, the reduced 
responsiveness of adenylyl cyclase to p-adrenergic stimulation may 
be a more representative reflection of the true tissue adenylyl 
cyclase situation. It is unclear whether the reduced responsiveness 
to p-adrenergic stimulation is a primary abnormality in the SHR or 
secondary to some other event. Studies in other hypertensive models 
and in animals at an earlier stage in the developm ent of 
hypertension are appropriate in order to investigate this further. 
Chapters 5 and 6 study G-protein function and levels in the Milan 
hypertensive strain compared with the Milan normotensive strain in 
adult and young rats, respectively.
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Chapter 4 Comparison of vascular G-proteins in SHRs. Wistar
rats, and WKY rats
4.1 Introduction
As has been discussed in section 3.1, altered regulation of ACA has 
been well documented in vascular tissue from the SHR (Amer e t aI., 
1974; Amer, 1973; Triner e t al., 1975; Bhalla and Sharma, 1982; 
Anand-Srivastava, 1988; Bhalla and Ashley, 1978; Bhalla e t al., 
1980; Sharma e t al., 1982 and Kumano e t al., 1 9 8 3 ), and may 
contribute to increased vascular reactivity. These studies used WKY 
rats as the normotensive control group. However, as mentioned 
previously, genetic heterogeneity has been reported in these rats 
from different commercial suppliers, and indeed, in rats from the 
same supplier (Kurtz and Morris, 1987 and Kurtz e t al., 1989). These 
reports highlight the difficulties in finding a suitable control group 
for studies with the SHR. Indeed, genetic heterogeneity has also 
been reported in SHRs from different sources (Nabika e ta /., 1991). 
Hence, difficulties may arise when results from studies using rats 
from different suppliers are compared i.e. the differences in the 
genome of SHRs and WKY rats from different suppliers may vary, and 
these differences may interfere with the overall results of the 
study.
To address these points, G-protein levels and function were 
studied in vascular tissue from the SHR and also Wistar and WKY 
rats. Two normotensive control groups were included in these 
experiments to examine whether the differences between SHRs and 
WKY rats were also seen when a different normotensive control was 
used. Furthermore, the three strains of rat in this study were 
purchased from a different supplier to the one that supplied the rats 
for the study detailed in Chapter 3. Hence, the results from similar 
studies using rats from different sources could be compared.
Abnormalities of phospholipase C (PLC) activation have been 
reported in vascular and non-vascular tissues from the SHR 
(Millanvoye et al., 1988; Kato and Takenawa, 1987 and Remmal e t al., 
1 9 8 7 ). The enzyme PLC alters the intracellular concentrations of the 
second messengers inositol 1 ,4 ,5 -tris p h o s p h a te  (IP 3 ) and 
diacylglycerol (DG), and is linked to cell surface receptors by a 
G-protein named Gp (Cockcroft and Gomperts, 1 9 8 5 ). Recent 
evidence has indicated that this polypeptide is a member of the 
G q / G n  subfamily of G-proteins (Gutowski e t al., 1991 ). Millanvoye
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e t al. (1 9 8 8 )  have reported higher PLC activity in response to  
angiotensin n in SHR aortic smooth muscle cells compared with WKY. 
Increased activity of PLC has also been noted in erythrocyte ghosts 
from the SHR compared with WKY (Kato and Takenawa, 1987 ), while 
experiments involving thrombin stimulation of lipid metabolism by 
Remmal e t al. (1 9 8 7 ) suggested enhanced PLC activity in SHR 
platelets compared with WKY. It was, therefore, of interest to  
examine whether these reported increased PLC activities in the SHR 
reflected increased levels of G q / G n .
4.2 Materials and Methods
4.2.1 Rats
Spontaneously hypertensive, Wistar and W istar-Kyoto rats were 
purchased from Harlan Olac Ltd., Oxon, United Kingdom. The rats 
were male and were sacrificed at 11 weeks of age. Prior to  
sacrifice, the rats had their systolic blood pressures and weights 
measured (see section 2.2 for details): SHR 202±9m m Hg; Wistar 
137±4; WKY 130±6 (p=0.001 for Wistar vs. SHR and WKY vs. SHR) and 
SHR 205±5g; Wistar 270±2; WKY 212±8  (p=0.001 for SHR vs. Wistar 
and WKY vs. Wistar), respectively. Measurements were made from  
ten rats of each strain and significance was assessed by t - te s t  
analysis.
4.2 .2  Smooth muscle cell preparation and maintenance
VSMC were isolated by enzymic digestion from mesenteric arteries 
according to the procedure outlined in section 2 .5 .1 . The cells were 
grown in culture through four passages by following the methods of 
sections 2.5.2 and 2.5.3.
4.2.3 Preparation of membranes
Production of plasma membranes from mesenteric arteries and 
VSMC is outlined in section 2.6.
4 .2 .4  Measurement of protein concentration
Protein concentrations in the membrane preparations were 
determined using the method outlined in section 2.7.
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4.2.5 Adenvlvl cvclase activity
The regulation of adenylyl cyclase activity was monitored by the 
method of Salomon (1 97 9 ) outlined in sections 2.8.1 and 2.8.4.
4 .2 .6  Quantification of G-protein subunits
The levels of the G-protein subunits were quantified using a 
combination of SDS-PAGE (see section 2 .9  for details) and 
immunoblotting with specific anti-peptide antisera (see section 
2 .1 0  for details).
4 .3  Results
4.3.1 Regulation of adenvlvl cvclase activity in VSMC membranes
Basal ACA (whether measured in absence/presence of Mn2+ ions) 
was similar in SHR and WKY membranes, but both were significantly 
lower than basal ACA measured in Wistar membranes (Figure 4 .1 ). 
Table 4.1 shows that the addition of Mn2 + ions resulted in an 
inhibition of ACA in SHR, WKY and Wistar membranes. A high 
concentration of Mn2+ ions uncouples adenylyl cyclase from its 
regulatory G-proteins (Limbird e ta /., 1979 ). In these VSMC, there 
appears to be a much greater measurable input from Gs than Gj, 
hence uncoupling these G-proteins would probably tend towards 
inhibition of ACA. A similar trend in activities was seen in the 
presence of forskolin (1 0 “4 M), which activates the catalytic unit of 
adenylyl cyclase directly (Figure 4 .1 ). In view of these inherent 
differences in enzyme activity, the responses to the various agents 
studied were expressed as % change over basal (measured in 
absence/presence of Mn2+ ions).
(i) S tim ulatory effects  expressed relative to  basal activ ity  
measured in the absence of MnCl?
Figure 4.2 shows the % change in ACA expressed relative to basal 
activity measured in the absence of Mn2+ ions in SHR, Wistar and 
WKY VSMC membranes after the addition of forskolin (1 0 ’4M), NaF 
( 1 0 ”2M), isoproterenol (1 0 -4M) and PGEi (1 0 _5M). The response to 
forskolin was similar in Wistar and WKY membranes; however, a
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Figure 4.1 Adenylyl cyclase activity in SHR, Wistar and WKY VSMC 
membranes measured in the absence and presence of MnCl2 
( 2 x 1 0 -2 M), and in the presence of forskolin ( 1 0 '4M). Data are 
mean±S.E. for seven (SHR and Wistar) and eight (WKY) experiments 
using different membrane preparations.
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Figure 4 .2  % Change in ACA expressed relative to basal activity  
measured in the absence of MnCl2 in SHR, Wistar and WKY VSMC 
membranes in the presence of forskolin ( 1 0 '4m), NaF (1 0 _2M ), 
isoproterenol (1 0 _4M) and PGEi (1 0 ‘ 5M). Data are mean±S.E. for 
seven (SHR and Wistar) and eight (WKY) experiments using different 
membrane preparations.
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Forskolin NaF Isoproterenol PGEi
SHR W istar WKY
Basal 1 1 0 7 1 4 8 * 2837±522 1 2 2 7 ± 6 6 *
(no Mn2+ ions)
Basal 10 2 4 ± 1 31* 19861119 9 9 8 1 8 6 *
(+  Mn2+ ions)
Table 4.1 Basal adenylyl cyclase activities in the absence and 
presence of MnCl2 (2 x10 "2M) in SHR, Wistar and WKY VSMC 
membranes. Adenylyl cyclase activity measurements represent pmol 
cAM P/15m in/m g. Data represent meanlS.E. for seven (SHR and 
W istar) and eight (WKY) experiments using d ifferent membrane 
preparations. "^Statistically significant when compared with Wistar 
results (see Figure 4.1 for p values).
significantly increased stimulatory response was observed in SHR 
membranes compared with both normotensive controls (SHR 
1 4 1 8 ± 1 11% ; W istar 8 8 6 ± 6 9 % ; WKY 9 0 0 ± 5 2 % ). A nother  
receptor-independent stim ulatory agent, NaF, also caused 
significantly greater stimulation in SHR membranes compared with 
both Wistar and WKY, while responses to NaF were similar in both 
control groups (SHR 472±24% ; Wistar 260±49% ; WKY 346±33% ). Use 
of the p-adrenergic agonist, isoproterenol, and PGEi allowed 
measurement of receptor-dependent stimulation of ACA via two 
different types of receptors. The stimulatory effects in response to 
isoproterenol were significantly d ifferent in all three sets of 
membranes. The responses in SHR and Wistar membranes were 
significantly reduced compared to WKY, while the SHR response was 
significantly increased compared with Wistar (SHR 96±17% ; Wistar 
34±9% ; WKY 138±15% ). The stimulatory responses measured on the 
addition of PGEi were not significantly different in the three sets 
of membranes (SHR 52±18%; Wistar 16±10%; WKY 40±17% ).
( ii)  Stim ulatory effects expressed relative to  basal activ ity  
measured in the presence of MnCI?
Figure 4.3 shows the % change in ACA expressed relative to basal 
activity measured in the presence of MnCl2 (2x10_2M) in SHR, Wistar 
and WKY VSMC membranes after the addition of forskolin (1 0 -4M), 
NaF (1 0 _2M), isoproterenol (10"4M) and PGEi (1 0 ‘ 5M). The response 
to forskolin was similar in Wistar and WKY membranes; however, an 
increased stimulatory response was observed in SHR membranes 
compared with both normotensive controls (statistically significant 
in the case of WKY only) (SHR 1593±116% ; Wistar 1271±219% ; WKY 
1 1 6 9 ± 1 0 4 % ). NaF was responsible for an increased stimulatory 
response in SHR membranes; however, this was not significantly 
different from the responses measured in the two control groups 
(SHR 565±80% ; Wistar 356±45% ; WKY 458±38% ). Isoproterenol was 
responsible for similar stimulatory responses in SHR and Wistar 
membranes; however, both these responses were significantly 
reduced compared with WKY (SHR 121 ±22% ; Wistar 89±32% ; WKY 
201 ±25% ). The stimulatory responses measured on the addition of 
PG Ei  were not significantly d ifferent in the three sets of 
membranes (SHR 96±42%; Wistar 67±45%; WKY 59±5% ).
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Figure 4.3  % Change in ACA expressed relative to basal activity 
measured in the presence of MnCl2 (2x10_2M) in SHR, Wistar and 
WKY VSMC membranes in the presence of forskolin (1 0 _4M), NaF 
(1 0 _2M), isoproterenol (1 0 '4M) and PGEi (lO ^M ). Data are meantS.E. 
for seven (SHR and Wistar) and eight (WKY) experiments using 
different membrane preparations.
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(iii) Inhibition of isoproterenol-stimulated adenvlvl cvclase activity
Gj function in SHR, Wistar and WKY membranes was demonstrated by 
the biphasic effects of GTP on isoproterenol-stimulated ACA (Figure 
4 .4 ). These GTP dose-effect experiments showed that activation of 
Gs and Gi occurred over similar concentration ranges of GTP in SHR, 
WKY and Wistar membranes. The extents of inhibition were measured 
from  the differences in adenylyl cyclase activities at GTP 
concentrations of 5x10_5M and 10’4M. Gj function was found to be 
similar in the three sets of membranes (SHR -5 .6± 1 .5 % ; Wistar 
-9 .2±2.3% ; WKY -9 .3±4.7% ). However, although the GTP response in 
SHR and WKY membranes was similar, it was significantly reduced 
in comparison to the response measured in Wistar membranes. (The 
GTP response was significantly reduced in SHR membranes compared 
with Wistar at a GTP concentration as low as 1 0 -7 M, while the 
difference in GTP responses in WKY and Wistar membranes became 
significant at 5x10"6M GTP.)
4 .3 .2  Levels of G-protein subunits in VSMC membranes
The levels of the different G-protein a-subunits (i.e. Gsa (4 4  and 
42kDa forms), Gj2« and Gj3a) and the level of the p-subunit were 
quantified in SHR, Wistar and WKY VSMC membranes using 
125 |-labelled anti-rabbit IgG. There were no significant differences 
in the levels of the different G-protein a-subunits and the level of 
the p-subunit in SHR, Wistar and WKY VSMC membranes (Figures 4.5, 
4.6, 4.7, 4.8 and Table 4.2).
The level of the a-subunit for G q /G n  was also quantified in 
SHR, Wistar and WKY VSMC membranes, using an antiserum raised 
against a synthetic peptide which represents the C-terminal 
decapeptide of the a-subunit of these two G-proteins (Mitchell e t  
al., 1 9 9 1 ). There were no significant differences in the levels of 
G q a /G n a  present in SHR, Wistar and WKY VSMC membranes (Figure 
4.9 and Table 4.2).
4 .3 .3  Levels of G-protein subunits in mesenteric artery membranes
The levels of the various G-protein a-subunits and the level of the 
p-subunit were also quantified in SHR, Wistar and WKY mesenteric 
artery membranes. There were no significant differences in the 
levels of Gsa (both forms), Gj2a, Gj3a, the p-subunit and G q a /G n a  in
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Figure 4 . 4  D o s e - e f f e c t  exper iments  for  GTP on 
isoproterenol-stim ulated ACA in SHR, Wistar and WKY VSMC 
membranes. ACA was monitored in the presence of isoproterenol 
(1 0 _4M). Data are mean±S.E. for five (SHR and Wistar) and four (WKY) 
experiments using different membrane preparations.
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Figure 4 .5  Nitrocellulose sheet with SHR, Wistar and WKY VSMC 
membranes probed with Gsa-specific Ab (CS1). 5 ( Vg  of membrane 
protein was loaded in each lane. Two forms of Gsa are apparent (44  
and 42kD a), with the 44kDa form being predominant in VSMC 
membranes. 1&2=Wistar membranes, 3&4=SHR membranes, 5&6=WKY 
membranes and 7=human platellet membrane.
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Figure 4 .6  Nitrocellulose sheet with SHR, Wistar and WKY VSMC 
membranes probed with transducin a, Gjl a , Gj2a-specific Ab (SG2). 
Since rat VSMC membranes do not express detectable levels of Gjl 
and t r a n s d u c i n  d i s t r i b u t i o n  is r e s t r i c t e d  to  
photoreceptor-containing tissues, the antiserum SG2 will only 
identify Gj2 in rat VSMC membranes. 60\ig  of membrane protein was 
loaded in each lane. 1&2=Wistar membranes, 3&4=SHR membranes, 
5&6=WKY membranes and 7=human platelet membrane.
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Figure 4 .7  Nitrocellulose sheet with SHR, Wistar and WKY VSMC 
membranes probed with Gj3a-specific Ab (I3C). 50ng of membrane 
protein was loaded in each lane. 1&2=Wistar membranes, 3&4=SHR 
membranes and 5&6=WKY membranes.
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Figure 4 .8  Nitrocellulose sheet with SHR, Wistar and WKY VSMC 
membranes probed with p-subunit-specific Ab (B N 3). 5 (V g  o f 
membrane protein was loaded in each lane. 1&2=Wistar membranes, 
3&4=SHR membranes, 5&6=WKY membranes and 7=human platelet 
membrane.
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Figure 4 .9  Nitrocellulose sheet with SHR, Wistar and WKY VSMC 
membranes probed with G q a /G i ia-specific Ab (CQ2). 25^g  of 
membrane protein was loaded in each lane. l&2=W istar membranes, 
3&4=SHR membranes, 5&6=WKY membranes and 7=human platelet 
membrane.
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G-protein subunit SHR (cpm) Wistar (cpm) WKY (cpm)
Gsa (44kDa) 7641135 9371113 9941151
Gs« (42kDa) 137±39 95126 139123
G j2 a 228191 301159 216156
G j3 a 131±25 165131 142116
P 1402160 16081212 13631132
G q a /G l 1a 1572178 1624159 17011115
Table 4.2 Quantification of bands on nitrocellulose sheets with SHR, 
Wistar and WKY VSMC membranes using [ 12 5 l]-labelled Ab. Data 
represent meanlS.E. for four experiments using different membrane 
preparations. Statistical analysis of results did not disclose any 
significant differences.
SHR, Wistar and WKY mesenteric artery membranes (Figures 4 .10 , 
4.11, 4.12, 4 .13, 4 .14 and Table 4.3).
4 .4  Discussion
4.4.1 Choice of rats
In this study, two normotensive control groups, namely the outbred 
Wistar strain and WKY strain, were included in experiments. The 
Wistar strain was chosen in addition to WKY rats as a normotensive 
group in view of evidence that the WKY rats obtainable from most 
commercial suppliers display marked genetic heterogeneity (Kurtz 
and Morris, 1987 and Kurtz e t a/., 1989) (for details see section 3.1). 
Indeed, genetic heterogeneity has also been reported in SHRs 
supplied by commercial suppliers (Nabika e ta /., 1991), thus, for this 
study, rats were purchased from a different supplier (Harlan Olac 
Ltd.) to the one that supplied the rats for the study detailed in 
Chapter 3 (Charles River Ltd.).
4 .4 .2  Adenvlvl cvclase catalytic subunit
The basal activity of adenylyl cyclase in SHR VSMC membranes was 
similar to that measured in WKY membranes; however, the basal 
ACAs in both SHR and WKY membranes were significantly lower than 
th a t observed in Wistar membranes. On the addition of MnCl2 
( 2 x 1 0 “2 M), the basal ACAs in the three sets of membranes were 
reduced, resulting in a situation similar to basal measurements i.e. 
SHR and WKY ACAs were similar, but both were significantly 
reduced compared with Wistar. Hence, results were expressed as % 
change over basal measured in the absence/presence of Mn2+ ions.
Forskolin, which directly activates the catalytic subunit of 
adenylyl cyclase, produced similar stimulatory responses in both 
control groups; however, SHR membranes exhibited a significantly 
increased response compared with both controls (statistically  
significant compared with WKY only, when results expressed 
relative to basal activity measured in the presence of Mn2+ ions). 
These results suggest an alteration at the enzyme level, possibly an 
increased level/responsiveness of the catalytic subunit of adenylyl 
cyclase in SHRs compared with control(s). In Chapter 3, forskolin 
produced similar effects in SHR and Wistar VSM membranes (rats 
supplied by Charles River Ltd.), suggesting no alteration at the
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Figure 4 .1 0  Nitrocellulose sheet with SHR, W istar and WKY 
mesenteric artery membranes probed with Gsa-specific Ab (CS1). 
50^g of membrane protein was loaded in each lane. Two forms of Gsa 
are apparent (44  and 42kDa), with the 44kDa form being predominant 
in VSM membranes. 1&2=human platelet membranes, 3&4=WKY  
membranes, 5&6=SHR membranes and 7&8=Wistar membranes.
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Figure 4 .11 Nitrocellulose sheet with SHR, W istar and WKY 
mesenteric artery  membranes probed with transducin a , G j la ,  
Gj2a-specific Ab (SG2). In rat VSM membranes, the antiserum SG2 
will only identify G j2a. 60^g of membrane protein was loaded in 
each lane. 1&2=human platelet membranes, 3&4=WKY membranes, 
5&6=SHR membranes and 7&8=Wistar membranes.

Figure 4 .12  Nitrocellulose sheet with SHR, W istar and WKY 
mesenteric artery membranes probed with Gj3a-specific Ab (I3C). 
50ng of membrane protein was loaded in each . lane. l& 2=W istar  
membranes, 3&4=SHR membranes and 5&6=WKY membranes.

Figure 4 .1 3  Nitrocellulose sheet with SHR, W istar and WKY 
mesenteric artery membranes probed with p-subunit-specific Ab 
(BN3). 5 (V g  of membrane protein was loaded in each lane. 
1&2=Wistar membranes, 3&4=SHR membranes, 5&6=WKY membranes 
and 7&8=human platelet membranes.

Figure 4 .1 4  Nitrocellulose sheet with SHR, W istar and WKY 
mesenteric artery membranes probed with G q a /G n a -sp ec ific  Ab 
(CQ2). 25^g of membrane protein was loaded in each lane. 
1&2=Wistar membranes, 3&4=SHR membranes, 5&6=WKY membranes 
and 7&8=human platelet membranes.

G-protein subunit SHR (cpm) Wistar (cpm) WKY (cpm)
Gs« (44kDa) 197±20 247±21 193±17
Gs« (42kDa) 96±21 118±18 103±25
G j2a 71 ±9 102±17 85±21
G j3a 105±12 111±15 97±8
p 561±39 748±63 6 1 9±50
G qa/G l 1a 298±23 276±19 314±16
Table 4.3 Quantification of bands on nitrocellulose sheets with SHR, 
Wistar and WKY mesenteric artery membranes using [ 1 25 l]-labelled  
Ab. Data represent meaniS.E. for four experiments using different 
membrane preparations. Statistical analysis of results did not 
disclose any significant differences.
adenylyl cyclase catalytic subunit level in these SHRs. In a study of 
another animal model which displays insulin resistance, the  
streptozotocin -d iabetic  rat, Bushfield e t al. (1 9 9 0 a ) reported 
increased levels of the catalytic subunit of adenylyl cyclase in 
hepatocyte and liver plasma membranes compared with control, 
although basal ACA was actually decreased in hepatocyte plasma 
membranes from diabetic animals. Unfortunately, the level of the 
catalytic subunit of adenylyl cyclase was unable to  be quantified in 
the three sets of membranes, as an appropriate antibody was not 
available.
4 .4 .3  G-orotein subunit levels
The levels of the G-protein subunits responsible for the regulation 
of ACA were quantified in SHR, W istar and WKY VSMC and 
mesenteric artery plasma membranes. No significant differences 
were found in the levels of Gsa (44  and 42kDa forms), Gj2a, Gj3a and 
the p-subunit in SHR, Wistar and WKY membranes. This was also the 
case in VSM membranes from Charles River Ltd. SHRs and Wistar 
rats (see sections 3.3 and 3.4  for details). G-protein subunit levels 
have also been measured in aorta and heart from SHRs and WKY rats 
by Anand-Srivastava et al. (1991 ). The level of Gja was significantly 
increased in the hearts and aortas from SHRs, while the level of Gsa 
was similar in SHRs and WKY rats. Indeed, Anand-Srivastava e t al. 
(1 9 9 1 )  observed significantly higher mRNA levels of Gj2a and Gj3a 
in heart and aorta from SHRs as compared to WKY rats, however, the 
mRNA levels of Gsa were not different in SHRs from WKY. However, 
these changes in SHR heart may not be primary abnormalities in 
hypertension, but may reflect changes secondary to increased blood 
pressure.
4 .4 .4  Function of
Gs function was assessed in VSMC membranes by NaF, like forskolin, 
a receptor-independent stimulatory agent. When the results were 
expressed as % change relative to basal activity measured in the 
absence of Mn2+ ions, the situation was similar to that of forskolin 
i.e. the stimulatory responses to NaF were similar in Wistar and WKY 
membranes; however, SHR membranes produced a significantly 
increased response compared with both controls. These results 
suggest that the function of Gs does not appear to be altered in SHR
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membranes compared with controls. When the results were 
expressed as % change relative to basal activity measured in the 
presence of Mn2+ ions, an increased response in SHR membranes was 
again noted, although it was not significantly different from the 
responses measured in the controls. Thus, while a significantly 
increased response to forskolin in SHR membranes compared to WKY 
was observed, this was reduced to a non-significant difference in 
the presence of NaF. This may suggest that an alteration in Gs 
function, i.e. decreased activity, exists in SHR membranes compared 
with WKY. In Chapter 3, a significantly decreased response to NaF 
was observed in SHR VSM membranes compared with Wistar using 
rats from a different supplier (see sections 3.3 and 3 .4  for details), 
suggesting altered Gs function or coupling in these SHRs compared 
with Wistar controls. Indeed, Murakami and colleagues (1 9 8 7 )  
observed a reduction in the functional activity of Gs in SHR cardiac 
membranes. This group observed that the stimulation of ACA by 
either forskolin or purified Gs was higher in SHRs; however, 
stimulation of ACA by isoproterenol and GTP was similar in SHRs 
and WKY rats. Although there was no difference in the amount of Gs 
in SHR m em branes, the fun ction a l a c tiv ity  o f Gs in 
cholate-extracted membranes from SHRs was significantly lower 
than that from WKY rats. The group observed no strain differences in 
the number and affinity of p-adrenergic receptors, the function and 
amount of Gj, and the amount of py-subunits. The levels of both 
forms of Gsa and the p-subunit were not altered in the three sets of 
membranes investigated in this study. However, the reduction in 
ACA in SHR membranes in response to NaF compared with forskolin 
may reflect functional differences in Gs from SHR and WKY 
membranes.
4 .4 .5  Function of Gi
Gj function was demonstrated by showing biphasic effects of GTP on 
isoproterenol-stimulated ACA. In this instance, low concentrations 
of GTP promote activation of adenylyl cyclase by stimulating the 
coupling of the p-adrenoceptor to Gs, whereas high concentrations 
cause inhibition due to activation of Gj (Cooper, 1982 and Heyworth 
e t a/., 1 9 84 ). Biphasic effects due to GTP were observed in SHR, 
Wistar and WKY VSMC membranes showing that Gj function was not 
different among the strains. The extents of inhibition measured in 
the three sets of VSMC membranes were relatively low compared
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with other systems (Coquil and Brunelle, 1 9 8 9 ). Indeed, the ACA 
assay was not sensitive enough to measure the inhibition in 
response to low concentrations of p(NH)ppG and GTPyS, and also 
neuropeptide Y and lysophosphatidic acid in the three sets of 
membranes (data not shown). Chapter 3 reported that Gj function 
was also similar in SHR and Wistar VSM membranes (rats purchased 
from Charles River Ltd.). However, decreased Gj function has been 
reported in platelets from the SHR by Coquil and Brunelle (1 9 8 9 ). 
However, the relevance of platelet studies in hypertensive animals 
is uncertain, and no direct measurement was made of Gs function in 
that study.
4.4.6 B-Adreneraic receptor num ber/affinitv/couplina
Although the GTP response in SHR and WKY membranes was similar, 
it was significantly reduced in comparison to the response measured 
in Wistar membranes. This suggests an alteration in the coupling of 
p-adrenoceptors to Gs in SHR (and WKY) membranes compared to 
Wistar. Cardiac membranes from the obese Zucker rat, which is not 
diabetic , but nevertheless profoundly insulin-resistant and 
hypertensive, demonstrated reduced p-adrenergic stim ulation of 
adenylyl cyclase in comparison to lean controls (Strassheim e t al., 
1 9 9 2 ). The heart tissue membranes from obese Zucker rats showed 
both reduced p-adrenergic receptor number and altered coupling 
between p-adrenergic receptors and Gs.
Reduced ACA in response to p-adrenergic stimulation in SHR 
vascular tissue has been well documented (Amer et al., 1974; Amer, 
1 9 7 3 ; T riner e t al., 1 9 7 5 ; Bhalla and Sharm a, 1 9 8 2 ;  
Anand-Srivastava, 1988; Bhalla and Ashley, 1978; Bhalla e t ah, 
1980; Sharma e t ah, 1982 and Kumano e t ah, 1 9 8 3 ). Isoproterenol 
stimulation, in VSMC membranes, was significantly reduced in the 
SHR compared with WKY. Whether the results were expressed as % 
change relative to basal activity measured in the absence or 
presence of Mn2+ ions, did not alter the finding, consistent with 
decreased p-adrenergic receptor num ber/a ffin ity  in SHR (and 
W istar) membranes compared with WKY. The reduced ACA in 
response to isoproterenol is consistent with the observed reduction 
in arterial relaxation in response to p-adrenoceptor stimulation in 
the SHR: studies by Asano and colleagues (1 9 8 8 )  using isolated 
femoral artery material from the SHR suggested, on the basis of
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indirect evidence, that this was a consequence of reduced Gs 
function.
Receptor-mediated stimulation of ACA was also examined 
using PGEi. The responses PGEi produced were not significantly 
different in the three sets of membranes. However, when the 
increased response to NaF is compared with the decrease in ACA in 
response to PGEi in SHRs, the data suggest decreased PGEi receptor 
number/affinity in SHR membranes compared with Wistar and WKY. 
The extents of stimulation in response to isoproterenol and PGEi 
were measured in VSM membranes from Charles River Ltd. SHRs and 
Wistar rats (see sections 3.3 and 3.4 for details). In these rats, the 
stimulatory responses to both ligands were significantly reduced in 
SHR membranes compared with Wistar.
4 .4 .7  Activity of phospholipase C and levels of its regulatory 
G-oroteins
The adenylyl cyclase enzyme is not the only effector system linked 
to cell surface receptors by G-proteins. The enzyme PLC, which 
alters the intracellular concentrations of the second messengers IP3 
and DG, is linked to cell surface receptors by a G-protein named Gp 
(Cockcroft and Gomperts, 1985). Recent evidence has indicated that 
this polypeptide is a member of the G q /G n  subfamily of G-proteins 
(Gutowski e t a/., 1991). Millanvoye et al. (1 9 8 8 ) have reported higher 
PLC activity in response to angiotensin I I  in SHR aortic smooth 
muscle cells compared with WKY. Increased activity of PLC has also 
been noted in erythrocyte ghosts from the SHR compared with WKY 
(Kato and Takenawa, 1987), while experiments involving thrombin 
stimulation of lipid metabolism by Remmal e ta /. (1 9 8 7 ) suggested 
enhanced PLC activity in SHR platelets compared with WKY. It was 
of interest to  examine whether these reported increased PLC 
activities in the SHR were a consequence of increased levels of 
G q / G n .  However, no significant differences were found in the levels 
of G q a /G n a  in SHR, Wistar and WKY VSM membranes.
4 .4 .8  Conclusions
Differences in the regulation of ACA have been identified among the 
three strains studied. There appeared to be an alteration at the 
adenylyl cyclase catalytic subunit level in SHR membranes compared 
with WKY. There may also be an alteration at this level in SHR
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membranes compared with Wistar control, but this did not reach 
statistical significance. Depending on how the results were 
expressed, there may be decreased Gs activity in SHR membranes 
compared with WKY; however, the function of Gs in SHR and Wistar 
membranes appeared to be similar.
GTP dose-effect experiments on isoproterenol-stimulated ACA 
demonstrated that Gj function was not altered in SHR membranes as 
compared with W istar and WKY; however, these experiments  
highlighted an alteration in the coupling of p-adrenoceptors to Gs in 
SHR m em branes compared to  W istar. This a lte ra tio n  in 
p-adrenoceptor-G s coupling was also present in WKY membranes 
compared to Wistar.
As with other studies (Amer e t  a/., 1974; Amer, 1973; Triner 
e t  a/., 1975; Bhalla and Sharma, 1982; Anand-Srivastava, 1988; 
Bhalla and Ashley, 1978; Bhalla et a/., 1980; Sharma e ta /., 1982 and 
Kumano e t a/., 1983), a reduced response of ACA to isoproterenol in 
SHR membranes compared to WKY was noted. This reduced 
p-adrenergic stimulation was also observed in Wistar membranes 
compared to WKY. It can be seen, therefore, th a t there are 
differences in the regulation of ACA among the three strains, and 
differences in the regulation of ACA between the two normotensive 
control strains are obvious. While these changes may reflect 
hypertension and its genetic antecedent, the possibility is raised, by 
inclusion of the Wistar control group, that the genetic heterogeneity 
reported in SHR and WKY strains (Nabika e t  a/., 1991; Kurtz and 
Morris, 1987 and Kurtz et a/., 1989) may contribute substantially to 
the differences detailed in this (and other) studies of ACA, and raise 
the possibility that these changes are not directly linked to the 
development of increased blood pressure.
Chapter 3 detailed a study examining G-protein levels and 
function in SHRs and Wistar rats supplied by Charles River Ltd. 
However, for this study, SHRs, Wistar and WKY rats were purchased 
from Harlan Olac Ltd., as genetic heterogeneity has been reported in 
both SHRs and WKY rats from different commercial suppliers (Nabika 
e t a/., 1991; Kurtz and Morris, 1 987  and Kurtz et al., 1 9 8 9 ). 
Differences in the regulation of ACA in SHR membranes compared 
with W istar were observed in both studies; however, these  
differences were not similar and seemed to depend on where the 
rats were purchased. Hence, the remainder of this thesis involved 
work using VSMC (obtained from one source) isolated from another
99
rodent model of genetic hypertension, the Milan hypertensive strain 
and its isogenic control, the Milan normotensive strain.
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Chapter 5 Comparison of vascular G-proteins in adult MHS and
MNS rats
5.1 Introduction
The Milan hypertensive strain and the Milan normotensive strain 
descend from two mating pairs of Wistar origin rats from an outbred 
colony, which had mean blood pressures of 164mmHg and 168mmHg. 
The hypertensive strain was obtained by breeding for high blood 
pressure and the control strain was obtained by breeding for normal 
blood pressure (Bianchi et al., 1984).
The MHS is a useful animal model for studying the mechanisms 
th a t may be responsible for human essential hypertension. For 
example, Bianchi e t al. (1 9 8 4 ) measured different factors in the 
prehypertensive phases of both rats and humans and compared the 
results with those obtained for appropriate controls of the same 
age. They chose the prehypertensive phase in order to detect changes 
that existed before the development of hypertension, and thus, 
cannot be secondary to the hypertension, per se. Moreover, during the 
tim e-in terval between birth and the developm ent of overt 
hypertension, the genetic factors responsible for hypertension may 
already have produced biochemical or physiological abnormalities. 
Due to the difficulty of defining a prehypertensive phase in human 
subjects, young normotensive subjects with two hypertensive 
parents were compared with subjects of the same age, but with two 
normotensive parents, on the assumption that, later in life, the 
former will develop hypertension more frequently (about 50% ) than 
the latter (about 2%). This group observed that a number of features 
in the MHS are similar to those observed in human essential 
hypertension, with simliar changes in whole-kidney function  
(glomerular filtration rate and renal blood flow), morphology of the 
kidney and adrenal (by light or electron microscopy), 24 hour urinary 
e le c tro ly te  ou tpu t, extracellu lar fluid volum e, to ta l and 
exchangeable body Na+, plasma electrolytes, plasma and urine 
osmolarity, plasma aldosterone, and plasma catecholamines.
5.1.1 Renal abnormalities
The key role of the kidney in this animal model of genetic 
hypertension has been demonstrated. Studies of the effect of kidney 
cross-transplantation between adult MHS rats and adult MNS rats
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showed th a t the MHS kidney produced hypertension in MNS. 
Transplantation has also been carried out between MHS and MNS rats 
at one month of age, when the difference in donor blood pressure 
was slight and of short duration, to determine whether this pressor 
effect of the MHS kidney was primary in nature or secondary to renal 
injury due to prolonged perfusion at high blood pressure of the MHS 
donor kidney. The blood pressure measured 120  days after kidney 
transplantation into one-month-old MHS rats was 1 52±2m m Hg in 
recipients of MHS kidneys and 130±5m m Hg in recipients of MNS 
kidneys (p < 0 .0 1 ). Therefore, MHS kidneys have a greater pressor 
effect even when taken from young donors with almost equal blood 
pressure, demonstrating that the pressor effect of the MHS kidney 
exists prior to hypertension (Fox and Bianchi, 1976 ). In addition, the 
relative sodium retention in MHS during the development of the 
blood pressure difference between the two strains is in keeping 
with a renal origin of hypertension in MHS. To evaluate further the 
role of the kidney, whole kidney clearance and micropuncture 
techniques were used to study whole kidney and single nephron 
filtration rate and proximal fluid reabsorption in both strains 
before, during and after the development of hypertension in MHS. 
Both single nephron and whole kidney glomerular filtration rates are 
significantly lower in young MHS before the developm ent of 
hypertension, while in adult animals, whole kidney glomerular 
filtration rate is equal and superficial single nephron filtration rate 
is higher in MHS (discrepancy explained by lower number of 
glomeruli in MHS kidney) (Bianchi and Baer, 1976).
5.1.2 Ion flux changes
Na+ transport across brush-border vesicles isolated from proximal 
tubular cells has been reported to be faster in MHS. When 
erythrocytes and proximal tubular cells of MHS rats were compared 
to those of MNS rats, the former had smaller volume and Na+ 
content, whereas the Na+ transport was faster and the Ca2+ ATPase 
at V max was lower. This indicates that the cellular abnormality 
which may be responsible for the renal functional abnormality and 
hypertension is also present in erythrocytes. Moreover, MHS 
erythrocyte abnormalities are genetically determined within the 
stem cells and cosegregate with hypertension (Parenti e ta /., 1986  
and Bianchi e t a/., 1986). In addition, the MHS is characterised in the 
p re h y p e rte n s iv e  phase by a s ig n if ic a n t ly  fa s te r
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bumetanide-sensitive cell membrane Na+-K+ -C I_ cotransport as 
compared to age-matched MNS (Salvati e t a/., 1 9 9 0 ). These 
observations are in keeping with data showing an increased sodium 
transport across renal tubules of the MHS, and support the  
hypothesis that the abnormality in sodium and w ater handling by 
kidneys from MHS can be related to an alteration in sodium transport 
across the luminal membrane of the proximal tubule cells (Parenti 
et a/., 1986 ). Indeed, the activity of the (Na+-K+)-ATPase from the 
kidney cortex of the MHS has been reported to be increased, 
resulting in an increased ATP-dependent ouabain-sensitive sodium 
transport in MHS rats, supporting the hypothesis that a higher 
tubular sodium reabsorption may be involved in the pathogenesis of 
hypertension in this rat strain (Parenti e t a/., 1991 ).
As mentioned earlier, erythrocytes and proximal tubular cells 
of MHS rats possess similar cellular abnormalities, and because a 
correlation was also found in human hypertension between  
erythrocyte Na+ transport abnormality and renal function, it was 
proposed that the erythrocyte may be used for studying the genetic 
molecular mechanisms of hypertension. In comparison to MNS, 
erythrocytes in MHS were observed to be smaller and had lower 
sodium concentration, and Na+-K+ cotransport and passive 
perm eability were faster. These differences persisted a fte r  
transplantation of bone marrow to irradiated Fi (MHSxMNS) hybrids. 
Moreover, in normal segregating F2 hybrid populations there was a 
positive correlation between blood pressure and Na+-K+ 
cotransport, suggesting a genetic and functional link in MHS between 
cell membrane cation transport abnormalities and hypertension 
(Ferrari e t al., 1987 ). The erythrocytes of MHS rats have a faster 
Na+-K+-CI- cotransport than erythrocytes from MNS rats. However, 
the difference in Na+-K+-Ch cotransport is no longer present in 
inside-out vesicles of erythrocyte membranes, and data support the 
hypothesis that an abnormality in the membrane skeletal proteins 
may play a role in the different Na+-K+-Ch cotransport modulation 
between MHS and MNS erythrocytes (Ferrari e t a/., 1992).
Abnormalities at the cellular level have also been observed in 
MHS thoracic aortic vascular smooth muscle cells. It has been noted 
that smooth muscle cells from MHS rats exhibit increased growth in 
culture in comparison with the MNS, associated with higher 
N a+-K +-Ch cotransport activity (Vallega e t al. , 198 9 ). While the 
number and affinity of angiotensin I I  (Ang n) receptors were similar 
in VSMC from both strains, cultured smooth muscle cells from MHS
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rats exhibited blunted phospholipase C, Na+-H+ exchange, and 
cytosolic Ca2+ responses to Ang II,  suggesting that in this model of 
low renin hypertension, Ang n receptor response is blunted during 
increased growth rates (Socorro e t a/., 1990).
5.1.3 g-Adreneraic receptor measurements
Since cerebral and renal a-adrenergic receptors play an important 
role in the control of blood pressure, the densities and affinities of 
«1 -adrenergic and a 2-adrenergic receptors have been examined in 
prehypertensive and hypertensive rats. In the cerebral cortex, no 
betw een-strain differences in « i-ad ren erg ic  and a 2-adrenergic  
receptor density and affinity were observed in prehypertensive and 
hypertensive rats. In the renal cortex, the differences between MHS 
and MNS rats concerned a 2 -adrenergic receptors only. MHS rats 
showed a lower affinity for the antagonist, [ 3H]rauwolscine, in the 
prehypertensive period and absence of the normal age-related  
increase in receptor density. A lower density of [ 3H]rauwolscine 
binding sites in the hypertensive period was also observed. In 
hypertensive rats, epinephrine bound to one class of sites in MHS 
rats and to two classes in MNS rats, while data suggest uncoupling 
of epinephrine receptors from its G-protein in MHS rats. The 
modifications of renal « 2-adrenergic receptors were more evident 
in the hypertensive period when the impaired tubular sodium 
reabsorption observed in the prehypertensive period had almost 
returned to normal. Taken together, these data suggest that the 
modification of renal a 2-adrenergic receptors in MHS rats could be a 
compensatory mechanism to counteract the increased renal sodium 
reabsorption, rather than the cause of the developm ent of 
hypertension in MHS rats (Parini e t a/., 1987 ).
5.1.4 Summary
In conclusion, although the MHS has not been as extensively studied
as the SHR, the role of the kidney in this model of genetic
hypertension has been demonstrated. Sodium transport in MHS
erythrocytes and proximal tubular cells, in comparison to MNS, has 
been observed to be abnormal, and this has been implicated in the 
pathogenesis of hypertension in this rat strain. Although
a-adrenergic receptors have been studied in the MHS and 
abnormalities noted regarding renal a 2-adrenergic receptors (Parini
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et al., 1987 ), p-adrenergic receptors have not been examined. Since 
reduced stimulation of ACA through p-adrenergic receptors has been 
extensively reported in SHR vascular tissues, and may play a role in 
this strain of rat's increased vascular reactivity (Asano e t a/., 
1 9 8 8 ), it was of in terest to investigate the p-adrenergic 
receptor-adenylyl cyclase system in vasculature from the MHS. 
Little has been reported on membrane signal transduction in the 
MHS, hence, the regulation of the key intracellular enzyme adenylyl 
cyclase by stimulatory and inhibitory G-proteins was investigated 
in VSMC in this study. As the activity of PLC has been reported to be 
diminished in MHS VSMC in response to Ang II ,  the levels of its 
regulatory G-proteins ( G q / G n )  were measured to ascertain whether 
an abnormality in the levels of G q /G i  1 contributed to  the blunted 
PLC activity in response to Ang n. VSMC isolated from thoracic 
aortas from  adult (hypertensive, 6 0 -d a y -o ld ) and young 
(prehypertensive, 30-day-old) rats were studied (Chapters 5 and 6 , 
respectively).
5.2 Materials and Methods
5.2.1 Rats
Milan hypertensive strain and Milan normotensive strain rats were 
sacrificed at 60 days of age. Rats, the same age as those used for 
preparation of VSMC, had their systolic blood pressures measured: 
MHS 170±1.9mmHg; MNS 138±1.8mmHg, p<0.001. Measurements were 
made from  19 and 16 rats of MHS and MNS, respectively  
(significance was assessed by t-test analysis).
5.2.2 Smooth muscle cell preparation and maintenance
VSMC were isolated by enzymic digestion from thoracic aortas from 
four rats of each strain according to the procedure outlined in 
section 2 .5 .1 . The cells were grown in culture through seven 
passages by following the methods of sections 2.5 .2 . and 2.5 .3 .
5.2.3 Preparation of membranes
Production of plasma membranes from VSMC is outlined in section 
2.6.
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5.2.4 Measurement of protein concentration
Protein concentrations in the membrane preparations were 
determined using the method outlined in section 2.7.
5 .2 .5  Adenvlvl cvclase activity
The regulation of adenylyl cyclase activity was monitored by the 
method of Salomon (1 97 9 ) outlined in sections 2.8.1 and 2.8.4.
5 .2 .6  Quantification of G-protein subunits
The levels of the G-protein subunits were quantified using a 
combination of SDS-PAGE (see section 2 .9  for details) and 
immunoblotting with specific anti-peptide antisera (see section 
2 . 1 0  for details).
5.2.7 B-Adreneraic receptor measurements
The number and affinity of p-adrenergic receptors in MHS and MNS 
VSMC membranes were measured according to the procedure outlined 
in section 2.14.
5.3 Results
5.3.1 Regulation of adenvlvl cvclase activity
Basal ACA (whether measured in absence/presence of Mn2+ ions) 
was significantly increased in MHS membranes (Table 5 .1 ). The 
addition of MnCl2 ( 2 x1 0 _2M) resulted in significantly different 
degrees of inhibition of ACA in MHS and MNS membranes (MHS 
-67 .4±2 .5% ; MNS -41.3±3 .0% , p=0 .0002). (A high concentration of 
Mn2+ ions uncouples adenylyl cyclase from its regulatory G-proteins 
(Limbird e t a/., 1979 ). In these VSMC, there appears to be a much 
greater measurable input from Gs than Gj, hence, uncoupling these 
G-proteins would result in a fall in ACA.)
A similar trend in activities was seen in the presence of 
forskolin (1 0 -4 M), which directly activates the catalytic unit of 
adenylyl cyclase (MHS 1 5 ,7 0 9 ± 5 3 2  pmol cAM P/15m in/m g; MNS 
6 ,5 9 7 ± 4 4 2 , p = 0 .0 0 0 2 ). In view of these inherent differences in 
enzyme activity, the responses to the various agents studied were
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MHS MNS p value
Basal 2477±232 858±45 p=0.0002
(no Mn2+ ions)
Basal 781 ±70 499±26 p=0.0058
(+  Mn2+ ions)
Table 5.1 Basal adenylyl cyclase activities in the absence and 
presence of MnCl2 (2x10-2M) in adult MHS and MNS VSMC membranes. 
A denylyl cyclase a c tiv ity  m easurem ents rep resen t pmol 
cAM P/15m in/m g. Data represent meantS.E. for ten experiments 
using different membrane preparations.
expressed as % change over basal (measured in the presence of Mn2+ 
ions, as this probably gives the closest approximation to the true 
basal activity). Figure 5.1 shows the % change in ACA over basal (in 
the presence of Mn2+ ions) in MHS and MNS membranes after the 
addition of (a) forskolin (1 0 _4 M) and (b) NaF (1 0 _2 M), isoproterenol 
( 1 0 “4 M) and PGEi (1 0 ‘ 5 M). Use of the p-adrenergic agonist, 
isoproterenol, and PGEi allowed measurement of receptor-dependent 
stimulation of ACA through two different types of stimulatory 
receptor. Both agonists caused significantly greater stimulation in 
MHS membranes compared with MNS (isoproterenol: MHS 324135% ; 
MNS 130±1 5%, p=0.0002 and PGEi: MHS 248130% ; MNS 107114% ,
p=0.0008).
To examine whether altered regulation of ACA in MHS was only 
apparent at the receptor level of the adenylyl cyclase system, or 
whether abnormalities were present at other levels of the signalling 
pathway, the responses of ACA to forskolin and NaF were studied. 
There was a significantly greater stimulatory response to forskolin 
in MHS membranes compared with MNS (MHS 2 0 3 4 1 1 7 2 % ; MNS 
12541114% , p=0.0046). However, the stimulations occurring in MHS 
and MNS membranes in response to another receptor-independent 
stim ulatory agent, NaF, were not significantly d ifferent (MHS 
490138% ; MNS 507139% ). When the data were expressed as % change 
from basal (no Mn2+ ions), NaF was the only stimulatory agent which 
produced significantly different stimulations in the two strains, 
with a reduced response observed in MHS membranes.
Gj function in MHS and MNS membranes was demonstrated by 
the biphasic effects of GTP on isoproterenol-stimulated ACA (Figure 
5.2). These GTP dose-effect experiments showed that activation of 
Gs and Gj occurred over similar concentration ranges of GTP in MHS 
and MNS membranes, suggesting that there was no difference in the 
function of Gj in MHS membranes compared with MNS (MHS 
-2 4 .1 1 2 .0 % ; MNS -1 9 .5 1 4 .5 % ). However, the stim ulatory GTP 
response in MHS membranes was increased in comparison to the 
response measured in MNS membranes. (Gj function was also 
measured using low concentrations of poorly hydrolysable analogues 
of GTP, namely p(NH)ppG and GTPyS. However, only very slight 
inhibitory responses were observed in these VSMC membranes (data 
not shown).)
In summary, these experiments examining the regulation of 
ACA, by expressing data relative to basal activity measured in the 
presence of Mn2+ ions, identified an increased ACA in MHS
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Figure 5.1 % Change in ACA expressed relative to basal activity 
measured in the presence of MnCl2 (2x10"2M) in adult MHS and MNS 
VSMC membranes in the presence of (a) forskolin (1 0 _4 M) and (b) NaF 
(1 0 “2M), isoproterenol (1 0 ‘4 M) and PGEi (10-5M). Data are meaniS.E. 
for ten experiments (nine for PGEi) using different membrane 
preparations.
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F ig ure  5 .2  D o s e -e ffe c t  e x p e rim e n ts  fo r GTP on 
isoproterenol-stim ulated ACA in adult MHS and MNS VSMC 
membranes. ACA was monitored in the presence of isoproterenol 
( 1 0 _4 M). Data are mean±S.E. for six experiments using different 
membrane preparations.
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membranes in response to directly activating forskolin and two 
ligands which mediate stimulation via receptors. However, NaF, 
which stimulates ACA via direct activation of Gs, resulted in 
similar levels of activity of the enzyme in both strains. These 
results suggest an increased level/responsiveness of the adenylyl 
cyclase catalytic subunit, decreased level/activ ity  of Gs and an 
increased number of p-adrenergic receptors in MHS VSMC 
membranes. When data were expressed relative to basal activity  
measured in the absence of Mn2+ ions, a decreased ACA in MHS 
membranes in response to NaF was identified, while similar 
stimulations were produced by forskolin, isoproterenol and PGEi in 
the two strains. These data suggest decreased level/activity of Gs 
and an increased number of p-adrenergic receptors in MHS VSMC 
membranes. Hence, although expressing the  data in the  
afore-mentioned ways results in different trends regarding the 
degrees of stimulation, the interpretations of these results are 
similar with respect to changes at the Gs and p-adrenoceptor level.
5 .3.2 G-protein subunit levels
Preliminary immunoblotting experiments identified Gsa (two forms; 
44 and 42kDa), Gj2a and Gj3a in VSMC plasma membranes, whereas 
Goa and G j la  were absent (Figure 5.3). The levels of these different 
G-protein a-subunits and the level of the p-subunit were quantified 
in MHS and MNS VSMC membranes using [ 1 25|]-labelled anti-rabbit 
IgG (Figures 5.4, 5.5, 5.6 & 5.7 and Table 5 .2). The Figures 5.4, 5.5,
5.6 & 5.7 (also 5.8, see later) show representative nitrocellulose 
sheets for each G-protein subunit, however, experiments were 
repeated three times using different membrane preparations. There 
was a significantly reduced level ( - 2 0 % reduction) of Gsa (both 
forms) in MHS membranes, while levels of G j2 a  were similar in MHS 
and MNS membranes. The level of Gj3a was dramatically reduced in 
MHS membranes ( -8 0 %  reduction) and a significant reduction in the 
level of the p-subunit ( -2 0 %  reduction) was also observed in MHS 
membranes.
The level of the a-subunit for G q /G n , the G-proteins coupling 
receptor activation to generation of DG and IP3 by PLC, was 
quantified in MHS and MNS membranes using an antiserum raised 
against a synthetic peptide which represents the C-terminal 
decapeptide of the a-subunit of these two G-proteins (Mitchell e t  
a/., 1 9 9 1 ) (Figure 5.8 and Table 5 .2 ). There was no significant
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Figure 5.3 Nitrocellulose sheet with adult MNS VSMC membrane 
probed with (a) Goa-specific Ab and (b) Gjla-specific Ab. 80^g of 
membrane protein was loaded in each lane. 1=MNS membrane and 
2 =rat brain membrane.
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Figure 5 .4  Nitrocellulose sheet with adult MHS and MNS VSMC 
membranes probed with Gsa-specific Ab (CS1). 5 (V g  of membrane 
protein was loaded in each lane. Two forms of Gsa are apparent (44  
and 42kD a), with the 44kDa form being predominant in VSMC 
membranes. 1 -3=MHS membranes and 4-6=MNS membranes.
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Figure 5 .5  Nitrocellulose sheet with adult MHS and MNS VSMC 
membranes probed with transducin a , G jla , Gj2a-specific Ab (SG2). 
Since rat VSMC membranes do not express detectable levels of Gjl 
and tra n s d u c in  d is t r ib u t io n  is r e s t r ic te d  to  
photoreceptor-containing tissues, the antiserum SG2 will only 
identify Gj2 in rat VSMC membranes. 60jig of membrane protein was 
loaded in each lane. 1-3=MHS membranes and 4-6=MNS membranes.

Figure 5 .6  Nitrocellulose sheet with adult MHS and MNS VSMC 
membranes probed with Gj3a-specific Ab (I3C). 50ng of membrane 
protein was loaded in each lane. 1-3=MHS membranes and 4-6=MNS  
membranes.
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Figure 5 .7  Nitrocellulose sheet with adult MHS and MNS VSMC 
membranes probed with p-subunit-specific Ab (BN3). 50ng of 
membrane protein was loaded in each lane. 1-3=MHS membranes and 
4-6=MNS membranes.

Figure 5 .8  Nitrocellulose sheet with adult MHS and MNS VSMC 
membranes probed with G qa/G n a-sp ec ific  Ab (CQ2). 25^g  of 
membrane protein was loaded in each lane. 1-3=MHS membranes and 
4-6=MNS membranes.

G-protein subunit MHS (cpm) MNS (cpm)
Gsa (44kDa) 2 2 6 8 ± 1 0 2 2 9 9 7 1 1 4 3 *
Gs« (42kDa) 9 2 1 ± 5 6 1 2 0 3 1 7 2 *
G j2 a 3 2 3 5 ± 1 6 5 3 1 0 7 1 1 8 3
G j3 a 1 9 5 ± 1 7 8 9 8 1 4 1 *
P 1 3 1 1 1 6 2 1 5 7 6 1 1 0 1
*
G q a /G l 1a 2 2 8 6 1 1 2 1 2 3 5 7 1 1 5 3
Table 5.2 Quantification of bands on nitrocellulose sheets with adult 
MHS and MNS VSMC membranes using [ 1 2 5 l]-labelled Ab. Data 
represent meanlS.E. for four experiments using different membrane 
preparations. *Statistically significant difference.
difference in the level of G q a / G n a  present in MHS and MNS VSMC 
membranes.
5.3.3 p-Adreneraic receptor measurements
The number and affinity of p-adrenergic receptors in MHS and MNS 
VSMC membranes were measured from the binding of the antagonist, 
[ 1 2 5 I]CYP, in the presence and absence of propranolol. The affinities 
of the receptors for antagonist were similar for both strains (MHS 
Kd 78.6±20.8pM ; MNS Kd 6 9 .4 1 1 7 .OpM), however, the number of 
receptors in MHS membranes was significantly increased compared 
with control (MHS Bmax 5 4 .4 0 1 3 .4 4  fmoles/mg protein; MNS Bmax 
22 .4014 .41  fmoles/mg protein, p=0 .0119). (p-adrenergic receptor 
measurements represent m eanlS.E. for five experiments using 
different membrane preparations.) Figure 5.9 shows the results from 
a representative binding assay using MHS and MNS VSMC membranes.
5 .4  Discussion
The Milan hypertensive rat has been less extensively studied than 
other rodent models of genetic hypertension, and there is, therefore, 
limited information on the pathophysiological associations and 
causes of its high blood pressure. Angiotensin I I  receptor linked 
stimulation of PLC has been reported to be abnormal (Socorro e t a/., 
1990 ); using the antibody CQ2, which identifies the a-subunit of 
G q /G n , it was shown that the levels of these subunits were similar 
in VSMC membranes from MHS rats when compared with  
normotensive controls. The blunted PLC response to angiotensin I I  in 
MHS VSMC cannot, therefore, be explained by altered levels of its 
regulatory G-proteins, and alternative explanations must be sought.
Major differences in ACA in VSMC membranes were noted when 
MHS and MNS were compared. Thus, basal activity (measured in the 
absence and presence of Mn2+ ions) was significantly increased in 
MHS derived membranes, and corresponding increases in stimulatory 
responses to forskolin (which acts directly on the catalytic unit of 
adenylyl cyclase), isoproterenol and PGEi (which activate ACA via 
receptors) were seen when data were expressed relative to basal 
activity measured in the presence of Mn2+ ions. These data contrast 
with those which were reported earlier in vascular tissue and VSMC 
from the Okomoto SHR, where stimulated ACA responses were 
reduced when compared with control strains (Chapters 3 and 4).
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Figure 5.9 Binding of [ 125I]CYP to VSMC membranes from adult MHS 
and MNS rats. Radioligand bound (fmoles/mg protein) plotted as a 
function of the ratio of bound to free radioligand (bound/free x 
1 0 -5 ). The intercepts with the abscissa are the maximal number of 
binding sites (Bmax); the slope is the apparent affinity (Kd). The data 
show a typical experiment which was repeated four times with 
different membrane preparations.
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Several possible explanations for the increased ACA response in MHS 
VSMC must be considered, including changes in p-adrenoceptor 
num ber/affinity, alterations in stimulatory or inhibitory G-proteins 
(or coupling of these to receptors and/or catalytic unit of adenylyl 
cyclase) and changes in the amount or activity of the catalytic 
subunit of adenylyl cyclase.
5.4.1 p-Adreneraic receptor measurements
It is likely that part of the explanation lies in the increased 
p-adrenoceptor number demonstrated in MHS VSMC membranes; 
receptor affinity for antagonist was not altered. This change in 
p-adrenoceptor number has not previously been reported in Milan 
rats, and further studies are required to ascertain whether similar 
changes are present in other relevant tissues. In contrast, the 
reduced p-adrenoceptor number which has been reported in vascular 
tissues from SHRs has been implicated in the impaired vascular 
relaxation noted in arterial tissue in response to isoproterenol 
(Asano e ta / . ,  1988 ). Vascular reactivity has not been extensively 
studied in the MHS, and the significance of the increased 
p-adrenoceptor number (and ACA) in this strain is unclear 
(discussed later).
5 .4 .2  Gg and Gi levels and activity
Alterations in the levels or activity of Gs or Gj seem unlikely to  
account for the increased ACA noted in MHS VSMC. Firstly, a minor 
decrease in the level of the a-subunit of Gs (both forms) was 
observed, by immunoblotting, in MHS VSMC membranes. The reason 
for this is uncertain, but reduced levels of the a-subunits for Gs 
would result in decreased ACA. Secondly, when ACA was stimulated 
by NaF, which directly activates Gs to stimulate ACA, no difference 
could be detected between MHS and MNS. In other words, bypassing 
p-adrenoceptors led to a loss of the increased response in ACA noted 
when receptors were activated by isoproterenol.
In theory, a reduced effect of the inhibitory action of Gj might 
explain an increased ACA response. For example, this explanation 
has been implicated in the increased ACA response noted in 
streptozotocin-diabetic animals, where significantly reduced levels 
and activity of Gj have been reported (Bushfield e ta /. ,  1990a). 
However, in the current study, no evidence for altered Gj levels or
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activity was shown to account for the increased ACA response. (To 
date, three sub-types of Gi have been identified, namely G jl, Gj2 and 
Gj3. As discussed imminently, it is proposed that it is Gj2 that is 
the inhibitory G-protein involved in ACA regulation in these 
membranes. The role of Gj3 in the inhibition of adenylyl cyclase is 
discussed later.) The level of the Gj2 a-subunit, measured by 
immunoblotting, was not altered between the two strains. A minor 
reduction in the level of the p-subunit in MHS membranes was 
observed, which would not lead to an increased ACA. Gj function was 
studied by examining the biphasic e ffe c ts  o f GTP on 
isoproterenol-stimulated ACA. In this instance, low concentrations 
of GTP promote activation of adenylyl cyclase by stimulating the 
coupling of p-adrenoceptors to Gs, whereas high concentrations 
cause inhibition due to activation of Gj (Cooper, 1982  and Heyworth 
e t al., 1984 ). In both MHS and MNS VSMC biphasic effects of GTP 
were observed with a similar degree of inhibitory e ffec t a t high 
concentrations, indicating th a t Gj function was not d ifferent 
between the two strains. These results also support the notion that 
in these membranes, Gj2 (as opposed to Gjl or Gj3) is the inhibitory 
G-protein involved in ACA regulation. Thus, inhibition of ACA was 
observed despite the fact that the membranes do not express 
detectable levels of G jl. Additionally, Gj function was similar in the 
two sets of membranes although the level of Gj3 in MHS was 
significantly reduced (discussed later).
In some tissues it is possible to observe receptor-mediated  
inhibition of ACA which is dependent on Gj2 function (McKenzie and 
Milligan, 1990 ). In this study, however, using a range of appropriate 
ligands (e.g. carbachol, 5-hydroxytryptamine and UK 1 4 3 0 4 ) it has 
not been possible to demonstrate receptor-mediated inhibition of 
ACA fo r reasons which are unclear. Indeed, only slight 
receptor-m ediated inhibitory responses were dem onstrated in 
vascular tissue from another rodent model of essential 
hypertension, the SHR (Chapter 3).
The extent of stimulation of ACA (in the presence of 
isoproterenol) with a low dose of GTP was greater in MHS VSMC 
membranes when compared to MNS. This may suggest altered 
coupling of p-adrenoceptors to Gs in MHS membranes compared with 
control, and may contribute, in addition to  the increased 
p-adrenoceptor number, to the increased ACA response to  
isoproterenol.
I l l
5.4.3 Adenvlvl cvclase catalytic subunit level and activity
Lastly, differences in the amount and/or activity of adenylyl cyclase 
catalytic subunit may contribute to the observed differences in ACA. 
This possibility is supported by the e ffec t of forskolin, which 
activates adenylyl cyclase directly. When expressed as absolute 
activity or as percentage stimulation from basal activity measured 
in the presence of Mn2+ ions, MHS was more responsive than MNS, 
suggesting th a t in the form er strain there is a g reater  
level/responsiveness of adenylyl cyclase catalytic subunit. The 
level of catalytic subunit was unable to be quantified directly in 
these studies, as an appropriate antibody was not available.
5.4.4 Summary
Taking all of these data together, therefore, the increased ACA 
response in MHS VSMC membranes appears to be a net change, 
reflecting possible increased adenylyl cyclase catalytic subunit 
ac tiv ity /leve l, increased p-adrenoceptor coupling to Gs and an 
absolute increase in p-adrenoceptor number. These changes may be 
partially offset by a reduction in the level of Gs. The reason for 
these changes remains unclear, as is the pathophysiological 
significance. As discussed earlier, the increased ACA response to 
isoproterenol contrasts with findings in the SHR, where reduced 
responses have been noted. Cyclic AMP, generated in response to 
stimulation of ACA, normally causes vascular smooth muscle cells 
to relax and modulates intracellular effects induced by a rise in free 
calcium ions (Tomlinson et a/., 1985). It is possible that the changes 
noted in MHS VSMC membranes are secondary phenomena in response 
to another primary cause of increased vascular contractility. It 
should be pointed out, however, that these changes are present in 
cultured vascular smooth muscle cells which have been through 
several passages, and where secondary changes in response to a 
primary rise in blood pressure would be expected to be greatly 
attenuated. It appears more likely that the changes are genetically 
determined; how they relate to the development of high blood 
pressure remains to be studied.
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5.4.5 The role of Gi3 in signal transduction
Finally, the unexpected and novel finding of a major reduction in the 
level of the a-subunit of Gj3 in MHS VSMC membranes when 
compared with MNS was observed. The functional role of Gj3 in 
membranes remains unclear, although there is increasing evidence 
th a t it may be involved in the regulation of voltage-gated  
transmembrane potassium flux (Codina e t at., 1988 ). It has recently 
been demonstrated that in anterior pituitary cells, the coupling of 
Dz dopamine receptors to potassium currents is specifically via 
Gj3a (Lledo e t at., 1992 ). If so, a major reduction in Gj3 might be 
expected to have significant effects  on transm em brane ion 
distribution. It may be relevant th a t a ltered ion transport 
distribution has been demonstrated in MHS cells (red blood cells, 
renal tubule cells and vascular smooth muscle cells), and it is 
possible that these changes may relate to the reduced Gj3a levels 
noted here.
The role of Gj3 in the coupling of inhibitory a 2-adrenergic 
receptors to adenylyl cyclase has also been investigated in different 
cell system s. CHO-K1 cells tran sfec ted  w ith the human
a 2 A-adrenergic receptor were used to provide evidence of
a 2 -adrenergic receptor coupling to at least two sub-types of Gj, 
namely Gj2 and Gj3, and gave the first evidence of functional
involvement of Gj3 in the inhibition of adenylyl cyclase (Gerhardt
and Neubig, 1991). However, McClue et al. (1 9 9 2 ) demonstrated that 
although Gj3 is activated by a 2-adrenergic agonists in membranes of 
clone 1C cells (produced by transfection of Rat 1 fibroblasts with 
genomic DNA encoding the a 2-C1 0  adrenergic receptor), it does not 
contribute to the transduction of receptor-mediated inhibition of 
adenylyl cyclase. The results presented here suggest th a t in 
membranes prepared from VSMC isolated from rat thoracic aortas, 
Gj3 is not involved in the inhibition of aderiylyl cyclase, as Gj 
function  (as m easured by biphasic e ffe c ts  o f GTP on 
isoproterenol-stimulated ACA) is unchanged in the presence of a 
dramatic reduction in the level of Gj3a. However, work involving the 
cloned 5 -H T ia  receptor may be of relevance to  the diminished 
stimulation of PLC which has been reported in response to  
angiotensin n  in MHS smooth muscle cells (Socorro e t at., 1990). The 
cloned 5 -H T ia  receptor, stably expressed in HeLa cells, has been 
shown by Fargin e t al. (1 9 9 1 ) to mediate the effects of 5-HT to 
inhibit cAMP form ation and to stim ulate the hydrolysis of
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phosphatidylinosito l. Using specific antibodies to  prevent 
receptor-G-protein coupling by binding to the regions of G-proteins 
putatively involved in interaction with receptors, this group 
demonstrated that Gj3 preferentially mediates the effects of 5-HT 
both to inhibit adenylyl cyclase and to stimulate PLC. The role of Gj3 
in the coupling of Ang n receptors to PLC is not known, but if it is 
involved, then the substantial decrease in the level of Gj3 in MHS 
membranes may account for the diminished PLC activity in response 
to Ang n in MHS VSMC. Further studies examining the relationship of 
this change to the development of high blood pressure in the MHS are 
appropriate.
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Chapter 6 Comparison of vascular G-proteins in vounq MHS and 
MNS rats
6.1 Introduction
A large proportion of the work that has been reported on the MHS rat 
has focussed on both the hypertensive and prehypertensive phases of 
development (see section 5.1 for details). Bianchi e t al. (1 98 4 ) chose 
the prehypertensive phase of the MHS to study, in order to detect 
changes that existed before the development of hypertension, and 
thus, cannot be secondary to the hypertension, per se. In addition, 
genetic factors responsible for hypertension may have produced 
biochemical or physiological abnormalities during the time-interval 
between birth and the development of hypertension, and are more 
s tric tly  linked to  the underlying mechanisms causing the  
hypertension. The study reported in Chapter 5 examined the adenylyl 
cyclase signalling pathway in adult, hypertensive MHS rats and 
identified abnormalities in comparison to age-matched control rats. 
This chapter examines the same system in young, prehypertensive 
MHS rats to observe whether similar abnormalities are present at an 
earlier stage in the development of hypertension in this animal 
model. VSMC were isolated from 30-day-old MHS and MNS rats, 
which had significantly different systolic blood pressures, but the 
MHS rats had not established hypertension.
6.2 Materials and Methods
6.2.1 Rats
Milan hypertensive strain and Milan normotensive strain rats were 
sacrificed at 30 days of age. Rats, the same age as those used for 
preparation of VSMC, had their systolic blood pressures measured: 
MHS 125±2.0mmHg; MNS 120±2.3mmHg, p<0.05. Measurements were 
made from 15 rats of each strain (significance was assessed by 
t-te s t analysis).
6 .2 .2  Smooth muscle cell preparation and maintenance
VSMC were isolated by enzymic digestion from thoracic aortas from 
four rats of each strain according to  the procedure outlined in
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section 2 .5 .1 . The cells were grown in culture through seven 
passages by following the methods of sections 2.5.2 and 2.5.3.
6.2.3 Preparation of membranes
Production of plasma membranes from VSMC is outlined in section 
2.6.
6.2.4  Measurement of protein concentration
Protein concentrations in the membrane preparations were 
determined using the method outlined in section 2.7.
6.2.5 Adenvlvl cvclase activity
The regulation of adenylyl cyclase activity was monitored by the 
method of Salomon (1 9 7 9 ) outlined in sections 2.8.1 and 2.8.4.
6 .2 .6  Quantification of G-protein subunits
The levels of the G-protein subunits were quantified using a 
combination of SDS-PAGE (see section 2 .9  for details) and 
immunoblotting with specific anti-peptide antisera (see section 
2 . 1 0  for details).
6.2.7 p-Adreneraic receptor measurements
The number and affinity of p-adrenergic receptors in MHS and MNS 
VSMC membranes were measured according to the procedure outlined 
in section 2.14.
6.3 Results
6.3.1 Regulation of adenvlvl cvclase activity
Basal ACA (whether measured in the absence/presence of Mn2+ ions) 
was similar in MHS and MNS VSMC membranes (Table 6 .1 ). The 
addition of MnCl2 (2 x1 0 _2 M) resulted in similar inhibitions of ACA 
in MHS and MNS membranes (MHS -26.9±7 .4% ; MNS -15 .6±4 .9% ). (A 
high concentration of Mn2+ ions uncouples adenylyl cyclase from its 
regulatory G-proteins (Limbird e ta /., 1 9 7 9 ). In these VSMC, there
116
MHS MNS
Basal 8671113 799147
(no Mn2+ ions)
Basal 572130 664136
(+  Mn2+ ions)
Forskolin 9 ,2731626 8 ,8931496
Table 6.1 Adenylyl cyclase activities in the absence and presence of 
MnCl2 (2xlO "2M), and in the presence of forskolin (1 0 _4M) in young 
MHS and MNS VSMC membranes. Adenylyl cyclase activ ity  
measurements represent pmol cA M P/15m in/m g. Data represent 
mean+S.E. fo r ten experim ents using d iffe re n t membrane  
preparations. Statistical analysis of results did not disclose any 
significant differences.
appears to be a much greater measurable input from Gs than Gj, 
hence uncoupling these G-proteins would result in a fall in ACA.) A 
similar trend in activities was seen in the presence of forskolin 
( 1 0 -4 M), which directly activates the catalytic unit of adenylyl 
cyclase (Table 6 .1).
The responses to the various agents studied were expressed as 
% change over basal measured in the presence of Mn2+ ions, as this 
probably gives the closest approximation to the true basal activity. 
Figure 6.1 shows the % change in ACA over basal (in the presence of 
Mn2+ ions) in MHS and MNS VSMC membranes after the addition of (a) 
forskolin (1 0 _4 M) and (b) NaF (1 0 _2M), isoproterenol (1 0 _4 M) and 
PGEi (1 0 _5 M). Use of the p-adrenergic agonist, isoproterenol, and 
PGEi allowed measurement of receptor-dependent stimulation of 
ACA through two different types of receptor. Isoproterenol caused a 
significantly reduced stimulation of ACA in MHS membranes 
compared with MNS, while PGEi produced similar stim ulatory  
responses in both strains (isoproterenol: MHS 14 61 1 5% ; MNS 
208117% , p=0.0155 and PGEi: MHS 68112%; MNS 80116% ).
To examine whether altered regulation of ACA in MHS VSMC 
membranes was only apparent at the p-adrenergic receptor level of 
the adenylyl cyclase system, or whether abnormalities were present 
at other levels of the signalling pathway, the responses of ACA to  
forskolin and NaF were studied. There was a significantly greater 
stimulatory response to forskolin in MHS membranes compared with 
MNS (MHS 1,519168% ; MNS 1 ,250157% , p = 0 .0211 ). However, the 
stimulations occurring in MHS and MNS membranes in response to 
another receptor-independent stimulatory agent, NaF, were not 
significantly different (MHS 397125% ; MNS 426133% ). When the data 
were expressed as % change from basal (no Mn2+ ions), significantly 
reduced stimulations were observed in MHS VSMC membranes in 
comparison to MNS in response to both isoproterenol and PGEi.
Gj function in MHS and MNS VSMC membranes was 
d e m o n s tra te d  by the biphasic e f fe c ts  o f GTP on 
isoproterenol-stimulated ACA (Figure 6 .2 ). These GTP dose-effect 
experiments showed that activation of Gs and Gj occurred over 
similar concentration ranges of GTP in MHS and MNS membranes, 
suggesting that there was no difference in the function of Gj in MHS 
membranes compared with MNS (MHS -21.812.2% ; MNS -18 .912 .6% ). 
The stimulatory GTP responses in MHS and MNS membranes were 
also similar (Figure 6 .2). (Gj function was also measured using low 
concentrations of poorly hydrolysable analogues of GTP, namely
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Figure 6.1 % Change in ACA expressed relative to basal activity  
measured in the presence of MnCl2 (2x10_2M) in young MHS and MNS 
VSMC membranes in the presence of (a) forskolin (1 0 “4 M) and (b) NaF 
(1 0 _2M), isoproterenol (1 0 “4 M) and PGEi (10-5M). Data are mean±S.E. 
for ten experiments using different membrane preparations.
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p(NH)ppG and GTPyS. However, only very slight inhibitory responses 
were observed in these VSMC membranes.)
In summary, these experiments examining the regulation of 
ACA in relation to basal activity measured in the presence of Mn2 + 
ions in prehypertensive MHS VSMC membranes identified a decreased 
ACA in response to isoproterenol which mediates stimulation via 
p-adrenergic receptors. Directly activating forskolin produced an 
increased ACA in MHS membranes, but this difference was 
eliminated in the presence of NaF. These results suggest an 
increased level/responsiveness of the adenylyl cyclase catalytic  
subunit, decreased level/activity of Gs and a decreased number of 
p-adrenergic receptors in MHS VSMC membranes. When data were 
expressed relative to basal activity measured in the absence of 
M n2+ ions, decreased enzyme activities in MHS membranes in 
response to both isoproterenol and PGEi were identified, while 
similar stimulations were produced by forskolin and NaF in the two  
strains. These data suggest a decreased number of p-adrenergic  
receptors in MHS VSMC membranes. Hence, whether the response of 
ACA to isoproterenol in MHS VSMC membranes is expressed relative 
to basal activity measured in the absence/presence of Mn2+ ions, 
there appears to be a reduction in enzyme response, suggesting 
decreased p-adrenoceptor number.
6.3.2 G-protein subunit levels
Preliminary immunoblotting experiments identified Gsa (two forms; 
44 and 42kDa), G j2 a  and G j3 a  in rat VSMC plasma membranes, 
whereas Goa and Gjl  a  were absent (data not shown). The levels of 
these different G-protein a-subunits and the level of the p-subunit 
were quantified in MHS and MNS VSMC membranes using 
[ 125 l]-labelled anti-rabbit IgG (Figures 6 .3 , 6 .4, 6.5 & 6 .6  and Table
6 .2 ). The Figures 6 .3 , 6.4, 6.5 & 6 .6  (also 6 .7 , see later) show 
representative nitrocellulose sheets for each G-protein subunit, 
however, experiments were repeated three times using different 
membrane preparations. There was a significantly reduced level 
( -2 0 %  reduction) of Gsa (both forms) in MHS membranes, while 
levels of G j2 a  were similar in MHS and MNS membranes. The level of 
Gj3a  was dramatically reduced in MHS membranes ( -8 0 %  reduction) 
and a significant reduction in the level of the p-subunit ( - 2 0 % 
reduction) was also observed in MHS membranes.
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Figure 6.3 Nitrocellulose sheet with young MHS and MNS VSMC 
membranes probed with Gsa-specific Ab (CS1). 50 m-g of membrane 
protein was loaded in each lane. Two forms of Gsa are apparent (44  
and 42kDa), with the 44kDa form being predominant in VSMC 
membranes. 1-3=MHS membranes and 4-6=MNS membranes.

Figure 6 .4  Nitrocellulose sheet with young MHS and MNS VSMC 
membranes probed with transducin a ,  Gjl a ,  Gj2a-specific Ab (SG2). 
Since rat VSMC membranes do not express detectable levels of Gjl 
and t ra n s d u c in  d is t r ib u t io n  is r e s t r ic t e d  to  
photoreceptor-containing tissues, the antiserum SG2 will only 
identify Gj2 in rat VSMC membranes. 6 (Vg of membrane protein was 
loaded in each lane. 1-3=MHS membranes and 4-6=MNS membranes.
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Figure 6.5 Nitrocellulose sheet with young MHS and MNS VSMC 
membranes probed with Gj3a-specific Ab (I3C). 5(Vg of membrane 
protein was loaded in each lane. 1-3=MHS membranes and 4-6=MNS  
membranes.
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Figure 6 .6  Nitrocellulose sheet with young MHS and MNS VSMC 
membranes probed with p-subunit-specific Ab (B N 3). 50^g of 
membrane protein was loaded in each lane. 1-3=MHS membranes and 
4-6=MNS membranes.

Figure 6 .7  Nitrocellulose sheet with young MHS and MNS VSMC 
membranes probed with G q a / G i  ia-specific Ab (CQ 2). 25ng of 
membrane protein was loaded in each lane. 1-3=MHS membranes and 
4-6=MNS membranes.

G-protein subunit MHS (cpm) MNS (cpm)
Gs« (44kDa) 3107±256 39851198 *
Gs« (42kDa) 1103178 1445193 *
G j2 a 28531104 29761115
G j3 a 223126 1125189 *
p 1651197 20591135
*
Gqtx/Gl la 19721103 1899154
Table 6 .2  Quantification of bands on nitrocellulose sheets with 
young MHS and MNS VSMC membranes using p  2 5 l]-labelled Ab. Data 
represent mean+S.E. for four experiments using different membrane 
preparations. ^Statistically significant difference.
The level of the a-subunit for G q /G n , the G-proteins coupling 
receptor activation to generation of DG and IP3 by PLC, was 
quantified in MHS and MNS VSMC membranes (Figure 6 .7  and Table
6 .2 ). There was no significant difference in the level of G q a /G n a  
present in MHS and MNS VSMC membranes.
6.3.3 B-Adreneraic receptor measurements
The number and affinity of p-adrenergic receptors in MHS and MNS 
VSMC membranes were measured from the binding of the antagonist, 
[ 125 I]CYP, in the presence and absence of propranolol. The affinities 
of the receptors for antagonist were similar for both strains (MHS 
Kd 33.3±5.6pM ; MNS Kd 22 .9±3 .3p M ), however, the number of 
receptors in MHS membranes was significantly decreased compared 
with control (MHS Bmax 18 .4±2 .0  fm oles/m g protein; MNS Bmax 
3 1 .7 ± 2 .9  fmoles/mg protein, p = 0 .0 13 1 ). (p-adrenergic receptor 
measurements represent mean±S.E. for six experiments using 
different membrane preparations.) Figure 6 .8  shows the results from 
a representative binding assay using MHS and MNS VSMC membranes.
6.4 Discussion
The Milan hypertensive rat has not been as extensively studied as 
other rodent models of genetic hypertension e.g. the SHR. Hence, 
there is limited information on the pathophysiological associations 
and causes of its high blood pressure. Stimulation of PLC in response 
to Ang I I  has been reported to be significantly diminished in MHS 
VSMC (Socorro et al., 1990); however, as in adult MHS and MNS rats, 
the levels of the a-subunit of G q / G n  were similar in young MHS and 
MNS VSMC membranes. Therefore, the blunted PLC response to Ang n 
in MHS VSMC cannot be explained by altered levels of these 
regulatory G-protein subunits in either the prehypertensive nor the 
hypertensive phase.
Significant differences in ACA in MHS VSMC membranes in 
response to stimulatory agents were noted. Basal activity of 
adenylyl cyclase (whether measured in the absence or presence of 
Mn2+ ions) was similar in membranes prepared from both strains. In 
the presence of forskolin (which acts directly on the catalytic unit 
of adenylyl cyclase), similar absolute levels of ACA were produced 
in MHS and MNS membranes. However, when results were expressed 
as % change over basal measured in the presence of Mn2+ ions (which
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Figure 6 .8  Binding of [ 125I]CYP to VSMC membranes from young MHS 
and MNS rats. Radioligand bound (fmoles/mg protein) plotted as a 
function of the ratio of bound to free radioligand (bound/free x 
1 0 -5 ). The intercepts with the abscissa are the maximal number of 
binding sites (Bmax); the slope is the apparent affinity (Kd). The data 
show a typical experiment which was repeated five times with 
different membrane preparations.
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probably gives the closest approximation to the true basal activity), 
a significantly increased stimulation in response to forskolin was 
apparent in MHS membranes. This difference was eliminated in the 
presence of NaF, and actually reversed in response to isoproterenol. 
The reduced stimulation of ACA in response to isoproterenol in MHS 
membranes is similar to the situation previously reported in 
vascular tissue and VSMC from the Okomoto SHR (Chapters 3 and 4). 
Several possible explanations for the altered ACA response in MHS 
VSMC membranes must be considered, including changes in 
p-adrenoceptor num ber/affin ity , alterations in stim ulatory or 
inhibitory G-proteins (or coupling of these to receptors and/or 
catalytic unit of adenylyl cyclase) and changes in the amount or 
activity of the catalytic subunit of adenylyl cyclase.
6.4.1 B-Adrenerqic receptor number
It is likely that part of the explanation lies in the decreased 
p-adrenoceptor number which was measured in MHS VSMC 
membranes; receptor affinity for antagonist was not altered. (As 
discussed later in section 6 .4 .4 , comparing the results from this 
study in young MHS and MNS rats with those from a similar study 
using adult MHS and MNS rats (Chapter 5 ), reveals opposing 
regulation of ACA by isoproterenol in prehypertensive and 
hypertensive MHS rats, as a consequence of altered p-adrenergic 
receptor number.) The reduced p-adrenoceptor number which has 
been reported in vascular tissues from SHRs has been implicated in 
the impaired vascular relaxation noted in arterial tissue in response 
to isoproterenol (Asano e t al., 1 9 8 8 ). Cyclic AMP, generated in 
response to stimulation of ACA, causes VSMC to relax and modulates 
intracellular effects induced by a rise in free calcium ions 
(Tomlinson e t al., 1 9 85 ). Hence, a reduced response of ACA to 
isoproterenol in these animal models of essential hypertension may 
be of relevance to increased vascular reactivity associated with 
hypertension.
6 .4 .2  Gg and Gi levels and activity
Alterations in the levels or activity of Gs or Gj seem unlikely to 
account for the altered ACA noted in MHS VSMC membranes. The 
increased stimulation produced by forskolin in MHS membranes was 
eliminated by NaF, suggesting decreased Gs levels or activity. A
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minor decrease in the levels of the a-subunits of Gs (44  and 42kDa) 
was shown, which may contribute to the NaF result; however, 
stimulation of ACA by isoproterenol resulted in a reversal of the 
trend in activities of the enzyme produced by forskolin i.e. 
decreased ACA was measured in MHS membranes. By stimulating 
ACA via p-adrenergic receptors, a reduced response was noted in
MHS membranes, suggesting aberrations at the receptor level.
Data suggest that altered Gj levels or activity do not account 
for the altered ACA response. The level of the Gj2 a -subunit, 
measured by immunoblotting, was not altered between the two 
strains. Gj function was studied by examining the biphasic effects  
of GTP on isoproterenol-stimulated ACA. In this instance, low 
concentrations of GTP promote activation of adenylyl cyclase by 
stimulating the coupling of p-adrenoceptors to  Gs, whereas high 
concentrations cause inhibition due to activation of Gj (Cooper, 
1982 and Heyworth et a/., 1984). In both MHS and MNS VSMC biphasic 
effects of GTP were observed with a similar degree of inhibitory 
effect at high concentrations, indicating that Gj function was not 
different between the two strains. These results also support the 
notion that in these membranes Gj2 (as opposed to Gjl or Gj3) is the 
inhibitory G-protein involved in ACA regulation. Thus, inhibition of 
ACA was shown despite the fact that the membranes do not express 
detectable levels of G jl . Additionally, Gj function was similar in the 
two sets of membranes although the level of Gj3 in MHS was 
significantly reduced (discussed later in section 6 .4 .4 ).
A minor reduction in the level of the p-subunit was shown in 
MHS membranes, which would lead to a decreased ACA. It has been 
reported that certain sub-types of adenylyl cyclase are stimulated 
by py-subunits (Federman e t a/., 1992 ). This e ffect of py-subunits 
requires co-stimulation by the GTP-bound form of the a-subunit of 
Gs- Hence, as minor decreases were noted in the levels of Gsa and 
the p-subunit, they may contribute to the decreased hormonal 
stimulation of ACA in MHS membranes.
The extent of stimulation of ACA (in the presence of 
isoproterenol) with a low dose of GTP was similar in MHS and MNS 
VSMC membranes. This suggests th a t th e  coupling of 
p-adrenoceptors to Gs is similar in both strains, and the reduced 
stimulation of ACA in response to isoproterenol observed in MHS 
membranes is probably a consequence solely o f reduced 
p-adrenoceptor number.
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6.4.3 Adenvlvl cvclase catalytic subunit
Lastly, differences in the amount and/or activity of adenylyl cyclase 
catalytic subunit may contribute to the observed differences in ACA. 
Basal activities of adenylyl cyclase measured in the absence and 
presence of Mn2+ ions were riot statistically different in the two 
strains. Indeed, in the presence of forskolin, similar absolute levels 
of ACA were observed in both sets of membranes. However, when 
this response was expressed as % change relative to basal activity 
measured in the presence of Mn2+ ions, a significantly increased 
stim ulatory response was apparent in MHS membranes. This 
suggests an increased level/activity of the catalytic subunit of 
adenylyl cyclase in MHS membranes. However, the level of the 
enzym e's catalytic unit was unable to  be quantified, as an 
appropriate antibody was not available.
6 .4 .4  Comparison of the adenvlvl cvclase signalling system in the 
prehvpertensive and hypertensive phases of MHS rats
As mentioned earlier, it is of interest and importance to compare 
these data with those from a similar study using older, hypertensive 
MHS and MNS control rats (Chapter 5). Similar changes in G-protein 
subunit levels were observed in both young and adult MHS rats. Thus, 
the levels of Gj2a and G qa/G na were similar in prehypertensive and 
hypertensive MHS rats compared with age-matched controls, while 
minor, but nevertheless significant, reductions in the levels of Gsa 
(both forms) and the p-subunit were observed in MHS VSMC 
membranes from both young and adult rats. The dramatic reduction 
in the level of Gj3a shown in adult MHS membranes was also 
observed to the same extent in young MHS rats. As discussed in 
Chapter 5 (section 5 .4 .5 ), the functional role of Gj3 in membranes 
remains unclear. However, if evidence can be found in the future 
linking Gj3 to the coupling of Ang I I  receptors to PLC, then the 
substantial decrease in the level of Gj3 in MHS membranes may 
account for the diminished PLC activity in response to Ang n  in MHS 
VSMC. This work regarding PLC activity (Socorro e t a/., 1990 ) was 
shown in VSMC from adult MHS rats. It would, therefore, be of 
interest to examine whether a similar diminished PLC activity is 
present in VSMC isolated from young MHS rats, as the reduced level 
of Gj3a was shown in both prehypertensive and hypertensive MHS 
rats. Also, as erythrocytes are genetically determined within the
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stem  cells, and any abnormalities in these cells would be 
genetically associated with hypertension, it would be interesting to  
investigate whether a reduced level of Gj3a is present in MHS 
erythrocytes.
The function of Gj was not altered in MHS rats in either of the 
age groups. Indeed, the extents of inhibition, as measured from the 
biphasic effects of GTP on isoproterenol-stimulated membranes, 
were ~20%  in both strains, in both age-groups. However, there were 
notable differences in the stimulation of ACA in the two different 
age groups. An increased basal ACA (in the absence and presence of 
Mn2+ ions) was observed in MHS membranes from older rats, while 
in young rats, basal activities were similar in the two strains. In 
both adult and young rats, an increased stimulatory response to 
forskolin in the MHS was noted, which was eliminated in the 
presence of NaF. Interestingly, isoproterenol produced opposite 
effects in the differently aged MHS rats. As mentioned previously, 
isoproterenol stimulation of ACA was reduced in young MHS rats, 
although it was observed to be increased in adult MHS rats. Indeed, 
in young MHS rats a reduced number of p-adrenoceptors was 
measured, whereas in adult MHS rats an increased number of 
p-adrenoceptors and a greater stimulatory GTP response were 
observed. The number of p-adrenergic receptors in MNS membranes 
did not alter significantly with age; however, in MHS membranes the 
number of p-adrenergic receptors increased ~3-fold in hypertensive 
MHS VSMC membranes in comparison to the number of receptors 
measured in young MHS rats. The GTP responses observed in young 
and adult MHS membranes were similar, whereas, the GTP response 
in MNS membranes decreased with age. The reasons for these 
differences in the regulation of ACA in different age groups of rats 
are unclear, but since alterations in G-protein subunit levels are 
similar in both adult and young rats, despite the fac t th a t  
isoproterenol produces opposite effects, it seems likely th a t the 
difference in isoproterenol response in MHS rats compared with MNS 
in both age-groups is a consequence of altered p-adrenoceptor 
number.
It is possible that the changes are secondary phenomena in 
response to  another primary cause of increased vascular 
contractility. It should be pointed out, however, that these changes 
are present in cultured VSMC which have been through several 
passages, and where secondary changes in response to a primary rise 
in blood pressure would be expected to be greatly attenuated. It
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appears more likely that the changes are genetically determined, 
illustrating the importance of measuring parameters at discrete 
stages in the development of hypertension. For example, a study 
examining a-adrenergic receptors in the cerebral and renal cortex of 
MHS rats has identified modifications between the prehypertensive 
and hypertensive phases (Paririi e t al., 19 8 7 ). Since cerebral and 
renal a-adrenergic receptors play an important role in the control of 
blood pressure, the densities and affinities of ai-adrenergic and 
a 2-adrenergic receptors have been examined. In the cerebral cortex, 
no between-strain differences in a 1-adrenergic and a 2-adrenergic  
receptor density and affinity were observed in prehypertensive and 
hypertensive rats. In the renal cortex, the differences between MHS 
and MNS rats concerned a 2 -adrenergic receptors only. MHS rats 
showed a lower affinity for the antagonist, [ 3H]rauwolscine, in the 
prehypertensive period and absence of the normal age-related  
increase in receptor density. A lower density of [ 3 H]rauwolscine 
binding sites in the hypertensive period was also observed. In 
hypertensive rats, epinephrine bound to one class of sites in MHS 
rats and to two classes in MNS rats, while data suggest uncoupling 
of epinephrine receptors from its G-protein in MHS rats. The 
modifications of renal a 2-adrenergic receptors were more evident 
in the hypertensive period when the impaired tubular sodium 
reabsorption observed in the prehypertensive period had almost 
returned to normal. Taken together, these data suggest that the 
modification of renal a 2-adrenergic receptors in MHS rats could be a 
compensatory mechanism to counteract the increased renal sodium 
reabsorption rather than the cause of the developm ent of 
hypertension in MHS rats. A similar compensatory mechanism could 
apply to the regulation of ACA by isoproterenol in young and adult 
MHS rats i.e. the increased p-adrenoceptor number in adult MHS 
VSMC membranes may be a compensatory mechanism to counteract 
the decreased p-adrenoceptor number in young MHS VSMC 
membranes. Also, basal ACA was significantly higher in adult MHS 
membranes compared with control (in the absence and presence of 
M n2+ ions), while basal activities of the enzyme were similar in 
young MHS and MNS rats (in the absence and presence of Mn2+ ions). 
( It  should be noted that the absolute level of basal ACA in MNS 
membranes is similar in both age-groups, while it is only the basal 
ACA in MHS membranes which changes with age.) The increased 
basal ACA and increased response of ACA to isoproterenol in adult 
MHS membranes may be a compensatory reaction to produce a higher
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concentration of the vasodilator, cAMP, in response to an elevation 
in blood pressure.
It would be of interest to examine whether a similar pattern 
of alterations regarding basal ACA and p-adrenergic receptor 
number exists in other relevant tissues (e.g. myocardium) from  
prehypertensive and hypertensive MHS rats. Also, the relevance of 
the abnormalities regarding p-adrenergic receptor number and Gj3 
a-subunit levels to the hypertensive phenotype could be investigated 
further by employing cosegregation studies. Every single one of the 
genetic differences present between disease and control strains 
represents a polymorphic marker that distinguishes with equal 
statistical power between strains, ye t only a tiny fraction  
represent disease-related genes. Hence, differences observed on any 
level (physiological, biochemical, or molecular genetic) between the 
hypertensive and the normotensive strains are, in fact, much more 
likely unrelated than related to hypertension. Geneticists many 
years ago proposed a seminal test for a polymorphic marker's 
relevance to the hypertensive phenotype involving cosegregation of 
the marker with blood pressure in a freely segregating F2 cohort 
bred from the two parental strains. This approach effectively filters 
out all polymorphic markers except the ones that are relevant to the 
phenotype of interest (Lindpaintner e t al., 1 9 9 2 ). It would be 
interesting to examine whether the changes in p-adrenergic receptor 
number and/or Gj3 a-subunit levels cosegregated with blood 
pressure in F2 MHS rats.
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Chapter 7 Final Discussion and Conclusions
7.1 Final Discussion
7.1.1 Choice of genetically hypertensive rat
Genetically hypertensive rats are valuable models of human 
essential hypertension, as it is possible to have direct access to 
vascular tissues, and hypertension develops in these rats with little 
influence from the environment. There are several genetically 
hypertensive rat strains available internationally, and the work of 
this thesis has employed tw o such strains, nam ely the  
spontaneously hypertensive rat and the Milan hypertensive strain.
The SHR is the most widely studied rodent model of genetic 
hypertension, and closely resembles human hypertensives with 
respect to  its pattern of development of hypertension, increased 
vascular smooth muscle contractility, and altered membrane cation 
transport. On the other hand, the MHS develops mild hypertension for 
the first two months after birth, but shows no further augmentation 
of hypertension during the process of aging. Hence, the  
developmental course of hypertension is different from essential 
hypertension, which tends to increase gradually with age. However, 
the key role of the kidney in the pathogenesis of hypertension in the 
MHS has been demonstrated (Fox and Bianchi, 1 9 7 6 ), and a 
correlation has been found between erythrocyte Na+ transport 
abnormality and renal function in both these rats and humans 
(Bianchi e t al., 1986).
Altered regulation of ACA has been dem onstrated in SHR 
vascular tissues (see section 3.1 for details); however, the role of 
regulatory G-proteins in this abnormality has not been studied in 
detail. Investigators utilising the SHR in studies of ACA regulation 
used WKY rats as the normotensive control. The studies in this 
thesis have been aware of possible genetic heterogeneity in SHRs 
and WKY rats and have, therefore, used rats from different suppliers 
and included the Wistar rat as an additional normotensive control. 
The adenylyl cyclase system has not been examined in any tissue 
from the MHS, and so it was of interest to pursue these studies 
further. Two genetically hypertensive rat strains were studied to 
investigate whether similar abnormalities regarding the regulation 
of ACA existed in the two strains, despite possible differences in 
their pathogenetic mechanisms.
126
7.1.2 Expression of results
G-protein function was inferred from studies of adenylyl cyclase 
activity using the method of Salomon (1 9 7 9 ). A range of agents was 
used in these studies to examine the abnormalities at specific 
levels of the adenylyl cyclase system. Stim ulatory agonists 
(isoproterenol and PGEi) were employed to investigate possible 
alterations at the receptor level, while NaF and forskolin revealed 
any alterations at Gs and the catalytic subunit of adenylyl cyclase, 
respectively. The responses to these agents were expressed relative 
to basal ACA, as there were generally differences in the basal 
activities of the enzyme in the strains being compared. In such 
instances, comparison of the absolute levels of ACA measured in 
response to a specific agent would not take this difference into 
account. Results were expressed relative to basal activity measured 
in the absence and presence of Mn2+ ions. The "Results" and 
"Discussion" sections of each of the four chapters encompassing 
these studies have considered the responses expressed relative to 
basal activity measured in the presence of Mn2+ ions in more depth. 
This is due to the fact that a high concentration of Mn2+ ions 
uncouples adenylyl cyclase from its regulatory G-proteins (Limbird 
et al., 1979), and so probably gives a more realistic measurement of 
basal activity of the enzyme without any influence from Gs and Gj.
7 .1 .3  Comparison of similar studies employing SHRs from different 
sources
Chapters 3 and 4 give details of studies examining the contribution 
of G-proteins to the altered regulation of ACA in SHRs bought from 
different suppliers. Genetic heterogeneity has not only been reported 
in the WKY rat (Kurtz and Morris, 1987 and Kurtz e t al., 1989), but 
also in the SHR (Nabika e t al., 1991 ) from different sources. Chapter 
3's study used the outbred Wistar strain of rat as an alternative 
normotensive control, while the study reported in Chapter 4 used 
both Wistar and WKY rats as controls to  examine whether 
differences between SHRs and WKY rats were still seen when 
another normotensive control was included.
Chapter 4 reported differences in the regulation of ACA among 
SHRs, WKY and Wistar rats; however, differences in the regulation of 
ACA between the two normotensive control strains were obvious. 
While these changes may reflect hypertension and its genetic
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antecedent, the possibility is raised, by inclusion of the outbred 
Wistar control group, that genetic heterogeneity in SHR and WKY 
strains may contribute substantially to the differences in the 
regulation of ACA, and raise the possibility that these changes are 
not directly linked to the development of increased blood pressure.
Differences in the regulation of ACA in SHR membranes 
compared with Wistar were observed in both Chapters 3 and 4. 
Although no significant differences in the levels of the various 
G-protein subunits in SHR and Wistar membranes were observed 
using rats from different suppliers, inconsistent differences in the 
regulation of ACA were obvious, and seemed to depend on where the 
rats were purchased. Hence, possible genetic heterogeneity between 
the two groups of SHRs from Charles River Ltd. and Harlan Olac Ltd. 
may have influenced the differing results of the similar studies.
7 .1 .4  Age-related changes in the MHS
»
Chapters 5 and 6 examined the regulation of ACA in VSMC prepared 
from  the thoracic aortas of adult (hypertensive) and young 
(prehypertensive) MHS rats, respectively. The differences in the 
levels of the various G-protein subunits in MHS and MNS membranes 
were similar in the two age-groups. It was also observed that Gj 
function was unaltered in MHS membranes with respect to MNS in 
both age-groups. The abnormal regulation of ACA in the MHS was 
consistent with age regarding the responses to  forskolin and NaF; 
however, the stimulations produced by isoproterenol were reversed 
when MHS and MNS rats were compared at the different ages. Young 
MHS rats exhibited a reduced ACA in response to isoproterenol in 
comparison to age-matched MNS controls, while an increased 
stimulation was produced by isoproterenol in adult MHS rats. This 
change in response to isoproterenol was paralleled by an appropriate 
alteration in p-adrenergic receptor number. It is unlikely th a t this 
age-dependent a lteration  in isoproterenol response (and  
p-adrenergic receptor number) is a primary cause of hypertension in 
the MHS, as the trend would be expected to be reversed if this were 
the case. Instead, it may represent some sort of compensatory 
mechanism in the MHS, to combat the increased VSM contractility 
which may result with elevated blood pressure.
128
7.1.5 Similar abnormalities in the SHR and MHS?
The work of this thesis has concentrated on two rodent models of 
human essential hypertension, which probably have d ifferent 
pathogenetic mechanisms. The role of G-proteins in the altered 
regulation of ACA was investigated in VSM from the two models and 
their controls. No significant differences were observed in the 
levels of the various G-protein subunits in SHR membranes compared 
with controls (Wistar and WKY). The function of Gj was unchanged in 
SHR, WKY and Wistar membranes; however, data suggest that the 
function of Gs may be decreased in the SHR compared with Wistar 
(Charles River Ltd. rats), and this may also be the situation in SHRs 
compared with WKY controls (Harlan Olac Ltd. rats). Significant 
reductions in the levels of G s a  (both forms), G j3 a  and the p-subunit 
were shown in both young and adult MHS rats. The function of Gj was 
again unchanged in the two age-groups of MHS rats in comparison to 
age-matched controls. Hence, it was suggested that in these rat 
VSMC membranes, Gj3  does not contribute to the inhibition of 
adenylyl cyclase activity. Gs function appeared to be decreased in 
MHS membranes of both ages, and this decreased Gs activity may be 
explained, in part, by the reduced levels of Gsa noted in MHS VSMC 
membranes.
The responses of ACA to stimulation by isoproterenol in the 
two models were of notable difference. In the SHR (adult, 
hypertensive), a reduced response to isoproterenol was observed in 
comparison to Wistar (Charles River Ltd.) and WKY (Harlan Olac Ltd.) 
rats. A reduced response to isoproterenol was also noted in young 
MHS rats, whereas this was reversed with age, and an increased 
response to this p-adrenergic agonist was shown in adult MHS rats. 
The decreased isoproterenol stim ulatory response in adult, 
hypertensive SHRs may contribute primarily to the hypertension in 
this model. Production of less cAMP via p-adrenergic receptors 
would, in effect, potentiate the existing increased VSM contractility 
in the SHR, and lead to increased severity of the hypertension. On the 
other hand, as mentioned in section 7 .1 .4 , it is unlikely that the 
age-dependent alteration in isoproterenol response (increasing 
response with age) in the MHS is a primary contributor to its 
hypertension. A more plausible explanation is that the alteration in 
isoproterenol response (and indeed p-adrenergic receptor number) 
between young and adult MHS rats may represent some form of 
compensatory mechanism. As the MHS rat becomes older and its
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blood pressure increases, production of more cAMP via an increased 
number of p-adrenergic receptors would tend to antagonise possible 
increases in VSM contractility associated with hypertension. Hence, 
as possible different pathogenetic mechanisms are responsible for 
the hypertension in the SHR and MHS, the stimulation of ACA by 
isoproterenol may play varying roles in their pathogenesis, with it 
being of primary importance in the case of the SHR, while it may 
serve as a compensatory relief to the effects of hypertension in the 
MHS.
7.2 Conclusions
Altered regulation of ACA has been identified in VSM from the SHR 
and MHS. Alterations in the levels of regulatory G-protein subunits 
were not observed in the SHR with respect to its controls; however, 
slight, but significant reductions in the levels of Gsa (both forms) 
and the p-subunit were observed in the MHS, and may contribute, 
albeit in a minor way, to its altered ACA. A substantial reduction in 
the level of G j 3 a  was shown in MHS VSMC membranes from both 
age-groups. If Ang n stimulates PLC via Gj3,  then this could be the 
reason for the blunted PLC activity in response to Ang n in MHS 
VSMC (Socorro et a/., 1 9 9 0 ) .  Also, as Gj3  has been implicated in the 
regulation of voltage-gated potassium channels (Yatani e ta /. ,  1 9 8 8 ) ,  
a reduced level of G j 3 a  may be linked to the altered transmembrane 
ion fluxes in MHS rats. It is possible that the activity of Gs is 
decreased in both the SHR and MHS, and data also suggest that 
changes may exist in the level/activity of the catalytic subunit of 
adenylyl cyclase. The stimulatory response of ACA to isoproterenol 
appears to be a consequence of p-adrenergic receptor number in the 
MHS, and this is probably also the case in the SHR. In adult rats, 
isoproterenol produced opposite responses in the SHR and MHS in 
comparison to their controls. This may re fle c t d iffe re n t  
pathogenetic mechanisms giving rise to hypertension in the two 
models.
It is worthy to note that similar studies using SHRs from  
different sources produced dissimilar results. Therefore, possible 
genetic heterogeneity with regard to SHRs (and WKY rats) from  
different suppliers must be borne in mind for future studies. Also, it 
is of interest to examine parameters at d ifferent stages in the 
development of hypertension, as age-related alterations may be
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revealed, such as age-dependent p-adrenergic receptor number in 
MHS VSMC membranes.
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